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ABSTRACT 
T cell leukemogenesis induced by slowly transforming retroviruses 1s a 
multistep process associated with a long latency period and clonal 
selection within the thymus. To circumvent the long time required for 
leukemia development, a Radiation leukemia vlfus (RadL V)-infected 
cell line, C 1-V l 3D, was investigated as a model for studying the 
oncogen1c process. This cell line was tested and shown to undergo 
progressive transformation when passaged serially through the 
thymus, allowing at each step a dissection of event(s) associated with 
multi-step carcinogenesis. On this basis, C 1-V l 3D was used as a model to 
elucidate the mechanism(s) contributing to oncogenic progression 1n 
T cell leukemia induced by retroviruses. 
Investigations into changes 1n C 1-V l 3D during intrathymic replication 
indicated that this cell line was capable of differentiation and 
expression of T cell surface antigens. This result supported several 
lines of evidence that progression 1n leukemia was often associated 
with a shift towards a more mature cell phenotype, despite the fact that 
the disease usually originated in an immature or stem cell population. 
Genetic changes associated with differentiation of C 1-V l 3D within the 
thymus may have involved proto-oncogenes associated with cellular 
growth and differentiation. 
Further retroviral events have been associated with the oncogen1c 
process, either through generation of more leukemogenic vnuses by 
recombination, or through disruption of cellular genes via proviral 
integration. Studies undertaken to determine if further retroviral 
events had occurred in C 1-V l 3D indicated that these events did not 
contribute to the emergence of progressively tumorigenic C 1-V l 3D at 
each intrathymic passage. 
Characterisation of cellular genes 1n the vicinity of retroviral 
integration sites 1n Cl-V13D was initiated with the objective of 
uncovering novel proto-oncogenes which may play a role 1n the 
transformation of precursor lymphoid cells . Several provnuses were 
found to be integrated into regions of DNA carrying repeat elements . 
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Some of these elements have been documented to encode proteins or 
have regulatory roles. In addition, they have been associated with 
many cancers as a result of their ability to retrotranspose. The 
frequent presence of repeat elements in the vicinity of proviral 
integration indicated that retroviral insertions in C 1-V 13 D may not be 
completely random. Repeat elements may play a significant role in cell 
transformation or oncogenic progression. 
A mouse flanking sequence adjacent to the 5'L TR in a provirus cloned 
from C 1-V l 3D was also characterised. Preliminary investigation has 
indicated that the expression of this gene is tissue specific in the adult 
mouse. Computational analysis revealed that this flanking sequence 
could encode a stretch of charged amino acid residues. Similar stretches 
of charged amino acids have been associated with proteins with 
regulatory functions. The cloning of a cDNA corresponding to this 
region from Cl-Vl 3D 1s proposed as a future strategy for more 
definitive characterisation. 
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CHAPTER 1 
General Introduction 
1.1 Discovery of the . murine leukemia . viruses 
It was only 1n 
established by Ludwick 
1951 that the viral etiology of leukemia 
Gross. He successfully induced leukemia 
was 
1n 
newborn C3H mice by inoculating them with cell-free extracts of tumour 
tissues from Ak mice (Gross, 1951 ). The murine leukemia viruses (MuL Vs) 
are now described as a large family of replication competent retroviruses 
endogenous to laboratory and wild mice. Leukemia induced by these viruses 
involves complex interactions between the virus and host which 1s 
dependent on both the host genetic constitution and the nature of the virus 
(Tsichlis & Lazo, 1991). 
1.2 Leukemia . viruses of the mouse 
Following the isolation of a leukemogenic virus responsible for 
spontaneous leukemia 1n an Ak mouse (subsequently designated the 
Passage A virus) (Gross, 1957), a number of other MuL Vs were also isolated 
(Schoolman et al., 1957; Friend, 1957; Graffi, 1958; Moloney, 1960; Liebern1an 
& Kaplan, 1959). Some of these, in particular the pathogenic recombinant 
MCF (Mink cell focus forming) viruses (Hartley et al., 1977; Chattopadhyay 
et al., 1982) and the defective BM5d murine acquired immunodeficiency 
(MAIDS) virus (Chattopadhyay et al., 1991), have been used extensively to 
study the mechanisms underlying the onset and development of murin e 
leukemia. 
Many attempts have been made to establish the relationship between 
various MuL Vs on the basis of host range, the type of leukemia induced and 
host immunological responses (Gross, 1964; Moloney , 1962; Rich et al., 1965; 
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Old & Boyse, 1965; Kaplan, 1967; Decleve et al., 1976, 1977 & 1978). Further 
studies have also been carried out to compare viral genomes by restriction 
endonuclease mapping and sequencing (Rassart & Jolicoeur, 1980; 
Shinnick et al., 1981; Chattopadhyay et al., 1982; Grymes et al., 1983; Wolff et 
al., 1983; Bestwick et al. , 1984; Aziz et al., 1989; Poliquin et al. , 1992). 
Differences 1n leukemogenic potential and tissue/cell tropism between 
MuL Vs and their variants have now been mapped to specific viral 
determinants like the LTR, env, gag or gag-pol genes (Lenz et al. , 1982; 
DesGroseillers et al., 1983 & 1984; Villemur et al., 1983; Janowski et al. , 1985 ; 
Rassart et al., 1988; Jolicoeur, 1991). 
This review will concentrate on munne T cell leukemogenesis 
induced by non-acute type C retroviruses. However, the issues discussed in 
the following sections, such as target cells for MuL V infection , 
chromosomal abnormalities and insertional mutagenesis will also relate to 
other munne leukemias and to other types of retrovirally-induced cancers . 
These have been included for discussion where necessary to illustrate some 
of the general concepts and principles relating to retroviral pathogenesi s . 
1. 3 Models for studying leukemogenesis and . oncogen1c 
. progression 
1.3.1 MuLVs as models 
Murine leukemia bears many clinical and morphologi cal 
similarities to leukemia observed 1n humans (Furth et al., 1935; Gross, 1983 ). 
As a result , MuL Vs have been used widely as convenient model s to elucidate 
the mechanism(s) underlying the development of spontaneous leukemi a 
(Dofuku, 1975 ; O'Donnell et al., 1984; Hays et al. , 1989 & 1990). MuL V models 
have also been useful in the study of tumour induction and progression 
(Haran-Ghera, 1976; Haas et al. , 1984; Tsichlis et al., 1985 ; Storch et al., 198 5; 
Davis et al. , 1987; Klinken et al., 1988 ; Bergeron et al., 1991). Non -oncogene 
bearing type C murine retroviruses such as the Moloney murine leukemia 
(MoMuL V) virus, which induce T cell leukemia, have been used extensively 
to identify novel cellular oncogenes involved in the different stages of the 
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tumorigenic process (Cuypers et al., 1986; Breuer et al. , 1989; Bear et al. , 
1989; Tsichlis et al., 1990). 
The Radiation leukemia viruses (RadL Vs) are also type C 
retroviruses which carry no host sequences or oncogenes. Isolates of 
RadL V have been used to infect and immortalise primary spleen cells in 
vitro (O'Neill, 1992). One cell line established using this procedure has been 
investigated here as a model for studying T cell leukemogenesis. The use of 
RadL V as the leukemogenic agent could provide a model for studying 
leukemogenesis since RadL V-induced leukemia resembles poorly diffuse 
human lymphocytic lymphoma in its generalised form. It also mirrors 
pnmary mediastinal lymphoma of childhood, 1n which massive 
enlargement of the thymus and its invasion of the mediastinum causes 
death pnor to generalized dissemination (Kaplan, 1977). The marked 
thymotropism of RadL V has indicated an important role for the thymus in 
the development of T cell leukemia (Miller, 1959; Haran-Ghera, 1966). 
Efficient replication of RadL V in immature thymocytes also makes this 
virus a useful tool for the study of intrathymic T-cell differentiation 
(Boniver et al., 1989). 
The RadL Vs are ecotropic viruses, which means that they can 
only replicate in the species of origin. They were first isolated from thymic 
tumours induced in C57BL/Ka strain mice following split dose whole body 
irradiation (Lieberman & Kaplan, 1959). The inconsistent presence of these 
viruses 1n radiation-induced lymphoma cells has challenged their 
involvement in the disease (Ihle et al. , 1976; Lieberman et al., 1979; Sankar-
Mistry & Jolicoeur, 1980; Yefenof et al., 1980; Rassart et al. , 1983; Janowski et 
al., 1986). Despite the possible lack of a common etiology, both RadL V and x-
ray irradiation have 
thymic lymphomas 
thymus (Kaplan, 
been 
after 
1967; 
observed to produce morphologically similar 
a lengthy process of clonal selection 1n the 
Yefenof et al., 1991 ; Kothler et al., 199 4). 
Leukemogenic isolates of RadL V have now been cloned from the BL/VL3 
cell line, which was established by Lieberman and colleagues ( 1979) from a 
RadL V-induced thymic tumour. They have been extensively characterised 
and found to be distinctly different from other MuL Vs and from other non-
leukemogenic type C viruses endogenous to C57BL mice (Dec.Ieve et al., 19 7 6 
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& 1978; Manteuil-Brutlag et al., 1980; Grymes et al. , 1983; Janowski et al. , 
1985). 
1.3.2 Use of special mouse strains 
Nude mice and severely immuno-deficient sc id mice have also 
proved useful as in vivo models for studying some human leukemias. 
Kamel-Reid et al. (1989) demonstrated that disease development following 
injection of a human lymphoblastic leukemic cell line into sci d mice was 
similar to that seen 1n children. This model could be used for studying 
disease progression and for testing new treatment strategies . Recently , 
transgenic mice have been used to study the mechanisms underlying 
disease progression and to devise new therapeutic approaches to disease 
treatment. For example, Metcalf and Rasko (1993) used GM-CSF (Granulocyte 
macrophage colony stimulating factor) transgenic mice to study the 
effects of GM-CSF on the FDC-Pl cell line, which is GM-CSF dependent. When 
inoculated with the GM-CSF dependent FDC-Pl cells , these GM-CSF 
producing transgenic mice die within 3 months from FDC-Pl overload 1n 
the lungs, liver, kidney, lymph nodes and spleen. This model lends itself to 
a re-evaluation of sustained GM-CSF administration to myelodysplastic 
patients with abnormal, potentially preleukemic granulocyte-macrophage 
populations. In cases like this, GM-CSF administration could lead to death , 
from accumulated pre-transformed or fully transformed leukemic cells . 
1.3.3 Cell lines as models 
The establishment of cell lines from tumours as experin1ental 
'tools' has been valuable in the study of the oncogenic process (Haas & 
Meshorer, 1979; Schwartz et al., 1986; Metcalf & Nicola , 1991; Zhang et al ., 
1993 ). Thymic epithelial or bone marrow culture systems have been used to 
study cellular interactions that are essential for both normal and tumour 
lines, as well as spontaneous transformation zn vitro (Nishi et al., 1982 ; 
Naparstek et al., 1986; Ogawa et al. , 1989). Using retroviral construc ts 
carrying oncogene(s) to infect hematopoietic cell s in vitro, it has been 
possible to investigate the mechanisms by which oncogenes mediate 
growth and differentiation of different hematopoietic cell types (Schwartz 
et al., 1986; Stapleton et al. , 1991 ; Bonham et al. , 1992 ; Chisholm & Symonds, 
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1992; Miller et al., 1992). By using cell lines as models , it has also been 
possible to demonstrate that growth factor independence in vitro is often 
parallelled by tumorigenicity development in vivo. Studies have indicated 
that this process 1s controlled by oncogenes (Sachs , 1978; Heldin & 
Westermark, 1984; Gordon et al. , 1985; Heard et al., 1986; Ikeda et al. , 1993 ) . 
The pnmary advantage of using cell lines as models for 
studying tumorigenicity is that it is possible to perform experiments under 
conditions defined by the investigator. Factors involved 1n multistep 
progression to neoplasia can be dissected and studied, either alone or in 
combination, under well defined conditions . While the study of oncogenes 
using cell lines may not exactly parallel neoplastic transformation in vivo, 
it does provide a convenient system which can be used to confirm events 
occurring in vivo. Since leukemogenesis involves a multitude of events , it 
is not hard to justify the use of cell line models, in the hope of analysing 
just one or a few steps in this complex process. 
1. 4 Cells susceptible to infection and neoplastic 
transformation 
The identification of the pnmary target cell type in many human 
leukemias 1s important 1n terms of disease association , progno sis and 
effective therapy (Campana et al. , 1987; Bassan et al. , 1992 ; Meng-er et al. , 
198 8). An analysis of human lymphoid leukemia cells by Greave s (198 2) 
using a panel of antibodies revealed that the majority of these cells closely 
resemble lymphoid precursor or progenitor cell s . Thi s support s the 
hypothesis that most leukemias originate from expans ion of immature 
lymphoid or stem cells. 
Similar efforts have al so been made to characteri se th e ce ll type 
susceptible to infection and initial neopla stic transformation 1n mun ne 
leukemias. Immature T cell precursors have been found to be prefe rred 
targets for MoMuL V transformation (Storch et al ., 19 85 ; Lazo et al. , l 9 9 0 ), 
while lymphomagenic MCF vlfu ses have been reported to se lec tivel y 
replicate in rapidly dividing immature lympho cy te s pre sent 1n the thymic 
cortex (Cloyd , 1983 ; O' Donnell et al., 1984 ). In the case of RadL V-induced 
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leukemia, many studies were also conducted to localise the site of initial 
transformation. The results remained controversial. Some groups have 
found potentially neoplastic cells (preleukemic cells) 1n the bone marrow 
(Haran-Ghera , 1980; N aparstek et al., 1986) while others have reported the 
presence of such cells in the thymus (Lieberman & Kaplan, 1966; Boniver 
et al., 1981; Cloyd et al., 1983). 
Studies carried out to identify target cells for RadL V infection have 
relied upon light and/or electron microscopy (Haran-Ghera et al., 1966 & 
1979; Carnes et al., 1968; Decleve et al., 1974 & 1975) , cell selection or 
depletion methods (Cloyd et al., 1983) and transplantation assays , in which 
RadL V-infected or X-ray-irradiated cells from the thymus or bone marrow 
were inoculated into susceptible hosts (Lieberman & Kaplan, 1966; Kaplan & 
Lieberman, 1976; Boniver et al., 1981). In situ studies on the location of 
infected cells, as well as transplantability of infected cells derived from the 
thymus and bone marrow have shown that although RadL V is capable of 
infecting many cell types in the fetal liver, lymph node , bone marrow , 
spleen and thymus, active viral replication only occurs 1n thymocytes 
which are at the earliest stage of T cell differentiation (Lieberman & 
Kaplan, 1976a). Recent data obtained from 1n situ hybridization 
experiments to detect viral transcripts has confirmed the susceptibility of 
the most immature thymocytes to RadL V infection (Boniver et al., 19 8 9). 
An 1ncreas1ng number of reports have documented instances 1n 
which leukemic cells from both human and mouse co-express markers 
normally restricted to a single cell lineage (Smith et al., 1983; Ha et al., 1984; 
Palumbo et al., 1984; Holmes et al. , 1986; Bassan et al., 1992; Bonham et al., 
1992; O'Neill, 1992; Defresne et al., 1993). This phenomenon has been termed 
'lineage infidelity' to reflect altered gene expression 
genetic misprogramming (Palumbo et al., 1984). This 
with studies by Greaves (1982) who used a panel 
brought about by 
concept contrasted 
of antibodies to 
demonstrate that leukemic cells were faithful with respect to cell lineage. 
The asynchrony of maturation-linked phenotype frequently observed 1n 
leukemic cells was proposed to reflect instead 'lineage pron1iscui ty'. This 
was attributed to transient-phase bipotential or multipotential progenitors, 
simultaneously expressing different lineage-related or unrelated markers, 
under maturation arrest (Greaves et al., 1986a). This alternative 
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explanation lends support to earlier evidence that immature or stem cells 
are the primary target cells for initial leukemic transformation. 
1. 5 Oncogenic . progression in T-cell leukemogenesis 
1.5.1 Preleukemic cell trafficking: The role of the 
thymic microenvironment 
The need for an intact thymus during development of 
spontaneous leukemia in AKR mice and in RadL V-induced T cell leukemia 
was reported by Metcalf (1962) and Kaplan & Lieberman (1976), 
respectively. This was consistent with earlier studies which demonstrated 
that thymectomy substantially reduced the development of leukemia 
(Kaplan, 1950; Miller, 1959) and that susceptibility to the disease could be 
restored by thymic grafts (Kunii et al., 1966). These studies do not exclude 
the possibility that cells could be infected elsewhere and subsequently 
migrate to the thymus for further transformation and disease progression 
(Asjo et al., 1985). While a variety of cell types are susceptible to infection, 
the strict tropism of RadL V for thymocytes, and the formation of 
exclusively thymic lymphomas by RadL V, suggest a unique thymic 
dependence. This dependence could have arisen from a combination of 
factors including viral tropism, the nature of the target cell and the 
specific interaction of RadL V and RadL V-infected cells with thymic stron1a 
or cellular elements. Thymic cellular elements have in fact been shown to 
stimulate the proliferation of leukemic T cell lines (Pinto & Rock, 1991) and 
to transform thymocytes in vitro in both the AKR and RadL V systems 
(Waksal, 1976; Haas et al., 1977, respectively). A close symbiotic relationship 
has also been demonstrated between neoplastic lymphoid cells, specialised 
thymic nurse cells (TN Cs) and stromal cell components (Hiai et al. , 19 8 1). 
These studies highlight the complexity of the leukemic 
process and accord with the view that the thymus plays a dominant role 1n 
T cell leukemogenesis. The thymus could allow transmission of 
leukemogenic viruses to susceptible thymocytes, produce factors needed 
for cell and viral replication (Schnittman et al. , 1991) or it could act as a 
safe, nurturing haven for preleukemic cells to survive, proliferate and 
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differentiate 1n the absence of a strong immune response (Werkele & 
Ketelsen, 1980; Nishi et al., 1982; Ezaki et al., 1991 ). The unique role of the 
thymus as an organ in which migrating, preleukemic hematopoietic cells 
can differentiate and progress to overt neoplasia 1s discussed 1n the 
following section. 
1.5.2 Differentiation as a mechanism for oncogenic 
. progression 
Non-acute munne type C retroviruses have been reported to 
influence cellular differentiation by modulating or modifying the 
response of infected cells to normal regulators (Lieberman & Sachs, 1977). 
The murine leukemia viruses Moloney, MCF and RadL V produce T cell 
leukemias which reflect more mature T cell phenotypes and show 
phenotypic heterogeneity indicative of different stages of T cell 
differentiation (Lieberman et al., 1979; O'Donnell et al., 1984; Yefenof et al., 
1991 ). Two explanations are possible: a) T cells at all stages of development 
are susceptible to infection and transformation by these vHuses or (b) 
these viruses transform immature T-cell progenitors , which then undergo 
further (possibly selective) differentiation 1n the thymus during 
oncogen1c progression. 
Numerous laboratories have produced indirect evidence 
supporting differentiation as an event intrinsic to the oncogen1c process. 
For example, O'Donnell and colleagues ( 1984) demonstrated that during 
leukemogenesis, one of the changes occurring 1n the late preleukemic 
period in AKR mice was the shift to a more mature phenotype. A few 
independent but related studies on intrathymic cellular interactions have 
also supported this observation. One example 1s the remarkable increase in 
the number of TNCs before or at the time of onset of spontaneous thymomas 
in BUF/Mna rats (Ezaki et al., 1991). These TNC populations were found to be 
hyperactive 1n their number and nursing capacity, resulting 1n an 
unusual increase m the number of Thy-1+ cos+ co4+ thymocytes. TNCs 
have been shown to be directly involved in T cell differentiation and 
maturation (Kyewski & Kaplan, 1982; De Waal Malefijt et al., 1986), and the 
presence of immature thymocytes within TNCs therefore relates to a 
critical stage of T cell differentiation . Using RadL V as a model, it was also 
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observed that the first RadL V-producing cells and the first leukemic cells 
were both located preferentially within TN Cs (Goffinet et al., 1983 ). These 
were identified using the marker for alkaline phosphatase. This 1s an 
enzyme expressed by cells at an early stage of T cell differentiation, such as 
lymphoblasts of the fetal thymus and lymphoid blast cells 1n close 
association with TNCs in the adult thymus. This data implied that the target 
cell population must undergo a critical differentiation step within the 
thymus in the natural progression to T cell leukemia. Earlier observations 
that immature cells are targets for infection and initial transformation 
(reviewed 1n Section 1.4 ), and that tumour cells continue to differentiate in 
vitro and zn vivo (Green et al., 1985; Lazo et al., 1990) are consistent with 
the view that differentiation in the thymus is an important event in the 
progression of T cell leukemogenesis. 
Recent evidence directly linking maturation events, 
increased tumorigenicity and disease progression was provided by Ishii 
and colleagues (1993) who reported the expression of CDlO by a leukemia 
cell line at the time of onset of dissemination of leukemia, using FACS 
analysis and PCR amplification. This correlated with progression of disease 
in sci d mice. CD 10 plays an undefined role in normal and malignant pre-B 
cell proliferation and differentiation (Law & Clark, 1994; Rosenberg et al. , 
1994) and is not expressed on pro-B cells. It is, however, expressed by pre-B 
cells. The induction of CD 10 could therefore indicate a further step along 
the differentiation pathway. Further supporting evidence was provided by 
Hibi and colleagues (1993) using a retroviral vector to introduce the v-Ha-
ra s gene into the non-tumorigenic FDC-Pl cell line. It was shown that 
infected FDC-Pl cells became not only tumorigenic but also showed 
increased monocytic differentiation zn vzvo. Differentiation and 
tumorigenicity in vivo was shown to correspond to an increase in activated 
ras gene expression. Although these cells displayed a more differentiated 
phenotype than the parental FDC-Pl cells, they did not undergo terminal 
differentiation, suggesting that the ras gene could be blocking 
differentiation at some later stage 1n the maturation pathway . The 
differentiation event which occurred was sufficient to further transform 
the cells and to confer tumorigenic capacity in vivo. 
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Alexander and colleagues ( 1992) demonstrated that karyotypic 
lesions were co-selected with differentiation in vitro and suggested that 
some of the genetic regions involved in transformation may exert a crucial 
regulatory role in growth and differentiation. However, it is also possible 
that not all changes are phenotypically detectable during the process of 
transformation, and that genetic events associated with growth and 
differentiation may take place without endowing the leukemic clone with 
an extrachromosomal 'product' which could serve as a qualitative or 
phenotypic marker to indicate their occurrence. The conclusion that can 
be drawn from these studies IS that the dysregulation underlying the 
emergence of a leukemic clone might be quite subtle, and intimately linked 
with the target cell's program for differentiation (Greaves, 1986b) . 
1.5.3 Involvement of cellular 
mutagenesis associated 
integration 
genes: insertional 
with retroviral 
Retroviruses exert mutagenic effects by integrating into the 
host genome, a natural step in the viral replication cycle. This process 
disrupts the host genome and may lead to misregulation of host genes by 
either activation or inactivation of a proto-oncogene (reviewed in Section 
1.5.5). Three mechanisms by which retroviral insertion can activate proto-
oncogenes have been identified. They are 3 'L TR promotion , 5'L TR 
promotion and enhancer insertion. In 3'L TR promotion , the provirus IS 
inserted at the 5' end of the proto-oncogene in the same transcriptional 
orientation as the gene. Transcription starts with the R and U5 regions of 
the 3' L TR and no other viral sequences are involved as they are largely 
deleted. In 5'LTR promotion, readthrough activation occurs and the 
oncogene transcripts usually contain viral leader sequences, since the 
5'LTR IS used to initiate transcription. Transcription therefore extends 
through the viral genome and through cellular sequences downstream of 
the insertion site. In enhancer activation, the orientation and positioning 
of the provirus IS immaterial. The activated proto-oncogenes produce 
transcripts identical in size to their normal counterparts since they are 
initiated from natural or cryptic promoters (reviewed by Kung et al. , 1991 ). 
1 0 
Murine leukemia virus-induced leukemogenesis has been described as a 
series of genetic events whereby cell populations with distinct proviral 
integrations are continuously selected. The insertion of a provirus in or 
near specific cellular DNA domains has also been shown to be an important 
mechanism for virus-induced leukemogenesis 1n chickens and mice 
(Hayward et al., 1981; Steffen, 1984; Cuypers et al., 1984; O'Donnell et al., 
1985). Cellular genes brought under the control of powerful regulators of a 
newly integrated virus can become misregulated. Recombination between 
viral and cellular genes can result in the latter becoming oncogenic. 
Proviral integration sites like pim-1 (Cuypers et al., 1984), pim-2 
(Breuer et al., 1989), Tpl-1 (Bear et al., 1989) and Tpl-2 (Patriotis et al., 1993) , 
int-1 and int-2 (Peters et al., 1986) appeared to be involved in various stages 
of oncogenic progression. A high frequency of proviral integration 1n the 
pim-1 region, for example, was observed to be associated with early T cell 
leukemogenesis (Cuypers et al., 1984). Insertion near the pim-2 locus was 
shown to be a late event in the development of MoMuL V-induced leukemia 
(Breuer et al., 1989). Provirus integration in Mlvi-4 by MoMuLV has been 
demonstrated to activate/affect expression of at least 3 genes, namely c -
myc, Mlvi-1 and Mlvi-4; the latter two by cis-acting mechanisms operating 
over long distances of the genomic DNA (Tsichlis et al., 1990; Lazo, et al., 
1990). 
T cell lymphomas induced by munne leukemia viruses often have 
several rearranged DNA domains due to independent proviral insertion 
events in the same tumour. These multiple integration events appear to be 
significant 1n oncogenes1s. van Lohuizen ( 1989) showed that MuL V-
infected transgenic mice (bearing the pim-1 putative oncogene) developed 
T cell lymphomas much faster than similarly infected non-transgenic 
mice. In addition, all T cell lymphomas studied had either an activated c -
myc or n - my c gene due to proviral insertion, indicating a strong 
cooperation between pim-1 and c-my c in lymphomagenesis. 
Similar synergism has also been demonstrated 1n rat thymic 
lymphomas induced by MoMuL V 1n which concomitant proviral 
integration in the Mlvi-1 and Mlvi-2 cellular DNA domains was observed 
(Tsichlis et al., 1985). Breuer et al. (1989) found that insertion near pim-2 , 
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which is a relatively late event in MoMuL V tumorigenesis , was also often 
preceded by proviral insertions in other common insertion sites such as c -
myc within the same cell. Concerted activation of the two proto-oncogenes, 
int-1 and int-2 in carcinomas induced by mouse mammary tumour viru s 
has also been found (Peters et al. , 1986). These studies indicate that 
synergistic events are important in oncogenic progression. Evidence such 
as this supports a multi-step model for leukemogenesis , in which each step 
requires activation of distinct cellular genes, with cooperation between 
oncogenes (Hunter, 1991 ) . 
Preleukemic and leukemic cell clones invariably undergo 
clonal selection in vivo as well as in vitro . Spontaneous viral re-
integrations frequently occur, leading to acquisition of new proviruses 
(Seigel et al., 1986, Cuypers et al., 1986, Bear et al. , 1989). These observations 
have been questioned with respect to the significance of proviral 
insertions at the later stages of oncogenesis. Studies by Cuypers and 
colleagues ( 1986) on MoMuL V-induced T cell lymphomas have indicated 
that clonal selection IS biased towards cells with further retroviral 
integration events. New integrations in the locus Tpl-1 and -2 (Tumour 
progress10n locus 1 & 2) at a late stage of oncogenesis were shown to confer 
growth advantage to affected cell clones over unaffected ones (Bear et al. , 
1989; Patriotis et al. , 1993). 
1.5.4 Retro viral recombination 
Recombination between retroviruses IS a frequent event 
observed after infection and integration into the host genome (Hu & Temin , 
1990). This event has been reported to contribute to the oncogeni c process. 
A case in point is the formation of tumorigenic MCF viru ses in the thymu s 
during the preleukemic phase In AKR mice (Hartley et al. , 1977 ) . The 
presence of these recombinant viruses has been found to accelerate the 
onset of spontaneous leukemia (Cloyd et al. , 1980; Difronzo & Holland , 1993 ). 
The virological events leading to the generation of thi s leukemoge ni c 
agent were recently mapped by Stoye and colleagues (1991 ). Thi s process 
was shown to be complex and precise , resulting In th e generation of 
recombinant viruses with a defined structure. In th e case of MoMuL V-
induced leukemogenesi s, it was al so demonstrated that during outgrowth of 
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the tumour, clonal selection of cells carrying a certain recombinant 
proviral structure occurred. This structure was found to be conserved 
among many individual proviral recombinants and was considered to be a 
prerequisite for the onset of neoplasia (van der Putten, 1981 ). 
MCF viruses generated by recombination have been shown to 
be leukemogenic in their own right. Homologous recombination between 
integrated proviruses can also result in chromosomal rearrangements. This 
has been reported for MoMuL V- and avian leukemia virus (A VL)-induced 
lymphomas (Lazo & Tscihlis, 1988; Ihle et al., 1989; Nottenburg et al., 1987). 
The resulting chromosomal aberrations were shown to contribute to 
tumour induction and progression. 
1.6 Role of oncogenes 
leukemia 
. 
ID multistep . . carc1nogenes1s and 
The association of oncogenes with proliferation and differentiation 
1s important in the context of normal development and in oncogenesis. As 
both proliferation and differentiation are closely linked events 1n a cell's 
developmental program, it is very likely that any alteration in one process 
will affect the other. 
A few studies have linked differentiation with proto-oncogene 
expression. Elevated expression of c-myb, for example, has been shown to 
prevent differentiation of Friend erythroleukemia cells after they were 
transfected with a myb expression vector (Clarke et al., 1988). Studies on 
the ra s and s r c oncogenes have also shown that they can suppress or block 
differentiation in a number of different cell types (reviewed by Boettiger, 
1989). The specific mode of action is not clearly defined, but could relate to 
the growth factor receptor or cell signalling, at least for the src oncogene. 
Recently, elevated levels of ra s expression have been associated with 
monocytic differentiation and tumorigenicity in vivo (Hibi et al. , 1993). 
Evidence supporting the involvement of oncogenes in tumorigenesi s 
has increased in recent years. For example, viral oncogene products have 
been found to share structural and functional similarities to growth factors 
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and their receptors. This was exemplified by the similarity between 
transforming protein p28SIS of simian sarcoma virus and the platelet 
derived growth factor, PDGF (Waterfield et al. , 1983 ). Some oncogenes 
encode growth factors while others encode products which are signal 
transducers [H-ras, c-mos , pim-1, v-src, v-abl] or nucleoproteins [c -m y c, 
c-jun, c-myb] (reviewed by Bishop, 1985; Butturini & Gale, 1990). The RB 
(retinoblastoma susceptibility gene) and the p53 gene represent a class of 
recessive oncogenes classified as tumour suppressor genes (Lee et al., 19 8 7 ; 
Donehower et al., 1992). Both are known to be involved in cell cycling and 
signal transduction pathways, and there 1s 1ncreas1ng evidence for their 
involvement in many cancers. 
Models have been constructed to study oncogene-driven tumour 
progression by introduction of exogenous oncogenes via either retroviral 
vectors or other forms of gene transfer into the cell. Their expression was 
then assayed during the course of transformation (Chisholm & Symonds, 
1992; Bonham et al., 1992; Hibi et al., 1993). The data indicated that elevated 
expression of oncogenes was associated with the tumorigenic process. One 
of the mechanisms by which expression of an oncogene could contribute to 
oncogenes1s was shown to be the induction of endogenous production of 
growth factors which could then stimulate the proliferation of the 
producer cell in an autocrine manner. 
could explain the transition from 
Autocrine-driven cell proliferation 
factor dependence to factor-
independence in some transformed cell lines. 
Insertional mutagenesis, point mutation, chromosomal translocation, 
deletion and amplification have been identified as some of the mechanism s 
by which cellular oncogenes can be misregulated during oncogenes1s. In 
particular, translocations between or within chromosomes, deletion and 
amplification of chromosomal domains and chromosomal loss or gain are 
common genetic changes that have been identified in leukemias (Rowle y, 
1976). Translocations affecting proto-oncogenes are common 1n human 
leukemias and some of these could be attributed to location at or near 
breakpoints or fragile sites m the chromosome. A well studied example 1s 
the c-myc gene, which has been shown to be consistently translocated to 
various immunoglobulin genes 1n Burkitt 's lymphoma (Leder et al., 19 8 3). 
Chromosomal abnormalities have also been linked to disease progression in 
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spontaneous AKR leukemias (Dofuku et al., 1975; Wakonig & Stich, 1960) and 
1n RadL V-induced lymphomas (Wiener et al., 1978). In these cases, trisomy 
of chromosome 15 (and also 17 in the case of RadL V) was the identified 
genetic lesion. Direct evidence that karyotypic lesions were associated with 
differentiation and tumour progression of an immature thymic tumour cell 
was recently demonstrated in vitro by Alexander and colleagues ( 1992). 
Their studies suggested that the chromosomal regions involved have an 
important regulatory role in cell proliferation and/or differentiation. 
1. 7 Concluding remarks and objectives of this study 
A feature common to many blood cell cancers is the uncoupling of 
normal proliferative and differentiative events, both of which are 
intimately linked in the cell's developmental program (Jacob, 1980). It has 
been shown that terminal differentiation 1n tumour cells such as 
teratocarcinomas, squamous cell carcinomas and myeloid leukemic cells 
can result in the reversal of malignancy and death of the cancer cell 
(Pierce & Wallace, 1971; Sachs, 1978; Jacob, 1980). In other cancers, further 
differentiative events have been associated with oncogen1c progression 
(Section 1.5 .2). Clearly the development of cancer is not the result of a 
single oncogenic event but rather a myriad of events which appear to 
proceed in concert 1n a step-wise fashion and which are likely to be 
influenced by the cellular microenvironment. 
The discovery of oncogenes and tumour suppressor genes and their 
functional characterisation have been extremely valuable 1n expanding 
our understanding of the molecular mechanisms underlying the oncogen1c 
process. Almost all cellular oncogenes identified so far are involved in cell 
development. The tumour suppressor gene, p53 1s also involved 1n 
regulation of the normal cell cycle. It plays a critical role in arresting the 
mitotic cell-cycle 1n response to DNA damage ans1ng from radiation or 
gene amplification. Mutation or loss of this gene results in loss of control, 
and cells continue in their mitotic cycle without DNA repair (Yin et al., 
1992; Livingstone et al. , 1992; Marx , 1994). 
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The objective of this study is to analyse oncogen1c progression 1n T 
cell leukemogenesis using a retrovirally-induced munne lymphoid cell 
line, Cl-Vl3D. This cell line was derived by in vitro infection of spleen cells 
with the thymotropic retrovirus, RadL V (O'Neill, 1992). These cells were 
shown to be capable of developing as a thymic lymphoma when injected 
intrathymically into mice. Using this cell line as a model, the nature of the 
target cell and genetic changes occurring during oncogen1c progression 
were investigated. The role of the thymus, virus-host interactions and 
significance of further retroviral events 1n the process of oncogenesis 
were assessed. An attempt was made to isolate and characterise cellular 
genes in the vicinity of retroviral integration by constructing a genomic 
library from Cl-V 13D. This was initiated with the objective of uncovenng 
novel cellular oncogenes which may play an important role 1n the 
transformation process. 
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CHAPTER 2 
Investigating 
• • progression 1n 
a 
T 
model 
cell 
for oncogenic 
leukemia induced 
by retroviruses 
2.1 Introduction 
Despite numerous studies conducted to elucidate the mechanisms 
governing the oncogen1c process, the factors which influence the 
proliferation of cells after infection with non-oncogene bearing 
retroviruses are still not fully understood. Most T cell leukemias and 
lymphomas induced by these slowly transforming viruses develop after 
a long latency period, and there is increasing evidence to indicate that 
the process of immortalisation and transformation of cells to neoplasia 
following infection involves sequential multi-step events (reviewed in 
Chapter 1). 
It has been shown that RadL V can infect and imn1ortalise 
lymphoid cells in vitro and that cell lines could be consistently derived 
within 8 weeks following infection (O'Neill, 1992). The use of established 
cell lines from lymphoid neoplasms as experimental 'tools' or models has 
provided many insights into the oncogen1c process (reviewed in Section 
1.3 ). This study was initiated to investigate the use of a RadL V-infected 
cell line, Cl-V13D, as an in vzvo model for studying oncogen1c 
progression in T cell leukemogenesis. Cl-V l3D was established following 
in vitro exposure of mouse spleen cells to RadLV (O'Neill, 1992). 
In this study, the capacity of C 1-V 13 D to grow in different 
microenvironments was tested in selected strains of mice , including 
syngeneic DBA/2j and allogeneic mice such as CBA/H, which do not 
carry any endogenous RadL V or RadL V-like viruses, and C57BL/6J mice , 
which are susceptible to the RadL V virus. RadL V is known to induce T 
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cell lymphomas after a lengthy selection process in the thymus (Kaplan 
& Lieberman, 1976; Yefenof et al., 1991; Kothler et al. , 1994). In an 
attempt to mimic this process, C 1-V l 3D cells were passaged serially 
through the thymus. At each passage, Cl-V13D cells were reisolated, 
subcloned and reinoculated into mice to test their ability to proliferate as 
a tumour in VlVO following inoculation via various routes. This 
procedure has been utilised as it circumvents both the long latency 
period required by these vuuses to induce leukemia in VlVO and the 
added difficulty of establishing cell lines from RadL V-induced thyn1ic 
tumours in vitro for future study. In this model, cell lines were tested for 
development of a more tumorigenic phenotype as an indication of 
oncogen1c progression (Duhrsen & Metcalf, 1988; Yefenof et al. , 19 91) . 
This was manifested as increased ability to kill the host, irrespective of 
strain and route of inoculation, as well as ability to metastasise and grow 
subcutaneously. 
2. 2 Materials and methods 
2.2.1 Origin and maintenance of cell lines 
Details regarding the derivation of the C 1-V 13 D cell line 
and isolation of V 13, a cloned full length RadL V, have been described 
previously (O'Neill, 1992; Rassart et al., 1986). Cl-V13D originated from a 
DBA/2j mouse and was shown to have a unique hematopoietic phenotype 
resembling a precursor lymphoid cell (O'Neill, 1992). Sub lines of C 1-V l 3D 
were isolated from thymic tumours which developed following 
intrathymic injection of Cl-V l3D cells. They were cloned twice by limit 
dilution plating and maintained 1n supplemented Dulbecco 's Modified 
Eagle Medium (sDMEM) containing 0.4% D-glucose, 0.006% Folic acid, 
0.36% L-asparagine, 0 . 116% L-arginine hydrochloride, 0.015% 
L-glutamine, 0.2% sodium bicarbonate, O.OlM Hepes, O.IM 
2-mercapthoethanol, 0.2U/ml penicillin, 0.2mg/ml streptomycin and 
10% foetal calf serum. Cells were passaged twice a week. 
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2.2.2. Mice 
Mice of 4 to 8 weeks old were used in all experiments. They 
were bred under specific pathogen-free conditions 1n the John Curtin 
School of Medical Research, Canberra, Australia . 
2.2.3 Electron . microscopy 
Cells (106) were prefixed for 2 hours using 2% 
glutaraldehyde (LADD, Australia) 1n O. lM cacodylate buffer/pH 7 .4 , 
washed thrice with O. lM cacodylate buffer and post-fixed for 90 minutes 
at 40c in 1 % osmium tetroxide. They were then stained en bloc in 2% 
urany 1 acetate in water for 2 hours, washed thrice with water and 
dehydrated 1n increasing concentrations of alcohol. Infiltration with 
Spurr's resin (All-Tech Agar, Australia) mixed with alcohol (50 : 50) was 
carried out for 4 hours, followed by infiltration with 100% resin 
overnight. A further infiltration was carried out with fresh resin for 
another 4 hours, after which the tissue or cells were embedded in 100% 
fresh resin overnight at 70°C. Ultra thin sections (50nm-70nm) were 
stained with lead citrate (2.6% lead nitrate, 3.5% sodium citrate, 0.16M 
sodium hydroxide) for 10 minutes. Sections were viewed under an 
electron microscope (Philips, Model 301, Netherlands). 
2.2.4 Fluorescent Activated Cell Sorter (FACS) 
analysis 
The method for immunofluorescent staining of cells for 
FACS analysis was adapted from Coligan et al. (1992) with modifications. 
Briefly , 106 cells were incubated with specific antibody at 4°C for 30 
minutes, washed thrice with sDMEM containing 0.1 % sodium azide and 
then absorbed, as appropriate, with fluorescein isothiocyanate (FITC)-
coupled sheep anti-rat lg , goat anti-hamster lg or sheep anti-mouse lg 
(Serotec, Australia), for another 30 minutes at 4° C. Cells were washed 
thrice with medium , followed by one wash with phosphate buffered 
saline (8% NaCl, 1.25 % Na2HP04.2H20, 0.4% NaH2P04.H20) and 
resuspended in fixative (1 % paraformaldehyde in normal saline/pH 7.4). 
Stained cells were kept in the dark at 4°C and analysed within 48 hours. 
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Fluorescence was measured either on a FACS IV or a FACSCAN instrument 
(Becton Dickinson, Mountain View, CA) using standard filters. Data was 
analysed using either WEFCS software (Frank Battye, WEHI , Australia) or 
Winlist (Verity House Software, USA). Saturating concentrations of 
antibody were used to analyse determinant expression. Median channel 
number was used as a measure of determinant expression. The antibodies 
and reagents used for flow cytometry were: A T83 , a rat IgM specific for 
Thy 1.2 from R. Ceredig; GK 1.5, a rat IgG2 b specific for CD4 from P. 
Marrack; 53-6.7, a rat anti-CD8 IgG2a from J. Ledbetter; IM7.8.l , a rat 
IgG2b specific for CD44 from I. Trowbridge; 145-2Cl 1, a hamster antibody 
specific for CD3-E from J. Bluestone; H57-597, a hamster antibody specific 
for TCR-a~ from R. Kubo; 34-1.2, a mouse IgG2a specific for H-2Kd from 
D. Sachs; RA3-6B2, a rat anti-B220 antibody from R. Coffman; l98D , a rat 
antiserum raised against C5 8NTD tumour which reacts with all MuL V 
proteins including gp70 from I. Weissman; Ml/70, a rat antibody specific 
for Mac-1 from D. Hume; 30H-l 2, a rat IgG2 b specific for Thy 1.2 
purchased from Becton Dickinson (Mountain View, USA); F23. l, a mouse 
IgG2a specific for TCR-V~s.1 ,8.2 ,8.3 from M. Bevan. All monoclonal 
antibodies were prepared as hybridoma culture supernatants and 
concentrated where necessary by ammonium sulphate precipitation. 
2.2.5 Preparation of a virus containing cell-free 
extract from Cl-V13D 
Virus was prepared as a cell-free extract by freezing 
C 1-V 13D cell cultures at -70° C and rapid thawing. This procedure was 
repeated thrice. The extract was centrifuged at 2000 x g for 30 minutes at 
4 ° C to remove cell debris and the virus-containing cell-free supernatant 
was stored at -70°C in small aliquots. 
2.2.6 Intrathymic injections 
Four-week-old CBA/H , DBA/2j and C57BL/6J mice were 
sublethally irradiated (4Gy, cobalt source) and three hours later 
anaesthesized with a mixture of 2mg/ml Ketamine (Parnell Laboratories , 
Australia) and lOmg/ml Rompun (Bayer, Australia) 1n 0.2ml normal 
physiological saline. A small longitudinal midline incision was made in 
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the skin and through the sternum sufficient to expose the thymus. Cells, 
virus or medium ( 10µ 1) was injected into one lobe with a 36G needle 
affixed to a glass Hamilton syringe and the incision was sutured after 
expelling au from the thoracic cavity by gentle pressure on the upper 
abdomen. Mice usually recovered within a day and were given antibiotic 
water containing Polymyxin B sulphate ( 106 U/L; Sigma, USA) and 
Neomycin sulphate (l. lg/L; Sigma, USA) for two weeks. Controls included 
unirradiated mice injected with virus and irradiated mice injected with 
medium. Animals were sacrificed and autopsied at vanous times after 
surgery or when symptoms of disease were apparent, 1.e. ruffled fur, 
hunched posture, laboured breathing and weight loss . Thymic tumours 
were explanted and processed for FACS analysis or establishment of in 
vitro cultures. 
2.2.7 Processing of exp/anted thymic tumours 
Thymic tumours were removed under sterile conditions and 
rinsed 1n sDMEM. Single cell suspensions were prepared by gently 
pressing the tumour against a fine wire-meshed sieve. The cells were 
washed twice with sDMEM, resuspended in growth medium and cultured 
in 25cm2 disposable tissue culture flasks (Corning Glass Works, USA). 
Autonomously growing cells were subcloned twice using limit dilution 
plating. 
For histological analysis, thymic tumours were fixed in 
formalin/saline immediately upon removal, embedded in paraffin wax 
and sectioned. The sections were stained using Haematoxylin and Eosin 
(H&E) . 
2.2.8 Southern analysis 
2.2.BA Preparation of genomic DNA 
DNA was prepared according to Blin & Stafford (1976). Cell s 
( 1 o9) were washed thrice with phosphate buffered saline, re suspended 
in lysis buffer (0.2M Tris, 0.2M EDTA, 1 % sodium N-lauroyl sarcosine) 
containing 0.1 % freshly prepared Proteinase K and incubated at 50° C for 
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6-8 hours. Five mis of TE buffer (0.01M Tris/pH 7.4, 0.001M EDTA/pH 8.0) 
was then added and the DNA was kept at 4°C. Processing involved the 
extraction of DNA twice with an equal volume of TE-saturated 
phenol:chloroform:isoamyl alcohol (24: 1: 1), followed by extraction with 
chloroform. Five mis of lOM ammonium acetate was added and the DNA 
was precipitated by adding an equal volume of isopropanol. The DNA 
pellet was washed twice with 95 % ethanol, dried 1n a rotary concentrator 
(Speed Vac, model #lOOH, Savant Instruments, USA) for approximately 
15 minutes. The pellet was dissolved in 500µ1 TE buffer at 4°C overnight. 
2.2.8B Endonuclease restriction and agarose gel electrophoresis 
DNA ( lOµg) was restricted using enzyme concentrations of 
< 4U/µg DNA for 4 to 16 hours under optimal conditions (as recommended 
by the supplier). The DNA was resolved by electrophoresis 1n agarose 
(Type II, Sigma, USA). Prior to loading, DNA samples were mixed with 
sample loading buffer (0.01 % Bromophenol Blue, 38 % sucrose, 0.067M 
EDTA/pH 8.0), heated for 10 minutes at 65°C and chilled briefly on ice. 
The gels were run at a constant voltage of between 25 and 30 volts for 
18-24 hours using T AE (0.04M Tris , 2.3% glacial acetic acid, 0.02M 
EDTA/pH 8.0) as electrophoresis buffer. 
2.2.8C Transfer of DNA to membranes 
Fractionated DNA was transferred by capillary action from 
agarose gels to Hybond-N+ membranes (Amersham, Australia) using 
0.4M NaOH (Reed & Mann, 1985). Transfer time varied between 6 to 16 
hours. Gels were soaked for 10 minutes in 0 .25M HCl and rinsed briefly 1n 
d d H 2 0 before transfer. After DNA transfer , membranes were rinsed 
briefly in 2XSSC (0.3M NaCl , 0.03M tri-sodium citrate/pH 7.0), vacuum 
baked for 2 hours at 80°C and stored dry between sheets of 3mm Whatman 
paper in sealed bags at -20°c. 
2.2.8D Synthesis of 32p_/abelled probes 
DNA probes were made using purified inserts as templates 
by the random priming method (Feinberg & Vogelstein, 1983) using 
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[a32p]-dCTP (3000Ci/mmol specific activity; Amersham , Australia). For 
labelling purposes, up to 100µ Ci of the radiolabel was used per 1 OOng of 
template DNA. The insert was boiled for 5 minutes, chilled immediately 
on ice followed by the addition of [a32p]-dCTP and 12.4µ1 of LSB buffer, 
containing 11.4µ1 LS mix and 1µ1 BSA (lOmg/ml). LS mix was prepared by 
combining 25 parts IM Hepes/pH 6.6, 25 parts DTM solution (lOOµM each 
of dATP, dGTP, dTTP [Pharmacia, USA], 0.25M Tris/pH 8.0 , 0.05M 
2-Mercaptoethanol, 0.025M MgCl2) and 7 parts OL solution [lmM Tris/pH 
7.5, lmM EDTA, 90 OD/ml oligo-deoxyribonucleotides (Hexamers-pd(N)6; 
Pharmacia, USA)]. Synthesis was carried out at room temperature for 
6-18 hours using 5 Units of DNA Polymerase I , Kienow fragment 
(Pharmacia, USA). Unincorporated label and nucleotides were separated 
from the labelled product by passage through a Sephadex G-50 column 
using STE buffer (0.01M Tris/pH 7.4, 0.59% NaCl, 0.001M EDTA/pH 8.0) as 
eluant. A specific activity of lxI07 to 5xI07 cpm/µg of template DNA was 
routinely achieved. 
2 .2 .BE Detection of specific nucleic acid sequences 
Both pre-hybridisation and hybridisation reactions were 
carried out in glass roller bottles at 42°C in a hybridisation oven (Hybaid 
Oven Model "Maxi-14"; Integrated Sciences, Australia) for 16-18 hours. 
Prior to hybridisation with labelled probes, blots were pre-wetted with 
2XSSC and then equilibrated with pre-hybridisation cocktail comprising 
50% Formamide, 3XSSC, 1 % SDS, lOX Denhardt solution [0.01 % Ficoll 400 
(Pharmacia, USA), 0.01 % Polyvinyl Pyrrolidone (BDH Laboratory 
Reagents, Australia), 0.01 % BSA] and O. lmg/ml salmon sperm DNA (Type 
III; Sigma, USA). The cocktail was removed and replaced with 
hybridisation cocktail (50% Formamide, 3XSSC, 1.5 % SDS , lX Denhardt 
solution, 9.9% dextran sulphate [Sigma, USA]) containing heat denatured 
32P-labelled probe (boiled for 5 minutes) at 5x106 to 107 cpm/ml. Blots 
were washed under conditions of high stringency, ie . twice with 
2XSSC/0.1 % SDS for 10 minutes at room temperature and then twice with 
0.2XSSC/0.5 %SDS for 15 to 20 minutes at 65° C. Specific signal s were 
visualized by exposure for an appropriate time to X-ray film (RP X-Omat ; 
Kodak, Australia) at -70°C with intensifying screens (Dupont, USA). Blots 
were stripped twice with boiling buffer (0.01M Tri s, O. lmM EDTA , 0 .023% 
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SDS/pH 8.0) after use and stored in sealed bags at -20° C. For reprobing, 
blots were returned to room temperature and soaked briefly 1n 2XSSC 
before pre-hybridization. The Va. 3 probe used in this study was derived 
from the C6VL/1 lymphoma cell line. It 1s a 468 bp fragment derived 
from the 5' end of the Vo.3 cDNA to the ApaLI site. It is a new member of 
the Va. 3 family and was cloned by Dr. Chris Jolly in this laboratory into a 
p GEM R plasmid vector (unpublished results). 
2.2.9 Statistical methods 
The Wilcoxon Rank Sum Test ( 1-sided) has been used to 
determine statistical significance. This analysis uses ordering of the 
actual times to death and therefore takes into account all information on 
survival, 1e. time and mortality. The analysis was performed by Dr. 
Terence J. O'Neill from the Statistical Science Program, Centre for 
Mathematics and its Applications, Australian National University, 
Canberra. 
2.3 Results 
2.3.1 Characteristics of Cl-V13D by electron 
microscopy and F ACS analysis 
C 1-V l 3D cells are factor-independent, grow autonomously 
1n culture and attach loosely to the surface of the flask. Unlike plasma 
and epithelial cells (Wheater et al., 1987), Cl-V 13D cells have essentially 
little or no endoplasmic reticulum. Instead the cytoplasm is filled with 
numerous free ribosomes and enlarged mitochondria. Electron 
micrographs of Cl-Vl 3D in comparison to a normal thymocyte are shown 
1n Fig. 1. The cells are approximately 2-3X larger than normal 
thymocytes with chromatin arranged 1n a thin perinuclear fashion in 
the large euchromatic nucleus. There 1s little evidence of virus being 
produced although Cl-Vl3D carnes full length integrated ecotropic 
RadLV-like viruses (Fig. 3, Chapter 4). 
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a) 
b) 
Fig. 1 Transmisson electron micro graphs of (a) C 1- V l 3D 
and (b) a normal thymocyte. Cl-V l 3D cells are 2-3X larger 
than normal thymocytes and the cytoplasm is filled with 
numerous ribosomes and mitochondria. Chromatin 1s arranged 
in a tightly packed fashion along the nuclear membrane. 
The phenotype of C 1-V l 3D, as determined by a panel of 
monoclonal antibodies and antisera against lineage specific 
determinants, is summarised in Table 1. The phenotype is confirmed in 
this study to be Thy-1.2- co4-;g- CD3-£- TCR-a.~- Mac-1-, with high 
expression of CD44, B220, NK 1.1, T200 and the H-2Kd MHC class I molecule, 
as reported by O'Neill (1992). Cl-V13D cells also express high levels of the 
MuL V envelope gp70 protein. In contrast, thymocytes do not express 
B220 , and CD44 is expressed by only a small percentage of thymocytes in 
both DBA/2j and CBA/H mice. All DBA/2j thymocytes, but not CBA/H 
thymocytes, strongly bound the 34-1.2 antibody specific for H-2Kd (Table 
1). 
2.3.2 C 1-V 13D cell-free extract contains a 
leukemogenic agent(s) 
The cell-free extract of Cl-V13D was found to be highly 
leukemogenic when inoculated intraperitoneally into newborn 
C57BL/Ka mice. Approximately 85 % of inoculated animals developed 
thymic tumours with an average latency period of 12.2 months (Table 2). 
This suggested the presence of a thymotropic agent. In contrast, this 
same extract was only weakly leukemogenic when inoculated 
intrathymically into irradiated adult CBA/H mice. Only 2 out of 15 mice 
succumbed to disease and death at 11 and 12 months post-infection. In 
both cases, enlarged livers and spleens were observed in the absence of 
any thymic tumours. Adult CBA/H mice were relatively resistant to 
infection by RadL V. In comparison, the transfer of C 1-V l 3D cells 
intrathymically gave nse to thymic tumours within 2 to 3 weeks . 
Survival time was therefore significantly greater for mice inoculated 
with the cell-free extract from Cl-V13D than age-matched mice 
inoculated with Cl-V13D cells (Tables 2 & 3; p=7.77x1Q-6). It was therefore 
very unlikely that these thymic tumours were of host ong1n , ans1ng 
secondarily as a result of virus transferred from Cl-Vl 3D. 
2.3.3 Growth capacity of Cl-V13D . in . vivo 
Cl-V13D (5 x 105) cells were inoculated into vanous strains 
of mice and via various routes. In DBA/2j mice , enlargement of the 
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TABLE 1 Phenotype of Cl-Vl3D compared with thymocytes from CBA/H and DBA/2j mice 
Controls 
Cl -Vl3D 
CBA/H thymus 
DBA/2j thymus 
l 98D 
MuLV 
52 
5 
5 
AT83 
Thyl.2 
97 
90 
GKI.5 
CD4 
53-6.7 
CD8 
10/66 21/97 
36/92 63/131 
Antibody binding {Median Channel Number by FACS analysis) 
IM7.8.1 
CD44 
55 
-/22 
-/3 6 
145-2Cl 1 H57-597 
CD3-£ TCR-a~ 
21/82 18/7 4 
4 2/ 11 9 15/91 
34-1.2 
MHC Class I 
85 
63 
RA3-6B2 
B220 
40 
PK136 
NKl.l 
4 1 
20/66 
M 1/70 
Mac-1 
ND 
ND* 
300-12 
T200 
53 
-/ 1 1 7 
-/ 122 
F23.l 
TCRv~8.l, 8.2, 8.3 
-/46 
-I 5 1 
Numbers represent specific fluorescence values after subtracting background binding. To determine background binding, sDMEM was used in place of 
specific antibody. When 2 values are shown, these represent the two major thymic subsets with different levels of determinant expression. Channel shifts 
of < 4 are considered as background staining and are presented as "-". 
*Bone marrow, used as a positive control, resulted in a median channel shift of 123. 
ND: Not done 
TABLE 2 Leukemogenicity of virus present in a cell-free 
extract of Cl-V13D 
Mouse strain Age 
C57BL/Ka newborn 
CBA/H adult 
Inoculation 
route 
Ip 
it 
Tumour 
incidence 
2/15 a* * 
Time to death 
(months) 
9,10,11,12,13,18 
11, 12 
A cell-free extract (10µ1) of Cl-V13D cells was tested for the presence of 
leukemogenic virus(es). 
* Only thymic tumours were observed. 
** Enlarged livers and spleens were observed. 
a Statistically significant (p<O .019 3) 
spleen, liver and sometimes the lymph nodes occurred following 
intraperitoneal (i p), intravenous (iv) or subcutaneous (sc) inoculation. 
Irradiation was found to significantly shorten survival time of 
syngene1c DBA/2j mice inoculated with Cl-Vl3D by each of these routes. 
C 1-V l 3D cells were unable to grow subcutaneously 1n unirradiated 
DBA/2j mice (Table 3). 
Cl-Vl3D was not tumorigenic 1n two allogeneic mouse 
strains tested, namely C57BL/6J and CBA/H, when inoculated via the 1p , 
sc or 1v routes. In contrast, Cl-Vl3D cells had the specific capacity to 
grow as a thymic tumour when inoculated directly into the thymus of 
irradiated allogeneic CBA/H (Table 3) or C57BL/6J x CBA/H(Fl) mice (data 
not shown). Irradiated 4 to 5 week-old mice died from massive thymic 
tumours occurring within 2-3 weeks post-inoculation (Fig . 2) and with 
an incidence of 80% in CBA/H mice. The incidence was significantly 
lower in C57BL/6J x CBA/H(Fl) mice (p<0.00549; data not shown). This 
could reflect the involvement of H h (hybrid histocompatibility ) gene s 
(Cudkowicz et al., 1983). No other organs or lymph nodes appeared to be 
involved. The lethal dose of cells was determined at 5x I o4 _IO 5 cells , with 
the incidence of tumour formation decreasing with age (data not 
shown). No deaths were observed 1n unirradiated mice whichever the 
route of inoculation (Table 3). 
2.3.4 Thymic tumours were identified as lymphomas 
by histology 
Thymic tumours ans1ng from intrathymic inocul tion of 
Cl-Vl3D lacked the clear cortex/medulla delineation of normal thymus. 
Foci of necrosis were also observed and there was a noticeable absence of 
normal lymphocytes. The cells that made up the tumour were identified 
as lymphoblasts, indicating that the tumour was a lymphoma. A section 
of a thymic tumour, which developed fallowing inoculation of C 1-V l 3D 
cells, is compared with that of a normal CBA/H thymus in Fi g. 3 (H&E 
staining ). 
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TABLE 3 Tumorigenicity of Cl-Vl3D 
. 
Ill mice 
Strain intraperitoneal 
I UI 
DBA/2j 3/3 2/3 
(14, 15[x2])a (2 l ,25)a 
CBA/H 0/3 0/3 
C57BL/6J O / 3 0/3 
Mortality and time to death (days) 
intravenous 
I 
3/3 
(13,14[x2])b 
0/3 
0/3 
UI 
2/3 
(2 l ,49)b 
0/3 
0/3 
subcutaneous 
I 
3/3 
(22,25,28)C 
0/3 
0/3 
UI 
0/3C 
0/3 
0/3 
intrathymic 
I 
2/2 
(13,15) 
12/15 
(13,14[x7], 
16[x2],21[x2]) 
NT 
UI 
2/2 
(14,33) 
0/5 
NT 
Deaths were scored for up to 5 months following inoculation of 5xl o5 C 1-V 13D cells. Four week-old mice were used . 
NT: Not tested 
I: Irradiated, whole body ( 4 Gy) 
UI: Un irradiated 
a,b ,c Statistically significant at the 5 % level by the Wilcoxon Rank Sum Test (I-sided) 
Fig. 2 Typical thymic tumour present m a CBA/H mouse 
inoculated intrathymically with 5x105 Cl-Vl3D cells. No 
other organs appeared to be involved. 
a) b) 
Fig. 3 Haematoxylin & Eosin stained sections of a normal thymus and a thymic lymphoma which developed following 
inoculation of C 1-V l 3D cells. 
a) The corticomedullary junction of a normal thymus showing small numbers of lymphoblasts (arrowed) scattered amongst 
the smaller lymphocytes in the cortical region. 
b) A typical thymic lymphoma showing the large lymphoblasts which make up the bulk of the tumour. Little or no normal 
lymphocytes were observed. 
(Magnification: 650X) 
2.3.5 Cell lines derived from explanted 
tumours phenotypically resembled 
thymic 
Cl-V13D 
Autonomously replicating cells could be isolated from 
thymic tumours within 2 days of in vitro culture. These were subcloned 
twice prior to cell surface marker analysis by flow cytometry . All 
sublines isolated this way were found to have the same cell surf ace 
phenotype as C 1-V l3D. Data obtained from 4 pnrpary clones, each 
isolated from a different thymic lymphoma is shown in Table 4 . All 
clones remained Thy-1.2- co4-;g - CD3-€- TCRa~- and expressed high 
levels of B220, CD44, RadLV gp70 envelope protein and the Class I H-2Kd 
epitope, indicating their clonality and donor origin . 
2.3.6 Increased tumorigenic potential of Cl-V13D 
cells following thymic residence 
Clones isolated from thymic lymphomas following one 
intrathymic passage into CBA/H mice and which phenotypicall y 
resembled the parental C 1-V l 3D were found to be more tumorigeni c 
when injected back into irradiated CBA/H mice (Table 5) . Mortality 
ranged from 33 % to 100% for different clones . Mice injected 
intraperitoneally died with liver and gut lesions (Fig. 4a), and 
phenotypically similar cells could be re-isolated from the ascitic fluid of 
these animals (data not shown) . Enlarged spleen , lymph nodes and liver, 
with tumour cells infiltrating into the liver were observed in all mice 
inoculated intravenously (Fig . 4b). The thymus was regressed 1n both 
cases. Subcutaneous inoculations did not produce an y local or 
generalised tumours . 
The tumorigenic potential of Cl-V13D was ob served to 
increase further with serial passage through the th ymu s. Th is was 
demonstrated using ET4-D , a subline cloned from th e T4 th ymic 
lymphoma (Table 4). Serial passage involved the re-i solation of a single 
clone after each passage , phenotypic characterisation by FACS anal ys is, 
and injection back into the thymus. The second and third passage clones 
have been named ET4-D (Tl-E) and ET4-D(Tl-E)M7A , respective ly. The 
origin of these cloned lines was confirmed as Cl-V l3D by thei r dis tinct 
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TABLE 4 Phenotype of autonomously replicating cell lines islolated from four different 
primary thymic tumours 
Antibody binding (Median Channel Number by FACS analysis) 
Tumour 
(clone) 
Tl(ETl-A) 
T2(ET2-D) 
T3(ET3-B) 
T4(ET4-D) 
Control 
thymocytes 
Host 
strain 
CBA/H 
CBA/H 
CBA/H 
CBA/H 
CBA/H 
,. ,. 
l 98D 
MuLV 
39 
45 
49 
49 
-
AT83 
Thyl.2 
-
-
-
-
............ 
95 
GKl.5 
CD4 
-
-
-
-
15/7 3 
,. ... ,. ,.,. ..... ,.,. .,,.,.,.,. 
53-6 .7 IM7.8.1 
CD8 CD44 
- 43 
- 43 
- 49 
- 49 
. .. ,.,. 
16/95 1 3 
145-2Cl 1 H57-597 
CD3-E TCR-a~ 
- -
- -
- -
- -
......... 
21/92 18/71 
.... 
34-1. 2 
MHC Class I 
ND 
63 
85 
83 
Numbers represent specific fluorescence values after subtracting background binding, as described in Table 1. 
Channel shifts of < 4 have been considered as background staining and are presented as " " 
ND: not determined. 
RA3-6B2 
B220 
ND 
45 
50 
43 
TABLE 5 Increased tumorigenicity of Cl-V13D clones following 
intrathymic replication 
% mortality (time to death, range m weeks ) 
Tumour clones* intraperitoneal intravenous subcutaneous 
Tl ETl-A 100 (2-3) 33 (3) 0 
Tl ETl-C 33 (8) 33 (7) 0 
Tl ETl-D 100 (4-6) 0 0 
T2 ET2-D 66 (3) 33 (2) 0 
T3 ET3-B 66 (2-3) 66 (2) 0 
T4 ET4-D 33 (2) 100 (2) 0 
Cl-V13D 0 0 0 
Tl, T2, T3 and T4 are different thymic tumours ansmg from the first intrathymic 
passage of C 1-V l 3D cells into irradiated CBA/H mice. 
* Clones were isolated after in vitro culture and limit dilution cloning of thymic tumours. 
To test for tumorigenicity, 5x 1 o5 cells of each cloned line were inoculated into 4-week 
old irradiated (4Gy, cobalt source) CBA/H mice. 
Fig. 4 C 1-V 13D cells acquired increased tumorigenic potential following 
intrathymic growth. Typical lesions resulting from inoculation of a clone 
derived from Cl-V13D into 4Gy irradiated allogeneic CBA/H mice are shown. 
a) Intraperitoneal inoculation 
Infiltration of tumour cells 
into the gut and liver was 
observed as white patchy 
growths. The thymus was 
extremely regressed. 
b) Intravenous inoculation 
Infiltration of Cl-V13D cells 
into the enlarged liver was 
evident as white nodules. 
The submaxillary and inguinal 
lymph nodes were also enlarged. 
The thymus was extremely 
regressed. 
RFLP (Restriction Fragment Length Polymorphism) pattern at the TCRa 
locus, which is different in the CBA/H host strain (Fig. 5). The passage of 
these cells through the thymus gave nse to cells of 
. . 1ncreas1ng 
tumorigenic potential. The pnmary clone, ET4-D, was significantly more 
tumorigenic than Cl-Vl3D by the intravenous route and the second 
passage clone, ET4-D(Tl-E), was significantly more tumorigenic than 
Cl-Vl3D by the intraperitoneal route (Table 6). By the third passage, 
several subcutaneous tumours were observed at or near the site of 
inoculation, indicating proliferation of Cl-V l 3D cells and some degree of 
metastasis. Subcutaneous growths were not observed with the primary 
(ET4-D) or secondary clones (ET4-D[Tl-E]) throughout this period of 
study. 
2.4 Discussion 
The capacity of C 1-V l 3D to grow only in the thymus of allogeneic 
CBA/H mice suggests an important role for the thymus in the oncogen1c 
progression of a RadL V-infected cell line. By using the allogeneic CBA/H 
model, Cl-V13D cells could be distinguished clearly from host thymocytes 
by cell surface marker expression and also by the different RFLP pattern 
at the TCR-a locus, using Southern analysis. This property of thymic 
replication 1s particularly important since Cl-V13D resembles a 
precursor lymphoid cell type. 
Electron microscopy showed that Cl-V13D resembles an immature 
lymphoblastic cell. This immature phenotype was further confirmed by 
FACS analysis using a panel of antibodies against cell surface markers 
expressed by hematopoietic cells. This result is consistent with earlier 
findings that immature cells are more susceptible to retrovirus infection 
and are targets for infection and initial transformation by many 
leukemogenic viruses (reviewed 1n Section 1.4 ). High cell surface 
expression of CD44 and NK 1.1 are not uncommon in tumour cells. NK 1.1 is 
highly expressed on cells infected with LP-BM5, a murine leukemia 
virus which induces immunosuppression (Markino et al. , 1993 ). CD44 1s 
strongly transcribed in many tumours as a splice variant (Herrlich et 
al., 1993) and also in >95 % of childhood leukemic cells (Kreindler et al. , 
28 
,< u 
[' [' 
~ ~ 
- - - - -CJ ~ ~ ~ ~ 
I I I I ,.c: 
ri ri ri ri 8 
A 8 8 8 8 -
C"") 
- - - -ri u A A A A A ~ 
> I I I I I I 
' I ,qi ,qi ,qi ,qi ,qi ,qi ,< 
ri 8 8 8 8 8 8 ill 
CJ ~ ~ ~ ~ ~ ~ CJ 
23.l 
Fig. 5 Southern analysis to compare the RFLP pattern at the TCRa 
locus in CBA/H thymus (Thy), Cl-Vl3D and subclones isolated upon 
1st (ET4-C, ET4-D), 2nd (ET4-D[Tl-C], ET4-D[Tl-E]) and 3rd (ET4-
D[Tl-E]M7 A, ET4-D[Tl-E]M7C) passage intrathymically. DNA was 
digested to comp letion with EcoRI. The probe used was a cDNA 
specific for the Va.3 gene. The migration of Hindlll - digested A DNA 
(kb) is indicated. 
TABLE 6 Increasing tumorigenic potential 
serial intrathymic passage into 
of Cl-V13D following 
irradiated CBA/H mice 
Incidence of thymic tumour formation 
(time to death, range in days) 
Clone Thymic Passage intravenous intraperitoneal subcutaneous 
Number 
ET4-D 1 3/3(16[x3])a 1/3(16) 0/3 
ET4-D(Tl-E) 2 3/3 4/4 0;3c 
(10[x2],14) (17[x3],18)b 
ET4-D(T 1-E)M7 A 3 3/3 3/3 0;3c* 
(10,16[x2]) (15,16[x2]) 
Cl-V13D 0/3(>4.5m) 3 0/3(>4.Sm)b 0/3 
CBA/H mice were irradiated (4Gy, Cobalt source) and inoculated with 5xl05 Cl-V13D cells. 
* Tumours were evident subcutaneously at 10-14 days post-inoculation but regressed 
within 4 weeks. 
a, b Statistically significant at the 5% level: day to death 
c time of tumour detection. 
m months 
1990). The CD44 antigen 1s also expressed on early fetal thymocytes and 
thymus-homing progenitor cells (Lesley et al., 1985a & b). Cl-Vl3D cells 
co-express high levels of B220 and T200, lymph_oid antigens which are 
specific markers for cells of the B (Coffman & Weissman, 1981) and T 
lineages (Thomas, 1989), respectively. The co-expression of related but 
different lineage antigens, which at first sight appears erroneous could 
be explained by lineage promiscuity (reviewed 1n Section 1.4), an 
intrinsic property of immature hematopoietic cells. This evidence 
indirectly lends support to the immature status of Cl-Vl 3D. 
Irradiation has been shown to temporarily suppress the host's 
immune response (Miller et al., 1988), restoring the adult immunologic 
responsiveness to near neonatal level (Lieberman & Kaplan, 1976b ). The 
transplantabili ty of Cl-V l 3D cells into sublethally irradiated syngeneic 
DBA/2j mice by various routes, but not with the same efficiency via 
subcutaneous route into unirradiated DBA/2j mice, suggests that C 1-V l 3D 
cells are not fully transformed. Using non-leukemogenic irradiation 
doses, the non-tumorigenic, factor-dependent FDC-Pl cell line has also 
been demonstrated to grow as a tumour in irradiated syngeneic mice 
(Duhrsen & Metcalf, 1988). The capacity of Cl-Vl3D to grow as a tumour 
was shown to be dependent on two factors: (a) an immune-suppressed 
host induced by irradiation and (b) the route of inoculation. Cl-V13D was 
unable to grow 1n irradiated or unirradiated allogeneic CBA/H and 
C57BL/6J mice following inoculation via the sc, ip or 1v routes . MHC 
differences and an immune response could account for this restriction . 
However, 1n irradiated CBA/H mice, C 1-V l 3D replicated successfully 
when inoculated intrathymically. This observation supports the 
hypothesis that thymus may be an immunologically privileged site, 
which can function as a safe haven for emergence, survival and 
proliferation of leukemic cells. In this model, irradiation would have 
depleted the thymus of mature T cells (Huiskamp et al., 1985), further 
enhancing the growth of Cl-V13D cells in the absence of any cell-
mediated immune response. The irradiation regime employed 1n this 
study (4 Gy) does not induce spontaneous leukemia (Kaplan & Brown , 
1952), nor was the physical manipulation a triggering mechanism for 
leukemogenesis because control mice injected with medium in place of 
cells did not develop tumours (data not shown). Since cells which 
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replicate 1n the thymic microenvironment developed increased 
oncogen1c potential, this would suggest an important role for the thymus 
1n oncogenic progression. As shown here, this can be best demonstrated 
1n the allogeneic model. 
Since RadL V 1s a thymotropic virus and can replicate efficiently 
and productively in the thymus, it was important to confirm that cells 
reisolated are not host cells which have become secondarily infected by 
RadL V. Cells reisolated from thymic tumours were verified as C 1-V l 3D 
progeny by several lines of experimental evidence. Firstly, cell-free 
extracts from Cl-V13D were shown to produce a leukemogenic virus(es ) 
which was tumorigenic in newborn C57BL/Ka mice . This same extract 
was only weakly leukemogenic in irradiated adult CBA/H mice, g1v1ng 
tumours only after a long latency period of approximately 1 year, and 
with a mere 13% incidence of leukemia and little thymic involvement. 
The results are consistent with reported findings that RadL V requires a 
long incubation period to induce lymphomas after infection and that 
adult CBA/H mice are relatively resistant to RadLV [(<25 % develop 
leukemia following infection with virus (Kaplan, 1967)]. In contrast , the 
inoculation of Cl-V13D cells into the thymus at a dose of 5x104 to 5xl05 
cells resulted in localised tumour formation within 2-3 weeks and rapidly 
growing cells could be established within 24 hours of in vitro culture. 
The coincident proliferation of other RadL V infected cells in the thymus 
is not disputed. However, the establishment of such cells in culture would 
require a much longer period of time . 
Conclusive evidence that the clones reisolated from thymic 
tumours were the progeny of C 1-V l 3D came from FACS and Southern 
analyses. All clones expressed the same markers as Cl-V13D upon 
subcloning and also demonstrated an RFLP pattern similar to C 1-V 13 D at 
the TCR-a locus, which is distinct from the allogeneic CBA/H host. 
However, Cl-Vl3D progeny clones exhibited 1n creaszn g tum ori ge ni c 
potential with each passag e through the thy mus and prog ressed 
sufficiently to grow sub cutaneously after the th ird passage, su ggesting 
at each step the occurrence of distin ct oncogenic change s . 
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This model lends itself to analyses aimed at elucidating events 1n 
retrovirus-induced oncogenes is, using cells isolated at various stages of 
transformation. The results presented here already provided evidence 
consistent with the involvement of the thymus 1n T leukemogenesi s 
induced by T cell tropic retroviruses. They also indicate how the thymus 
can act as an appropriate microenvironment for the survival and 
proliferation of leukemic cells 1n an immune suppressed allogeneic host , 
presumably via adaptation and progression to a more tumourigenic 
phenotype. Further experiments, aimed at analysing changes 1n Cl-V13D 
during oncogen1c progression in vivo, as well as the genes as sociated 
with the transformed phenotype , are presented 1n the following 
chapters. 
SUMMARY 
The objective of this study was to investigate the use of a RadL V-infected 
cell line , Cl-V13D, as a model for studying oncogen1c progress ion in T 
cell leukemo genesis . In vivo studies indicated that C 1- V 13 D is partiall y 
transformed but can undergo further progressive transformation at 
each serial passage through the thymus , thus confirming a role for this 
organ 1n oncogenes1s. The isolation of progressively tumorigenic 
Cl-Vl 3D cells allows for a step-by-step dissection of events contributing 
to multi-step carcinogenesis , and on this basis , Cl-V13D could serv e as a 
useful model for the study of T cell leukemogenesis. 
3 1 
CHAPTER 3 
A 
Oncogenic 
differentiation 
3.1 Introduction 
• progression: 
-
linked event? 
Cells susceptible to productive infection by RadL V are present 
amongst the most immature cell subset in the thymus (Boniver et al., 1989). 
However, cell lines established from RadL V-induced thymic tumours often 
exhibit characteristics of more mature T cell phenotypes (Lieberman et al., 
1979; Yefenof et al. , 1991). This 1s consistent with observations that 
leukemic cells shift towards a more mature phenotype during disease 
progression (O'Donnell et al., 1984; Davis et al., 1986a; Jensen et al., 1992). 
Leukemic cell lines have also been reported to exhibit unstable phenotypes 
and continue to differentiate further (Koeffler & Golde, 197 8; Lazo et al., 
1990). In the case of chronic myelogenous leukemia (CML), it was observed 
that expansion of the leukemic cell population takes place 1n the 
intermediate and more mature cell compartments rather than in the stem 
cell or early progenitor compartments, where the disease is known to 
originate (Clarkson & Strife, 1993). These observations are consistent with 
the hypothesis that cell differentiation 1s intrinsic to multistep 
leukemogenesis (reviewed in Section 1.5 .2). 
The mechanisms underlying differentiation-linked oncogenes1s are 
not clear. Some genes that regulate growth, differentiation and cell death 
have been mapped to unstable 'breakpoint' regions of chromosomes which 
are prone to mutation, recombination, translocation or deletion (Leder et 
al., 1983; Yunis, 1983; Hatano et al., 1991; Reed, 1994). Son1e of these 
alterations have been shown to occur spontaneously and with striking 
association between particular chromosome alterations and certain cell 
types (Rowley, 1990). For example translocations involving tne TCR-a locus 
have been found to be associated with T cell neoplasms (Croce et al., 1985). 
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Burkitt's lymphoma in humans is another example. In this case, the Epstein 
Barr virus is thought to stimulate proliferation of B cells which are targets 
for additional neoplastic events involving translocation of the c - m y c 
proto-oncogene next to the fragile rearranging immunoglobulin gene 
locus (Magrath, 1990). The mechanism for differentiation-linked 
oncogenic progression could therefore involve alteration of genes 
important in cell differentiation. These genes would be unique to the 
developmental program of the particular cell involved. 
Data presented in the previous chapter indicated a role for the 
thymus in oncogenic progression since C 1-V l 3D cells were shown to be 
progressively more tumorigenic after each successive intrathymic 
passage. This was reflected by a change towards a more tumorigenic 
phenotype when the cells were allowed to replicate under the selective 
pressure of the thymic microenvironment. This study is aimed at 
investigating differentiation-linked oncogenic progression in C 1-V l 3D. To 
this end, the capacity of Cl-V l 3D cells to undergo further differentiation 
and to express markers of T cells was tested after inoculation of Cl-V13D 
into the thymus. FACS analyses using antibodies specific for different 
hematopoietic lineage markers, including T cell markers, was used to assess 
any phenotypic changes in Cl-V13D cells following intrathymic transfers 
into allogeneic CBA/H mice and growth as a thymic tumour. The allogeneic 
model was used since Cl-V13D cells can be readily distinguished by 
expression of the Class I H-2Kd determinant. 
3. 2 Materials and methods 
3.2.1 Cell lines 
The cell lines analysed are clones isolated following serial 
passage of Cl-Vl 3D through the thymus. Their derivation and maintenance 
have been described in Sections 2.2.1 and 2.3.6, respectively. All clones 
isolated following initial inoculation of Cl-V13D intrathymically were 
designated as primary (1 °), and all second and third intrathymic passages 
as secondary (2 °) and tertiary (30), re spec ti vel y. 
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3.2.2 Mice 
CBA/H, DBA/2j and C57BL/6J X CBA/H (Fl) mice were used . 
They were bred under specific pathogen free conditions 1n the John Curtin 
School of Medical Research , Canberra, Australia. 
3.2.3 Intrathymic injections 
Intrathymic inoculations were carried out as described 1n 
Section 2.2.6. Unless otherwise stated, thymic tumours referred to in thi s 
study resulted from intrathymic inoculation of 5 x 1 os C 1-V l 3D cell s or 
Cl-Vl3D progeny cell lines. 
3.2.4 FACS analysis 
Cells were dissociated from the tumour mass and single cell 
suspensions were prepared as described 1n Section 2.2. 7. For FACS analysi s, 
cell suspensions were passed through sterile nylon mesh to remove cell 
clumps pnor to staining. The antibodies used and the method for FACS 
analysis have been described in Section 2.2.4. For two colour FACS analysi s, 
cells were first incubated with the primary test antibody , followed by FITC-
sheep anti-mouse or sheep anti-rat IgG. The cells were then incubated for 
30 minutes at 4°C with an isotype control antibody (mlgG1 ; 19XE5 from 
Nowinski). This antibody was used to block unbound FITC-anti-Ig. The 
cells were then washed thrice with medium and incubated with 
biotinylated 30H-12, an antibody specific for Thy-1.2 (Serotec , Australi a) 
and finally with streptavidin-R-phycoerythrin (PE) [Serotec , Australia ]. 
The cells were washed twice with medium and resuspended in fi xative ( 1 % 
paraformaldehyde in normal saline/pH 7.4) before analysi s. 
Cell sorting and analysis were carried out using a FACS 440 
Flow Cytometer (Becton Dickinson , Mountain View , CA) equipped with an 
Argon ion laser with 200mW output at a wavelength of 488nm . FITC 
emission was collected through a 530/20 Bandpass filter. Data was collected 
on a NEC 386/20 computer and analysed using WEFCS , a FACS data analys is 
package developed by Frank Battye (WEHI , Australia) . Red blood cell s and 
cell debris were gated out during analy sis. 
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3.2.5 Northern Analysis 
3 .2 .5A Preparation of RNA 
The extraction of RNA was carried out according to the method 
of Chomczynski and Sacchi ( 1987), with modifications for small scale 
preparation. Ice-cold lysis buffer (4M guanidine thiocyanate, 0.025M tri-
sodium citrate, 0.5% N-lauroyl sarcosine, O. lM 2-mercaptoethanol/pH 7 .0) 
was added to 106 pelleted cells. The mixture was vortexed vigorously for 
about 10 seconds, placing on ice between vortexing. Ice-cold 2M sodium 
acetate/pH 4.0 was added to a final concentration of 10% and the mixture 
was vortexed again. An equal volume of water-saturated phenol was added 
and briefly mixed, followed by a 5X volume of chloroform:isoamyl alcohol 
(24: 1). The mixture was vortexed again and centrifuged at 4°C for 5 minutes 
at 15,800 x g 1n a microcentrifuge. The aqueous phase was transferred to a 
new tube and the RNA was precipitated with an equal volume of 
isopropanol at room temperature for 15 minutes. One to two ml of 4M 
lithium chloride was added to the RNA pellet to solubilise polysaccharides. 
The RNA was again pelleted at 15,800 x g for 30 minutes at 4°C, dissolved in 
500µ1 TE-SDS (0.01M Tris-HCl/pH 7.5, 0.001M EDTA/pH 8.0 and 0.5% SDS) and 
re-extracted with an equal volume of chloroform :isoamyl alcohol. The 
aqueous phase was recovered after brief centrifugation to separate the 
phases. One-tenth volume of 2M sodium acetate/pH 4.0 was added, followed 
by an equal volume of isopropanol. The RNA was stored at -20° C under 
propanol, or pelleted at 4°C, redissolved in an appropriate amount of DEPC-
treated ddH20 and stored at -70°C in small aliquots. 
The method of Davis et al. (1986b) was used for the extraction 
of RNA from liver, thymus and spleen. Tissue ( < 0.5g) was snap frozen in 
GITC buffer ( 4 7 .3% guanidine isothiocyanate, 0.025M sodium acetate/pH 6.0, 
0.1 % 2-mercapthanol) using liquid nitrogen as the freezing medium. The 
tissues were homogenised immediately and the homogenate was stored at 
- 7 0 ° C until required. A volume of < 3 .3ml of homogenate was layered on a 
cushion of 1.7ml DEPC-treated caesium chloride (CsCl) buffer (96% CsCl , 
0.025M sodium acetate/pH 6.0) and ultracentrifuged at 149,000 x g usmg a 
SW55Ti rotor for 21 hours at 20°C 1n a Beckman L7 ultracentrifu ge 
(Beckman Instruments Inc., USA). 
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The GITC layer and interface were removed after 
ultracentrifugation with a pasteur pipette and the CsCI cushion was 
decanted. Tubes were drained for 10 minutes and excess liquid was removed 
with a sterile Eppendorf tip. The RNA pellet was resuspended in 270µ1 DEPC-
treated ddH2 0 after cutting off the top part of the tube at a level 
approximately 1 cm from the RNA pellet to prevent the collection of 
contaminating DNA. To this was added 3M sodium acetate/pH 5.6 to a final 
concentration of 10%. The RNA was precipitated with a 3.5X volume of ice-
cold ethanol at -70° C. When needed, it was pelleted, washed twice with 
ethanol, dried and resuspended in an appropriate amount of DEPC - treated 
ddH20. 
3.2.5B Electrophoresis of RNA and analysis 
RNA was electrophoresed using denaturing formaldehyde gels 
as described by Sambrook et al. (1989). Samples were heated at 65° C in 
sample loading buffer (8% Ficoll, 0.02% bromophenol blue, 0.04% xylene 
cyanol) and denaturing cocktail (50% formamide, 17.5% formaldehyde, 
0.01 % MOPS, 0.05% ethidium bromide) for 10 minutes prior to loading. 
Agarose (Sigma, Type II) gels, containing 3.5 parts agarose, 1 part 
formaldehyde and 1.1 part 5X MOPS (0.2M MOPS, 0.05M sodium acetate, O.OlM 
EDT A/pH 7 .0) were used. All equipment and solutions for RN A analysis were 
autoclaved immediately before use or treated with DEPC where autoclaving 
was not possible. After electrophoresis, gels were soaked (20°C, 60 mins) 1n 
20X SSC (3M NaCl, 0.3M tri-sodium citrate/pH 7 .0) before transferring to 
Hybond N+ membranes (Amersham, Australia). They were then baked 
under vacuum at 80°C for 2 hours and stored in sealed plastic bags at -20° C . 
Preparation of 3 2 P-labelled probe and detection of specific nucleic acid 
sequence were carried out as described in Section 2.2.8D & E. The TCR-C~ 
probe used for this study was provided by C. Okada (Stanford University). It 
is a 434bp EcoRI/Hindlll fragment cloned into the pSPT672 plasn1id vector 
and comprises the constant region of the T cell receptor ~ (TCR-C~) gene. It 
cross hybridises with the C~ I and C~2 genes. 
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3.3 Results 
3.3.1 FACS analysis of thymic tumours: delineation 
of tumour subpopulations by gating 
C 1-V l 3D cells were initially transplanted intrathymically into 
syngene1c DBA/2j mice. FACS analysis on cells which constituted 
developing thymic tumours indicated that C 1-V 13 D cells had differentiated 
and acquired mature T cell markers during the period of thymic replication 
(data not shown). However, it was not possible to conclusively distinguish 
Cl-V13D cells from syngeneic DBA/2j host thymocytes either by size or 
using the available antibodies. 
C 1-V l 3D proliferated in the thymus of allogeneic CBA/H mice 
and progressively became more tumorigenic (Chapter 2). This transfer 
system into irradiated allogeneic hosts provided an alternative system to 
study the differentiative capacity of Cl-V13D. Cl-V13D cells could be 
distinguished from host CBA/H thymocytes on the basis of high Forward 
Scatter as well as expression of high levels of H-2Kd, B220, CD44, and the 
RadL V gp70 envelope protein. The anti-H-2Kd antibody, 34-1.2, is cross-
reactive with different class I molecules (Ozato et al., 1982) but not with 
H - 2 K k, which is expressed by CBA/H thymocytes (Fig. 1 ). By gating the 
whole tumour population according to low and high 90° Scatter (Figs. 2a & 
b ), two and three subpopulations, respectively could be observed (Figs. 2c & 
d). This distribution of cell subpopulations by 90° Scatter gating was seen 1n 
all thymic tumours analysed, including those from syngeneic DBA/2j mice 
and C57BL/6J X CBA/H (Fl) mice (data not shown). 
The subpopulations A and 3, observed with both high and low 
90 ° Scatter comprised small cells (Figs. 2c and 2d). These subpopulations do 
not appear to express any of the T cell markers tested. In a normal 
unirradiated CBA/H mouse, this population of 'marker negative' 1s barely 
detectable (Fig. I). Since thymic tumours developed only in irradiated mice , 
the time frame required for normal thymic reconstitution following 
sublethal irradiation (4Gy) was analysed. This could be determined by FACS 
analysis and by the presence of the immature 
Full thymic reconstitution was indicated by 
'marker n~gative ' subset. 
an absence of 'marker 
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Fig. 1 FACS profile of Cl-Vl3D compared to normal CBA/H thymocytes . 
C 1-V l 3D can be distinguished from CBA/H thymocytes by the difference 
in size (indicated by Forward Scatter) and expression of B220 , CD44 and 
the binding of the 34-1.2 antibody specific for MHC Class I H-2Kd . 
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Fig. 2 Parameters used to delineate the different cell populations present in a typical 
thymic lymphoma at 14 days post-inoculation. By gating unstained cells according to low 
and high 90° Scatter (a & b, respectively), 2 and 3 subpopulations could be distinguished 
on the basis of Forward Scatter and background fluorescent staining (c & d, respectively). 
These subpopulations were seen in all thymic tumours analysed by 90° Scatter gating. The 
majority of Cl-V l 3D cells were observed to be in subpopulations 1 and 2, with some in 
subpopulation B. Red blood cells were gated out during analysis. 
negative' cells, similar to that observed in the thymus of unirradiated mice. 
The time taken for the recovery of normal thymus cell composition was 
found to vary between 11 and 14 days in most uninoculated , irradiated 
animals (data not shown). In contrast, sublethally irradiated (4 Gy) mice 
inoculated with Cl-V 13D cells retained a substantial subpopulation of small 
'marker negative' thymocytes ( 40% - 45% of tumour population) up to at 
least 21 days post-irradiation (Fig. 4, subpopulation A not shown). Thi s 
indicated impaired thymic regeneration in mice inoculated with C 1-V 13D 
cells and could be due to either a) the presence of foreign Cl-V13D cells or 
b) decreased ability of host thymic stromal cells to support normal 
hematopoiesis due to RadL V infection. 
Based on the staining with 34-1.2, the majority of Cl-V 13D cells were 
found in subpopulations 1 and 2 (Fig. 3). Cells in subpopulation B also bound 
the 34-1.2 antibody (-50%) as well as the T cell markers , Thy 1.2, CD4, CDS 
and CD44 (data not shown). However, the level of 34-1.2 staining was low 
and could represent the uptake of H-2Kd molecules by normal thyn1ocytes . 
The presence of Cl-VI 3D cells expressmg T cell markers in subpopulation B 
was indicated but this could not be tested definitively in this analysis. 
Analysis was therefore performed on C 1-V 13D cells present in 
subpopulations 1 and 2, using high 90° Scatter gating. 
3.3.2 Acquisition of T cell markers by Cl-V13D after 
serial intrathymic passage 
Cl-V13D replicating within the thymus was analysed for cell 
surface expression of the Thy-I , CD4, CDS and CD3-£/TCR-a~ determinants at 
different times post-inoculation. Analysis was difficult at 4 to 7 days po st-
inoculation as Cl-V13D cells were present in numbers equivalent to onl y 
about 5-10% of the input cell dose. By 10 days , however, cell numbers had 
increased and Cl-VI 3D cells were readily detectable by FACS analy sis. Most 
analyses were performed when the hosts were moribund . Thi s vari ed 
between 14 and 21 days post-inoculation. 
A high 90° Scatter gate was used to delineate C 1-V 13 D cell s for 
analysis in view of evidence that the majority of C 1-V 13D ce ll s were found 
in subpopulations 1 and 2 (Fig. 3). T cell markers such as Thy- I , CD4 and CDS 
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Fig. 3 FACS profile of ET4-D(Tl), a 2° thymic tumour at 15 days 
post-inoculation of ET4-D, a 1 ° clone. High 90° Scatter gating was 
used to delineate cells. (a) Three cell populations can be distinguished 
on the basis of Forward Scatter and background fluorescence staining 
(control staining in which medium was used in place of specific 
antibody). (b) Specific staining using 34-1.2 (anti-H-2Kd). The 
majority of cells in populations 1 and 2 bound the 34-1.2 antibody, 
indicating their C 1-V l 3D ongm. 
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seen. 
of C 1-V l 3D cells is 
appeared to be expressed by a small percentage of Cl-V13D cells in all the 1° 
thymic tumours analysed (data not shown). On the second passage , a clear 
subpopulation of Cl-V13D cells was found to express Thy-1, CD4, CD8 and 
T CR- a p in seven animals analysed. FACS analysis of a representative 2° 
thymic tumour ET4-D(Tl ), which developed at 15 days following 
intrathymic inoculation of ET4-D, is shown in Figure 4 . Subpopulation 2 was 
shown to comprise the larger Cl-V l3D cells (boxed) since these cells clearly 
expressed H-2Kd, RadLV gp70 env , CD44 and B220. FACS analysis also 
showed that greater than 30% of these cells expressed the T cell markers 
CD4, CD8, Thyl.2 and TCR-ap/CD3-E. 
The specific acquisition of T cell markers by C 1-V l 3D in 
several 2° and 3° thymic lymphomas was also confirmed using 2 colour 
FACS analysis. This analysis is represented by ET4-D(Tl-E)M7 , a 3° thymic 
lymphoma which developed 13 days following intrathymic inoculation of 
the 2° clone, ET4-D(Tl-E) [Fig. 5] . Biotinylated 30H-12, an antibody specific 
for Thy-1.2, was used. The binding of this antibody was detected with 
avidin-PE. Using high 90° Scatter gating , subpopulation 2 , which comprised 
C 1-V l 3D cells (Figs. 2 & 4 ), was chosen for analysis. The reprocessed data for 
ET4-D(Tl-E)M7 , showing two colour profiles of Cl-V13D cells 1n 
subpopulation 2 are shown in Figure 5a, along with data from a normal 
CBA/H thymocyte population . Gated C 1-V l 3D cells, identified by uniforn1 
binding of 34-1.2, also clearly bound the 30H-12 antibody at intermediate to 
high levels, confirming expression of the Thy-1 .2 antigen by 
approximately 100% of cells . Approximately 50 % of these large Thy 1.2+ 
Cl-V13D cells in addition bound antibodies specific for CD4 or CD8 and 
CD3-E/TCR-ap. One colour analysis using antibodies specific for TCR-ap and 
CD3-E showed that 50% and 30%, respectively , of thi s subpopulation of large 
Cl-V13D cells expressed these determinants (Fig. 5b). It was al so observed 
that some of the Cl-V13D cells in this subpopulation 2 had downregulated 
expression of CD44 and B220 (Fig. 5). In comparison , these determinants 
were unifom1ly expressed at high levels by the parental Cl-Vl 30 cells (Fig . 
1). 
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Fig. 5 Two colour FACS analysis of T cell markers on the 3° thymic tumour 
ET4-D(Tl-E)M7 at 13 days post-inoculation, compared to normal CBA/H 
thymocytes. Only the large C 1-V l 3D cells in subpopulation 2, obtained after high 
90° Scatter gating, was analysed and presented here. a) _The binding of Thy-1.2 
(red fluorescence) and T cell markers (green fluorescence) was analysed . b) One 
colour analysis using antibodies specific for the TCR-a ~ and CD3-E determinants 
also showed binding of these antibodies to the large C 1-V l 3D cells present in the 
tumour. 
3.3.3 Detection of T cell receptor . expression 
The acquisition of T cell surface markers by Cl-V l 3D cells 
replicating intrathymically could be a result of new gene expression 
during differentiation or the "capture" of cell surface molecules shed by 
dying normal thymocytes. In order to confirm that Cl-V13D cells did 
differentiate and express T cell markers, endogenous expression was tested 
using Northern analysis. To this end, Cl-Vl 3D cells were sorted from three 
freshly explanted 3° thymic tumours at 14 days post-inoculation of 
ET4-D(Tl-E), the 2° clone. Cells were sorted as before on the basis of high 
Forward Scatter and binding of the 34-1.2 antibody. Total RNA was prepared 
from these cells and pooled. Since FACS data has indicated the expression of 
CD3-e/TCR-a~ determinants by a subpopulation of Cl-V13D cells, Northern 
hybridisation analysis was performed to determine the presence of TCR-C~ 
gene transcripts which would indicate endogenous TCR expression. In vitro 
cultures of parental Cl-V13D cells and CBA/H thymocytes were also 
analysed as controls. Using the TCR-C~ probe, high level expression of 
1.35kb and 1.0kb TCR-~ chain transcripts were detectable in both the 
normal thymocyte population and in C 1-V l 3D cells sorted from the thymic 
tumours (Fig. 6). These transcripts reflected endogenous expression of full 
length VDJC transcripts and partial DJC transcripts of the TCR-~ chain from 
fully and partially rearranged ~ chain genes, respectively (Adkins et al., 
1987). The possibilty of the sorted population being contaminated by a small 
number of normal TCR-a ~ + thymocytes is disputed since cell sorting gives 
only an approximate 1-2% error rate. The difference in intensity in the 
fragments observed for normal thymus versus the sorted cells was 
observed to be only 7-8 fold, as measured by densitometry (data not shown). 
This confirmed that C 1-Vl 3D cells did differentiate and acquire TCR-~ gene 
expression during thymic residence. 
3. 4 Discussion 
The demonstration that Cl-V13D cells are capable of differentiating 
and expressing T cell markers lends support to the phenotypic 
characterisation of C 1-V l 3D as an immature lymphoid precursor cell 
(O'Neill, 1992; Chapter 2 of this study). This result is also consistent with 
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Fig. 6 Northern analysis showing TCR-~ chain expression by Cl-V13D cells 
reisolated from thymic lymphomas following third intrathymic passage. 
Cl-V13D cells from 3 thymic lymphomas were sorted on the basis of high 
Forward Scatter and 34-1.2 antibody binding and their RNA was pooled. A total 
of 1.6µg RNA was obtained, which was used in this analysis. RNA (2µg) from 
normal CBA/H thymus and in vitro grown Cl-V13D cells were included as 
controls. The Northern blot was analysed with a 32P-labelled cDNA probe 
representing the TCR-C~ gene. Specific signal was detected by autoradiography 
using X-ray film. RNA size markers (kb) are indicated. 
previous studies which showed that RadL V preferentially infects immature 
hematopoietic cells in the bone marrow, spleen and thymus (Lieberman 
and Kaplan, 1976a). However, the migration of immature cells into the 
thymus and replication at this site appeared to be required for vHus 
replication. 
The development of T cell leukemia has been documented as a 
lengthy process involving a period of clonal cell selection and 
differentiation 1n the thymus (reviewed 1n Chapter 1 ). In experiments 
described here, an attempt was made to subject Cl-V13D to the san1e 
selective pressure by serial passage through the thymus. Changes 
associated with differentiation and oncogenic progression were analysed 
using FACS analysis (this chapter) and in vivo studies (Chapter 2). Longer 
thymic residence was afforded by serial passages through the thymus. This 
seemed to result 1n a greater percentage of C 1-V 13 D cells expressing mature 
T cell surface markers, and progressively tumorigenic progeny cells being 
selected as the cells replicated under the influence of the thymic 
microenvironment. 
It has not been possible to determine by the methods used here 
whether C 1-V l 3D cells have the capacity to differentiate into fully 
functional T cells and to emigrate to other peripheral lymphoid organs. It 
has been documented that 24 hours following the injection of double 
negative (CD4-C D 8 -) thymocytes, many of these cells become double 
positives (CD4+Cn8+), with mature single positive cells evident in the 
periphery by 7 to 10 days (Scollay et al., 1988). However, when Cl-V13D 
cells were injected intrathymically, only thymic tumours developed and no 
other organs were involved at autopsy. This result was obtained for all cell 
doses and at each thymic passage. Three possible explanations could 
account for this apparent lack of infiltration by Cl-V13D cells into the 
periphery a) death of the host due to a thymic tumour occurred before 
C 1-V l 3D could proliferate to detectable numbers in the peripheral organs, 
b) emigrating, mature Cl-V13D were destroyed by the host immune system 
or c) Cl-V13D cells could only undergo limited differentiation. So far, there 
have been no conclusive reports on whether RadL V-infected thymocytes 
could undergo normal differentiation. It 1s possible that RadL V may 
interfere with normal proliferative and differentiation events either 
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directly by insertional mutagenesis (reviewed in Section 1.5.3) or 
indirectly by partially impairing the ability of thymic stromal elements to 
support normal hematopoiesis. The latter effect has been described for the 
LP-BM5 MuLV, a munne AIDS virus. Tse et al. (1993) have shown that bone 
marrow stromal cultures infected with LP-BM5 could not establish the 
required microenvironment for normal hematopoiesis, resulting in 
depressed numbers of stem cell progenitors. In mice inoculated with 
Cl-V13D, the 'marker negative' subpopulations "A" and "3 " (Fig. 2) 
represent approximately 40% to 50% of the tumour population . These mice 
appear to have partially impaired thymocyte development and this could be 
due to either RadL V infection of thymic stromal elements or the presence 
of replicating C 1-Vl 3D cells within the thymus. 
Despite clear expression of T cell markers by a substantial 
percentage of Cl-V13D cells at the third intrathymic passage, Cl-V13D cells 
isolated after in vitro culture of thymic tumours failed to show any 
evidence of differentiation. Initially, this was thought to be due to parental 
C 1-V 13 D cells outgrowing their more "differentiated" counterparts in 
culture. However, when "differentiated" C 1-Vl 3D cells were sorted by Thy-1 
expression and cultured in the absence of "parental" Cl-V13D cells, Thy-1 
expression was lost after only a week in culture (data not shown). The cell s 
which grew up did not express any other T cell markers such as CD4, CD8 
and TCR-o: ~ as shown in vivo, but resembled the original parental C 1-V 13D 
in cell surface marker expression. It is possible that the Thy-1 expressing 
C 1- V 13D cells detected zn vzvo represent only a transient phenotypi c 
change representative of the next step along the differentiation pathway 
and are incapable of replicating in the absence of an appropriate stimulus 
such as the thymic microenvironment. Similar results have been reported 
for the pre-B leukemic cell line G2 (Kamel-Reid et al. , 1992). Thi s cell line 
was observed to express CD IO in vivo, but subclones isolated and propagated 
in vitro were shown to be CD Io-. These became CD Io+ again when they 
proliferated 1n the scid mouse thymus. The expression of CD 10 on G2 cell s 
was shown to be inducible and was maintained during cell replication in 
the thymus, but this expression was consistently lost upon culture. The 
dependence on physiological inducers 1n the thymic microenvironment 
for maintenance of determinant expression is implied in both studi es . 
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Chemicals or growth factors have been used successfully to induce 
differentiation in leukemic cell lines along myeloid and erythroid lineages 
(Friend et al., 1971; Sachs, 1978). Tumour promoting phorbol esters have 
been used successfully to induce differentiation in some human leukemic 
lines (Nagasawa & Mak, 1980; Delia et al., 1982). Many attempts have been 
made to induce differentiation of Cl-V13D in vitro with various stimuli 
including phorbol esters and growth factors but without success (O'Neill, 
personal communication). Within the limits of the model described here, 
data has been obtained which indicate that RadL V-immortalised 'targets' 
are capable of differentiation and can express T cell surface markers while 
replicating under the influence of the thymic microenvironment. 
The inability of Cl-V13D cells to retain expression of T cell markers 
after explantation from the thymus does not permit a definite association 
between differentiation and oncogen1c progression to be made 1n this 
model. However, in view of the fact that differentiation is by itself a very 
complex process, it is possible that the increased tumorigenicity seen 1n 
C 1-V l 3D after intrathymic passage may be due to genetic changes 
associated with early differentiative events having no correlation with the 
T cell surface markers analysed here. These early events could be a 
necessary prerequisite for further differentiation and stable expression of 
mature T cell surface markers such as Thy-1, CD4 and CD8. Genetic changes 
due to retrovirus infection may have precluded full differentiation into 
functional, mature T cells. 
SUMMARY 
The development of T cell leukemia has been documented to involve a 
lengthy selection process 1n the thymus, which is also coupled with a shift 
towards a more mature T cell phenotype. Serial intrathymic passage of 
Cl-V13D cells into allogeneic CBA/H mice has been shown to result 1n 
increased tumorigenicity of the Cl-V13D cell line. Cl-V13D cells were 
therefore analysed in this study using flow cytometry for changes in cell 
surface marker expression related to differentiation in the thymus. The 
data obtained indicated conclusively that C 1-Vl 3D cells expressed the T cell 
markers , Thy-1.2, CD4 and CD8 and TCR-a~ / C D 3- e upon replication in the 
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thymic microenvironment, and supported earlier characterisation of 
Cl-V13D as an immature lymphoid cell (Chapter 2). The expression of TCR-~ 
gene transcripts was confirmed by Northern analysis on an isolated , sorted 
Cl-Vl 3D cell population. However, T cell marker expression was not stable 
and was consistently lost upon in vitro culture. Removal from the thymic 
microenvironment could account for this downregulation of marker 
expression. The increased tumorigenicity observed 1n C 1- V 13 D after 
intrathymic passage did not appear to be related to stable expression of 
mature T cell surface markers analysed in this study but could be associated 
with genetic events in early T cell differentiation. 
44 
CHAPTER 4 
Oncogenic 
retroviral 
• progression: 
integration 
4.1 Introduction 
the significance of 
and recombination 
Retroviral recombination and reintegration events which occur 
after initial retroviral infection appear to play an important role in the 
process of transformation and oncogenic progression in T cell leukemia 
induced by slowly transforming retroviruses. These events have been 
associated with the generation of new leukemogenic viruses and the 
enhancement of genetic instability in the host genome via retroviral 
integration (reviewed in Sections 1.5.3 & 1.5.4). 
A progressive increase in tumorigenic potential of C 1- V l 3D has 
been demonstrated in progeny clones derived from thymic tumours 
following first, second and third passages intrathymically (Chapter 2). 
The Cl-V13D cell line and the primary, secondary and tertiary clones 
derived from it were therefore used as a model for defining genetic 
events associated with transformation and . . oncogenic progression. This 
study is aimed at determining whether further retroviral integration 
and/or recombination, which could account for the observed increase in 
tumorigenicity, has occurred during serial intrathymic passage of 
Cl-V13D cells. DNA from randomly selected primary, secondary and 
tertiary clones was digested with various restriction endonucleases and 
the retroviral integration pattern was analysed using probes subcloned 
from RadLV/V13, a virus cloned by Rassart et al. (1986). Changes in 
retroviral integration pattern which may correlate with an increase in 
tumorigenicity were sought. Since it has been shown that cell 
differentiation may be linked to the oncogenic process (Chapter 3), it 1s 
anticipated that genetic changes which can be associated with an 
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increase In tumorigenic potential, such as further retroviral integration 
events, could occur proximal to genes related to the differentiation of 
early lymphoid cells. Such a process would be driven by the strong 
selective pressure for cell replication within the thymic 
microenvironment. 
4. 2 Materials and methods 
4.2.1 Cell lines 
The ongin, derivation and maintenance of cell lines has 
been described in Sections 2.2.1 and 2.3.6. 
4.2.2 Bacterial strains 
The E. coli host strains used were JPA101 (sup E, thi, D(lac-
proAB), recA, TcR(::Tn 10), ton, 1r, F'[traD36, proAB +, lac/Q, lacZ~M 15]) 
and DH5a' (supE44, DlacUl69 [f 80lacZ~Ml5], hsdRl7, recAl, endA l, 
gyrA96, thi-l, relAl, F'[traD36,proAB+, lac/Q, lacZ~Ml5]) which were 
compatible with blue/white colour screening and ampicillin selection. 
4.2.3 Electron . microscopy 
Cells were prepared for electron microscopy as described In 
Section 2.2.3. 
4.2.4 Derivation of viral probes for Southern analysis 
4.2 .4A Preparation of vector and insert DNA for cloning 
The fragments to be subcloned for use as probes were 
excised from the RadL V /V 13 proviral genome, which had been 
previously isolated and cloned into the pBR322 vector by Rassart et al. 
(1986). Briefly, RadL V /V 13 was digested with the appropriate enzymes 
and electrophoresed through 1 % GTG SEAKEM agarose (FMC Bioproducts, 
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USA) to separate the desired fragments. These were excised and the DNA 
was extracted from the agarose using the Geneclean kit (Progen, USA). 
The pGEMR plasmid vectors (Promega Corporation, USA) 
were used for subcloning. They were dephosphorylated with calf 
intestinal alkaline phosphatase (Pharmacia, USA) to prevent self-
ligation. Dephosphorylation was carried out according to Sambrook et al. 
( 1989). Appropriately digested vector and viral fragments were ligated, 
usually 1n a 1 :2 or 1 :3 vector:insert molar ratio 1n ligase buffer 
(Promega, USA) containing 1 Weiss unit of T4 DNA ligase (Pharmacia, 
USA) for 16 to 18 hours at 12°C for blunt end ligations, or 160C for 
cohesive end ligations. 
4.2.4B Trans/ ormation by heat shock 
E. coli cells for 'heat shock' transformation were made 
competent according to the method developed by Hanahan (1983). 
Briefly, the cells were grown to mid-exponential phase in 30ml to 100 ml 
of SOB medium (2% tryptone, 0.5% yeast extract, 0.05% NaCl, 250mM KCl, 
0.01M MgCl2, 20mM MgS04) and chilled on ice. The cells were ·recovered 
by centrifugation at 4000 x g for 10 minutes at 4° C. After completely 
draining away the last traces of media, the cell pellet was resuspended in 
20ml ice-cold FSB buffer ( lOmM potassium acetate/pH 7 .5, 45mM 
MgCl2.4H20, lOmM CaCl2, lOOmM KCl, 3mM hexamminecobalt chloride, 
10% [ v /v] glycerol) and kept on ice for 10 minutes. The cells were then 
pelleted, drained of buffer and resuspended again in 4ml ice-cold FSB 
buffer. Dimethyl sulphoxide (DMSO) was added to a final volume of 0.07% 
in 2 aliquots, allowing 15 minutes to chill on ice after the first DMSO 
addition. The cells were quickly dispensed into chilled sterile microfuge 
tubes, snap-frozen using liquid nitrogen and stored at -700C. 
The procedure for heat shock transformation was carried 
out according to Sambrook et al. (1989). Prior to transformation, 200µ1 
cells were thawed on ice for 10 minutes and then mixed with 25 to 50ng 
of the ligated vector/insert DNA. The DNA/cell mixture was incubated on 
ice for 45 to 60 minutes, heat shocked for 100 seconds at 42°C, and chilled 
immediately on ice. Pre-warmed SOC medium ( 1 % tryptone, 0.5 % yeast 
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extract, 0.5% NaCl, O.OlM MgCl2, 0.01M MgS04, 0.5% glucose/pH 7.0) was 
added to a final volume of 1ml. The cells were incubated at 3 7° C for 10 
minutes without agitation, after which they were incubated for another 
60 minutes at 3 7° C with gentle agitation at 150rpm in an incubator 
shaker (New Brunswick, USA). The transformed cells were pelleted , 
resuspended in 25µ1 LB medium (1 % tryptone, 0.5% yeast extract, 0.5% 
Na Cl) and plated on LB agar plates ( 1.2 % bacto-agar) containing 
lOOµg/ml Ampicillin (Sigma, USA), 0.5mM IPTG (isopropyl-~-D-
thiogalactopyranoside; Sigma, USA) and 40µg/ml X-gal (5-bromo-4-
chloro-3-indoy l-~-D-galactoside; Boehringer Mannheim, Germany). 
X-gal was prepared as a 50mg/ml stock solution In N,N' 
dimethylformamide. The plates were inverted and incubated at 3 7° C for 
18 hours. Six to eight white recombinant colonies from each ligation 
reaction were selected for restreaking twice before checking for clones 
bearing inserts of the correct size. 
4.2.4C Transformation by electroporation 
To prepare electrocompetent cells, 1 litre of cells was grown 
to exponential phase. The cells were chilled briefly on ice, harvested at 
4000 x g for 10 minutes at 4° C and washed twice with 500ml to 1 litre of 
cold ddH2 0. They were then resuspended in 20ml of cold 10% glycerol and 
kept at 4° C on ice overnight. Cells were pelleted and resuspended in 
approximately 3ml (final volume) of cold 10% glycerol. The cells were 
aliquoted, snap frozen in liquid nitrogen and stored at -70°C. 
DNA for transformation by electroporation was first 
precipitated by the addition of O. lX volume 3M sodium acetate/pH 5.2 and 
2.5X volume ethanol. The pellet was washed twice with ethanol , vacuum-
dried and resuspended in 5µ1 ddH2 0. Thawed electrocompetent cells ( 40µ1) 
were mixed with 2µ1 DNA chilled on ice and placed in an ice-cold single 
use electroporation microcuvette with a 2mm electrode gap (Biorad , 
USA). The cuvette was set in position In the sliding cuvette holder and 
electroporation was carried out with the Gene Pulser (Biorad, USA) set at 
2.5kV and 25µF capacitance and the pulse controller set at 200n 
resistance. The resulting pulse was 12.5 KV/cm with a time constant of 
4.0 milliseconds. Immediately following the pulse , the cells were mixed 
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with 1ml pre-warmed SOC medium and incubated at 37°C with gentle 
agitation as for heat-shock transformation. Cells were then plated on 
selective LB agar. 
4.2.4D Mini-scale plasmid preparation 
Preparation of plasmid DNA on a small scale for quick 
analysis was carried out according to the method of Wilimzig (1985). The 
cell pellet of a 2ml overnight culture was resuspended in cold 250µ1 TELT 
buffer (4% Triton X-100, 0.0625M EDTA/pH 8.0, 0.05M Tris/pH 7.5, 0.1% 
LiCI) and chilled on ice for 5 minutes. A 25µ1 volume of freshly prepared 
aqueous solution of lysozyme (1 Omg/ml) was added. The mixture was 
boiled for 1 minute and centrifuged at 15,800 x g in a microfuge for 30 
minutes at 4°C. The pellet (comprising bacterial chromosomal DNA and 
cell debris) was removed with a sterile toothpick and the plasmid DNA 
was precipitated with 2X volumes of 95% ethanol and pelleted 
immediately at 15,800 x g for 15 minutes. The DNA pellet was washed 
twice with 70% ethanol, vacuum dried and resuspended in 50µ1 of ddH2 0. 
Three to 5µ1 of the resuspended DNA was usually sufficient for a single 
restriction enzyme analysis. 
4.2.4E Large scale plasmid preparation 
A one-tenth volume of an overnight 5ml cell culture 
containing the desired recombinant plasmid was inoculated into 500ml 
LB medium and grown overnight at 37°C with vigorous agitation 1n an 
incubator shaker (approximately 300rpm). The cells were pelleted by 
centrifugation at 4000 x g for 15 minutes using a SA600 rotor m a Sorvall 
centrifuge (Du Pont Instruments, Australia) at 4°C, resuspended in 10ml 
of 25% sucrose/TE and maintained on ice. To this was added 1.5ml of 
freshly prepared lysozyme solution (20mg/ml in 0.25M Tris/pH 8.0) and 
5ml of 0.5M EDT A/pH 8.0. The mixture was swirled intermittently on ice 
for 5 minutes. To this mixture, 15ml of Brij/DOC solution (0.01M Tris/pH 
7.4, 0.001M EDT A/pH 8.0, 0.01 % Brij 58, 0.4% sodium deoxycholate) was 
added rapidly, mixed quickly by inversion several times and left on ice 
until lysis had occurred. Cell debris and chromosomal DNA were pelleted 
by centrifugation at 39,000 x g using a SS-34 rotor for 1 hour at 4°C. The 
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clear supernatant was carefully decanted into a clean polypropylene 
tube and 3% w/v NaCl and 1/4 volume of 50% polyethylene glycol (PEG 
6000) were added. The plasmid DNA/PEG complex was left on ice for at 
least 2 hours and pelleted by mild centrifugation. Dissolution of the 
pellet was facilitated by warming the solution to 65°C in 5ml TES (0.01M 
Tris/pH 7.4, 0.001M EDTA/pH 8.0, 0.58% NaCl). Caesium chloride (8.0g) and 
0.6ml of ethidium bromide ( lOmg/ml) were added. The caesium chloride 
was dissolved by inversion and the mixture was left on ice for between 
30 minutes and 1 hour. Under these conditions, PEG was displaced from 
the solution and formed a flocculent precipitate at the top of the tube. 
After centrifugation at 12,000 x g for 30 minutes at 4° C, the supernatant 
was decanted carefully into polyallomer ultracentrifuge tubes leaving 
the flocculent PEG precipitate adhering to the polypropylene centrifuge 
tube walls. The density of caesium chloride was adjusted to l.6g/ml by 
addition of approximately 1.5ml of TES. Paraffin oil was added using a 
syringe fitted with a 21 G needle and the tubes were balanced to within 
50mg by the addition of caesium chloride ( 1.6g/ml). The tubes were 
ultracentrifuged in a Beckman L 7 ultracentrifuge using a VTi65 rotor 
(Beckman Instruments Inc., USA) at 320,000 x g overnight at 18° C. The 
lower plasmid band was extracted with a side puncture just beneath it 
using a 1ml syringe fitted with a 19G needle . Ethidium bromide was 
removed by extracting the plasmid DNA thrice with an equal volume of 
water saturated butanol. The DNA was then dialysed against lX TE buffer 
with 3 changes and its concentration was measured at OD260· 
4.2.5 Southern analysis 
The procedure for Southern analysis, including 
hybridisation with specific DNA probes has been described ID Section 
2.2.8. The probes used were derived from RadLV /Vl3 , a full length 
ecotropic retroviral clone. They are the LTR probe , a 500bp Pstl / Kpnl 
fragment, the gp70 en v and p 15E probes which were cloned as 800bp 
Hp a II Ba m HI and 850bp Ba m HI / X b a I fragments , respectively , and the 
leader/gag (L) and pol probes, derived as 550bp P v ul/BstEII and 600bp 
Kpnl/Kpnl fragments, respectively (Fig. 1). The Rad/LV gp70 e n v probe 
overlaps the munne ecotropic en v specific probe as defined by 
Chattopadhyay et al. (1982). Restriction sites in RadLV/Vl3 were mapped 
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Fig. 1 Restriction map of the RadLV/ VI 3 clone. Restriction sites were mapped by Rassart et al. (1986) and confirmed in 
this laboratory. DNA fragments used as probes are indicated by solid black lines. These were subcloned from pBR322/VI3 
into pGEMR vectors. ( c:z::::c:a ) and ( """"" ) represent the position of the AKR ecotropic env probes used by 
Chattopadhyay et al. (1982) and Moore & Chan (1982), respectively . 
by Rassart et al. (1986) and also in this laboratory by Dr C. Jolly, and were 
found to be consistent with the complete nucleotide sequence of RadL V-
pMOL52 (Merregaert et al., 1987). 
Subcloned fragments were prepared for use as probes 
either by digestion with appropriate restriction enzymes or by 
polymerase chain reaction (PCR) with the primers T7 (5' T AA TAC GAC 
TCA CTA TAG G) and SP6 (5' ATT TAG GTG ACA CTA TAG) that flank the 
cloning sites of all pGEMR vectors. The PCR protocol comprised an initial 
denaturation at 94°C for 3 minutes, followed by 40 cycles of 94°C for 1 
minute, 48°C for 1 minute and 72°C for 1 minute. Amplification was 
performed under oil 1n a 50µ 1 reaction containing 1 X PCR buffer 
(Promega, USA), 100 pg DNA template, O. lµM each of primers SP6 and T7 , 
0.2mM dNTP (Pharmacia, USA) and 2U Taq polymerase (Promega, USA) 
using a water bath based thermal cycler (Bartelt Instruments, Australia). 
Amplified fragments were electrophoresed, excised and extracted from 
the gel using the Geneclean kit (~IO 101 Inc., USA). 
4.3 Results 
4.3.1 Increased virus production after intrathymic 
passage 
Although explanted thymic tumours were observed to be 
made up of cells with physical characteristics common to C 1- V 13D cells , 
they contained conspicuously more intracellular viral particles than the 
original Cl-V13D cells (Fig. 2a & b). Cl-V13D clones established in culture 
from these thymic tumours, and confirmed to have originated from C 1-
V 13D by FACS and Southern analysis (data not shown) also revealed the 
presence of many type C viruses, some budding from the plasma 
membrane (Fig. 2c). The data suggested that passage through the thymus 
had increased cellular permissiveness for viral replication. 
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a) 
Fig. 2 Electron micrographs of (a) a 1 ° thymic lymphoma 
which resulted from intrathymic inoculation of C 1-V l 3D 
and (b) a higher magnification of the boxed region showing 
the presence of intracellular virus particles. (c) One clone 
isolated following in vitro culture revealed numerous 
C-type viral particles , some of which can be seen budding 
from the plasma membrane. 
b) 
c) 
0.5µ 
4.3.2 Cl-V13D harbours numerous RadLV or RadLV-
like proviruses integrated into its genome 
DNA from Cl-V13D was compared with DNA prepared from 
syngene1c DBA/2j and allogeneic CBA/H mouse livers for the presence of 
any newly integrated RadL V-like viral genomes using the RadL V gp70 
en v probe, which 1s sufficiently specific for ecotropic envelope 
sequences (Chattopadhyay et al., 1982; Merregaret et al., 1987). DBA/2j 
mice carry only full length endogenous ecotropic RadL V or RadL V-like 
genomes, as indicated by Pstl and EcoRI digests (Fig. 3a & 3b). The single 
band was shown to represent at .least two proviruses, one or both of 
which has an internal Hind11I site (Fig. 3c). With this probe, no 
endogenous viruses were detectable in DNA from CBA/H mice, indicating 
that CBA/H mice do not carry any ecotropic RadL V or RadL V-like viruses. 
This result reinforces the suitability of the CBA/H mouse as a host strain 
1n this study. Cl-V13D was found to carry many newly integrated viruses 
1n its genome compared to DBA/2j liver DNA (Fig. 3 ). P st I digestions 
revealed the presence of four distinct viral fragments 1n Cl-V13D which 
were approximately 9.0kb, 5.5kb, 2.5kb and 1.9kb 1n size (Fig. 3a). The 
smaller fragments ( <6.6kb) could represent viruses with an internal P st I 
site, or defective viruses. Multiple bands, some clearly smaller than the 
full length virus were also observed in EcoRI- and HindIII-digested 
Cl-V13D DNA. Since the original RadLV/Vl3 clone does not carry any 
internal Hind III or Eco RI restriction sites, these smaller fragments 
represent either defective or recombinant viruses. 
The less specific RadL V probes which hybridised with the 
pol, L/gag and p15E sequences also detected multiple retroviral bands 1n 
both CBA/H and DBA/2j liver DNA (Figs 4 & 5; p15E data not shown). In 
comparison with DBA/2j germline DNA, however, Cl-V 13D showed 
several new viral bands. These were detectable with each of the 3 probes 
using the three different restriction enzymes, PstI, EcoRI and HindIII 
(Figs. 4 & 5, p 15E data not shown). 
52 
a) tj b) tj C ) tj () tD () tD () tD tD > () tD > tD > > 
' 
() () 
' 
~ 1--1 > ' 1--1 > 1--1 ' 
::x: u. I ' 
~ I ' 
I ~ 
< ::x: u. ::x: u. ........ ........ < < 
~ ~ 1--1 ........ ........ 1--1 
........ 1--1 ........ 
< w ~ ~ w ~ w ~ 
......... ......... 
tj < tj < tj < 
......... ......... 
......... 
......... 
-23.1 
-23.1 
-9.4 :....... ,. , 
- 6.6 
-23.1 
-4.4 I- -9.4 
-9.4 
-6.6 
-2.4 
-6.6 
-2.0 
-4.4 
-4.4 ' 
Fig. 3 Southern analysis showing the pattern of RadL V or RadL V-like proviral integrations in C 1-V 13D cells. DNA was digested with 
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4.3.3 Southern analysis revealed new retroviral 
events in some Cl-VJ 3D progeny cell lines 
derived after intrathymic passage 
Southern analysis was used to determine whether new 
retroviral integration events had occurred in C 1-V 13 D during the period 
of cell replication in the thymus. The leader/gag (L), pol, gp70 env, p15E 
and L TR probes were used to detect any changes in the viral integration 
patterns in Cl-V13D and progeny cell lines. Three restriction enzymes 
were used to digest DNA, namely Pstl, EcoRI and Hindlll. As mentioned 
previously, P s ti cuts the RadL V /V 13 viral clone once within each L TR 
and can therefore be used to assess the length of integrated viral 
genomes. Both EcoRI and Hindlll do not cut within the RadLV/V13 
genome (Rassart et al., 1986) and can therefore be used to assess the 
number of integration events and to provide a unique clonal integration 
pattern. 
DNA preparations from randomly selected clones were 
compared. They were derived in vitro from primary, secondary and 
tertiary tumours which developed following intrathymic inoculation of 
Cl-V13D cells. DNA was digested with Pstl, Hindlll and E c oRI and 
analysed using all 5 viral probes. The data from nine primary , two 
secondary and four tertiary clones are presented in Figures 6 , 7 & 8. 
Restriction analysis using P s ti detected no change in retroviral 
integration pattern, either with the LTR, L, p15E or the gp70 env probes 
(Fig. 6 & 7, some data not shown). A 5.5kb viral band in Cl-V13D and in 
progeny cell lines was detected with the gp70 en v probe (Fig. 7 , 
arrowed). This fragment also hybridised with the pol , L, LTR (Fig . 6a) and 
p 15E probes, albeit poorly with the latter (data not shown ) . A likely 
explanation is that this fragment is the 5'-end of a virus with a P s ti site 
within the p 15E region covered by the probe , or it is a defective virus 
with a deletion involving the p15E region . The smaller 2.4kb gp70 en v 
positive viral band (Fig. 7) has no coincident p o l or L/g a g sequence s 
which could be detected with the probes (Fig. 6) , and may al so represent 
a defective virus carrying only the RadL V gp70 en v and p 15E sequences 
or the 3'-end of a virus with an internal P s ti site different from the 
virus discussed above. 
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Fig. 7 Southern analysis using the gp70 env probe to detect changes in the pattern 
of RadLV integration in Cl-V13D primary clones and 2 tertiary clones, ET4-D(T-E)M4C 
& ET4D(Tl-E)M4D. DNA was digested with PstI. The 5.5kb fragment (arrowed) also 
hybridises with the pol, L, LTR and p15E probes. CBA/H thymus (Thy) DNA was 
included as the control. DNA size markers (kb) are indicated. 
The pattern of RadL V integration was also analysed 1n 
EcoRI- and HindIII-digested DNA using the RadLV-specific gp70 env 
probe (Figs. 8a & 9, respectively , some data not shown). At least 10 
fragments of size >9.4Kb were observed in EcoRI-digested Cl-V13D DNA 
and in DNA isolated from clones representing primary, secondary and 
tertiary thymic tumours (Fig. 8a). This suggested at least 10 different 
viral integration sites. Since this pattern was maintained through 
several thymic passages, it confirmed the clonal descent of the reisolated 
clones and also indicated that no further integration events involving 
RadL V or RadL V-like viruses had occurred, which could be associated 
with oncogenic progression in these clones. By reprobing the same blot, 
it was observed that the 4.6kb band (arrowed, Fig. 8a) did not hybridise 
with either the L, or pol probes (Figs. 8b & 8c), and could represent a 
defective virus lacking the pol and gag genes, or a recombinant virus 
carrying an internal Eco RI site 3' to the pol gene. A complex but 
conserved band pattern was also detected using the gp70 en v probe on 
Hi ndIII-digested DNA from a range of primary, secondary and tertiary 
clones (Fig. 9). Again, this suggested multiple viral integrations , many 
carrying internal Hind III sites which presumably arose by 
recombination. These were present 1n Cl-V13D, before it was passaged 
into the thymus. A similar pattern was also seen in other clones studied 
(data not shown). 
New bands were observed when Cl-V13D was compared with 
its cloned progeny using the po I probe. These differed only slightly in 
size. These new fragments were not uniformly present in all clone s 
analysed and were detectable only in EcoRI- and PstI-digested DNA (Figs . 
8c & 10). These bands did not coincide with bands detectable with other 
probes. However, it was possible that the complex pattern of viral 
integration detected with some probes , eg. LTR, could be obscuring other 
faint new bands (Figs. 6a & 11). As shown in Figure 3, CBA/H mice carry 
no viral genes related to RadL V /V 13 gp70 en v . The new viral bands 
detected with the pol probe appeared to lack env sequence s homologou s 
to RadL V , indicating that they probably arose by recombination 
involving viruses which do not carry RadL V or RadL V-like envelope 
sequences present in Cl- V 13D or CBA/H host thymus. 
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New fragments detectable with the pol probe in DNA 
digested with P st l were larger than 8.2kb, indicating the loss of at least 
one P st l site from the viral L TR (Fig. 10). These new recombination 
products differ from most full length munne retroviruses which 
typically contain one P stl site within each LTR, g1v1ng an 8.2kb viral 
fragment upon P s ti digestion (Chattopadhyay et al., 1982). New viral 
recombination and/or integration was apparent only 1n some clones 
isolated after primary thymic passage. The viral integration pattern in 
the ET4-A clone, for example, showed no change and was similar to that 
seen 1n Cl-V13D (Fig. 10). Tumorigenicity studies comparing ET4-A, B, C 
and D clones from the primary ET4 thymic tumour (Table 1) argue 
against the importance of these new recombination events in oncogen1c 
progression, since all clones were found to be equally tumorigenic in 
mice (Fig.10; Southern analysis of ET4-B not shown). It was concluded 
that these recombination events were probably incidental and random 
and had no significant bearing on the increased tumorigenic potential 
exhibited by primary clones represented in this study. 
The secondary [ET4-D(TI-E)] and tertiary [ET4-D(TI-E)M7A] 
clones, derived from serial passage of the primary ET4-D clone through 
the thymus, also did not show any further change 1n the viral 
integration pattern, as indicated by the pol probe. This was confirmed 
using Pstl and EcoRl restriction analysis (Figs. 8c & 10b). Since the 
increasing tumorigenicity observed with successive intrathymic 
passage of Cl-V13D could not be correlated with any further viral 
integration and/or recombination events, it 1s very probable that the 
changes detectable with the pol probe in this model are associated only 
with the primary growth of Cl-V13D in the thymus, ie. the first passage. 
4. 4 Discussion 
This study was aimed at determining whether further retroviral 
integration and recombination events were associated with the 
increased tumorigenic potential observed 1n progeny clones of Cl-V13D , 
derived after repetitive intrathymic passage. Electron microscopy 
demonstrated the presence of numerous type C virus particles in C 1-Vl 3D 
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TABLE 1 
Cell line 
1° Tumour 
ET4 
ET4 
ET4 
ET4 
Control 
Cl-V13D 
Increased tumorigenicity of clones derived from the 
ET4 thymic tumour 
Clone 
A 
B 
C 
D 
Ip 
2/3 
3/3 
3/3 
1/3 
0/3 
Incidence of tumour formation 
IV 
3/3 
3/3 
3/3 
3/3 
0/3 
SC 
0/3 
0/3 
0/3 
0/3 
0/3 
it 
NI' 
NI' 
NI' 
1 1 / 1 1 
12/15 
The ET4 thymic tumour which developed following inoculation of 5x105 C 1-V 13D cells 
intrathymically into irradiated (4Gy) CBA/H mice was explanted and cultured in vitro. 
C 1-V 13D progeny were isolated, subcloned twice and tested for tumorigenicity in 
similarly irradiated CBA/H hosts by inoculation via different routes . Death occurred 
within 14 - 21 days post-inoculation. Mice were studied for up to 15 months . 
NT: not tested 
progeny cell lines, as opposed to few or none seen 1n the original 
Cl-Vl 3D cell line. A parallel situation exists in HIV infection where the 
thymic microenvironment has been 
the VITUS 1n chronically infected 
found 
cells 
to upregulate expression of 
(Schnittman et al., 1991). 
Increased virus production and the presence of viral gene products have 
been correlated with oncogenes1s 1n the case of MoMuL V-induced 
lymphomas (Tsichlis, 1987). In the case of avian erythroblastosis VITUS , 
continual virus production and the presence of viral products was found 
to be necessary for maintenance of the leukemic state of infected cells 
(Graf et al., 1978). The increased number of virus particles seen in 
Cl-V13D cells after intrathymic passage may function similarly, 
contributing to the oncogenic process. 
In com pan son to germ line DBA/2j liver cells, C 1-V l 3D cells carry 
many full length RadL V-like proviruses 1n their genome. This was 
indicated by Southern analysis on Eco RI-digested DNA using the 
ecotropic RadL V gp70 en v probe. This probe appears to be specific for 
RadL V and RadL V-like envelope sequences and differs from the AKR 
ecotropic env probe used by Moore & Chan (1982). This probe was 
derived from A-AKR 623, which was cloned by Lowy et al. (1980). With 
this AKR ecotropic e nv probe (Fig. 1), single fragments of size 7 .Okb and 
6.5kb were detected in Hindlll-digested DNA from CBA and DBA mice , 
respectively. In the experiments described here using the RadL V gp70 
env probe, no RadL V-like ecotropic envelope sequences were detected in 
CBA/H liver DNA, while at least two proviruses , one with an internal 
Hindlll site, were detected in DBA/2j liver DNA. 
It is not possible to determine how many retroviral integration 
events had occurred at the time of initial virus infection of the C 1-V 13D 
cell line, or to determine whether further retroviral events occurred 
during the long process of adaptation of the cell line to in vitro culture . 
Studies are currently in progress to investigate this process more fully. 
Restriction mapping of integrated viruses in C 1-V 13D using P st I , E coR I 
and Hin dill has indicated that many proviruses present in C 1-V 13 D are 
recombinant viruses (see Chapter 5). Many of these have at least one 
new restriction site 1n their genome and differ from the original 
RadLV/Vl3 clone which does not contain internal E c oRI or Hindlll site s . 
56 
There is only the single Pstl site m each LTR (Rassart et al., 1986). Some 
of the viruses in Cl-Vl3D could be either MCF, ecotropic or xenotropic 
viruses. These viruses have been shown to carry internal Hi ndlll and/or 
EcoRI sites (Rands et al., 1981; Chattopadhyay et al., 1982). Multiple 
retroviral integrations in Cl-Vl3D appeared to be associated with the 
capacity of cells to proliferate continuously and autonomously in vitro. 
However, C 1-V l 3D is not fully transformed and further transformation 
has been achieved only after replication within the thymic 
microenvironment. 
The leukemogenic potential of many munne leukemia viruses, 
including recombinant viruses has been mapped to en v and L TR 
determinants (Lenz et al., 1984; Holland et al., 1985; Vogt et al. , 1985; 
Rassart et al., 1986 & 1988) and in a few cases, to the gag (Aziz et al., 1989) 
or gag/pol genes (Rassart et al. , 1983; Lenz et al., 1983; Tsichlis, 1987). 
New retroviral integration and/or recombination events involving the 
pol gene were detected In many clones isolated after pnmary 
intrathymic passage of C 1- V l 3D. Of four clones derived from ET4, Ie . 
ET4-A to D, only son1e showed recombination involving pol. However, all 
were shown to be tumorigenic in vivo (Table 1). ET4-A , with no 
detectable pol changes, was as tumorigenic as clones having new pol 
changes, indicating that this event was probably not directly related to 
the observed increase In tumorigenicity. On subsequent intrathymic 
passage of these clones, no further retroviral changes involving RadL V 
or other recombinant viruses were observed. This occurred despite an 
increase in tumorigenici ty in progeny clones with each thymic passage . 
This confirmed that retroviral integration or recombination was not 
required for increased tumorigenici ty which occurred with passage 
through the thymus. The complex retroviral integration pattern of ET4-
D, detectable with the pol probe, was maintained in the tertiary clone 
ET4-D(Tl-E)M7A. These results contrasted with studies In the AKR and 
Molony MuL V models , where viral recombination was shown to play a 
significant role in the oncogenic process (reviewed in Section 1.5.3). 
Results presented here also dissociated new retroviral integration or 
recombination events from differentiation events observed to occur In 
C 1-V 13 D cells during thymic residence ( Chapter 3). While differentiation 
was observed to occur consistently in vivo and with each intrathymic 
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passage (Chapter 3 ), the occurrence of retroviral changes involving the 
pol sequence shown 1n this chapter were random or incidental and bore 
no relationship to the progressive increase in tumorigenicity. 
Data presented here cannot be taken to undermine the importance 
of retroviral integration and recombination events 1n the 
transformation process. However, in the case of Cl-V13D, it would appear 
that genetic changes related to retroviral integration or recombination 
had already occurred during initial in vitro infection of C 1-V l 3D and 
the long term adaptation to tissue culture. These were sufficient to 
confer proliferative capacity and arrest maturation of the target cell. 
However, as shown 1n Chapter 3, Cl-V13D could proliferate and undergo 
limited differentiation if located 1n the correct microenvironment. In 
the absence of new retroviral events which can be associated with 
oncogen1c progression 1n Cl-V13D, the possibility that oncogen1c 
progression 1s mediated by genetic changes associated with the 
differentiation of C 1-V l 3D 1n response to the thymic microenvironment 
becomes more likely. This would also be consistent with data presented in 
Chapter 3. Any genetic changes may or may not act in concert with 
proto-oncogenes already functionally upregulated or dysregulated by 
retroviral integrations which occurred during the initial in vitro phase 
of Cl-V l3D immortalisation. 
SUMMARY 
Retroviral recombination and reintegration into the host genome are 
common events during retroviral replication within cells. In some cases , 
these events have been shown to contribute to the oncogenic proces s, 
either through the generation of more leukemogenic viruses through 
recombination or by dysregulation of cellular genes as a re sult of 
further proviral integration events. Southern analysis was performed to 
investigate retroviral integration events in C 1- V l 3D and progeny cell 
lines, which were isolated after first, second and third pass age s 
in trathym ic ally. Several different viral gene pro bes and restriction 
enzymes were used to determine whether further retroviral events were 
associated with the increased tumorigenicity of late passage clones. In 
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general, there was no evidence of reintegration of RadL V-like viruses 
detectable with the specific RadL V gp70 env probe . A large number of 
Cl-V13D progeny lines demonstrated the presence of new recombinant 
viruses involving the pol gene. These events did not correlate with an 
increase 1n tumorigenicity noted amongst C 1- V 13 D progeny . It 1s 
proposed that the initial retroviral integration events were sufficient to 
partially transform C 1- V l 3D cells in vitro. While replicating 1n the 
thymic microenvironment, Cl-V13D cells undergo neoplastic 
differentiation and further transformation towards a more tumorigenic 
phenotype. It 1s possible that genetic changes associated with 
differentiation within the thymus may have affected proto-oncogenes 
involved in cellular growth and differentiation. 
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Analysis 
CHAPTER 5 
of viral and flanking 
DNA 
5.1 Introduction 
• genomic 
Data presented 1n the preceding chapter indicated that multiple 
retroviral events had occurred during in vitro derivation of C 1-V 13 D. 
Subsequent retroviral events which occurred during replication of 
Cl-V13D in the thymus appeared to be unrelated to the oncogenic process. 
It was hypothesised that the retroviral integration and recombination 
events following in vitro infection and subsequent culture were sufficient 
to immortalise Cl-V l 3D, partially transform it and simultaneously arrest its 
maturation. Replicating under strong selective pressure 1n the thymic 
microen vironment, C 1- V l 3D could be induced to differentiate, indicating 
that while differentiation was blocked in vitro, it was not an irreversible 
event (Chapter 3). 
The hypothesis that tumour cells continue to undergo neoplastic 
differentiation 1n association with oncogen1c progression has been 
proposed in this study. This was based on evidence that some cellular proto-
onco genes involved with tumorigenesis also play an important role 1n 
regulating cellular proliferation and differentiation (reviewed 1n Chapter 
1). The experiments described 1n this chapter were initiated with the 
objective of finding novel cellular proto-oncogenes, whose functions have 
been disrupted due to retroviral integration and/or recombination, leading 
to immortalisation, maturation arrest and partial transformation of 
Cl-V13D. The strategy involved construction of a genomic library from 
Cl-V13D and selection for clones carrying the RadLV gp70 env sequence . 
Viral and genomic DNA flanking the site of retroviral integration were 
analysed using restriction mapping, Southern analysis using specific viral 
probes and sequencing. 
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5. 2 Materials and Methods 
5.2.1 Genomic library construction 
5.2.JA Partial digestion of Cl-V 13D DNA with Sau3Al 
Genomic DNA was prepared as described 1n Section 2.2.8A. 
The construction of a genomic library was carried out according to 
Promega's Protocols and Application Guide (Titus, 1991). Partial digestion 
of Cl-V13D DNA with Sau3AI was carried out to generate overlapping 
DNA fragments of 15-23kb. The digestion was optimized on a small scale 
using various dilutions of the enzyme. After 30 minutes incubation at 
3 7°C, the digestions were stopped by the addition of 0.5M EDT A/pH 8.0 and 
sample buffer (38% sucrose, 0.1 % bromophenol blue, 67mM EDTA). The 
degree of digestion was visualized on a 0.65% agarose gel. The amount of 
enzyme needed to produce the desired 15-23kb fragments could be 
determined from the intensity of fluorescence, which was directly 
related to the mass distribution of DNA. To minimise the number of DNA 
molecules smaller than the desired size in the large scale preparation , 
half the amount of enzyme that produced the maximum amount of 
fluorescence in the desired size range was used . 
DNA (lOOµg) was digested in a large scale preparation using 
conditions identical to that used in small scale reactions. The digested 
DNA was extracted with an equal volume of TE-saturated 
phenol :chloroform (24:1) by gentle . . 1nvers1on and subsequent 
centrifugation at 15,800 x g 1n a microfuge for 5 minutes. The upper 
aqueous phase was transferred to a fresh tube and extracted once with 
an equal volume of chloroform:isoamyl alcohol (24: 1 ) . After 
centrifuging again to separate the phases , the upper aqueous phase was 
removed into a fresh tube . The DNA was precipitated at -20°C for 30 
minutes by addition of O. lX volume of 7.5M ammonium acetate and 2X 
volumes of ethanol , pelleted again at 15 ,800 x g for 10 minutes and rinsed 
twice with 70% ethanol. It was dried under vacuum and resuspended in 
5 00 µl TE buffer/pH 7.4. 
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The DNA was size fractionated on a 10-40% continuous 
glycerol gradient for 24 hours at 83,000 x g ( 1 8 ° C) in a SW 41 Ti rotor 
(Beckman, USA). Fractions (about 5 drops per fraction) were collected by 
puncturing a hole at the bottom of the tube. A small aliquot was removed 
from each fraction and electrophoresed on a 0. 7% agarose gel to check 
the size distribution of the digested products. Fractions containing DNA 
of the desired size were pooled and precipitated using 7 .5M ammonium 
acetate and ethanol. The DNA was pelleted and dried as described 
previously, resuspended in an appropriate amount of TE buffer and 
stored at -20° C. 
5.2.JB 
(Promega, 
Ligation to )..,GEM-11 BamHI arms and preparation of host 
strains for infection 
The vector used for library construction 
USA). For optimal yield of recombinant 
was AGEM-11 
DNA molecules 
appropriate for packaging into A particles, the best molar ratio of A a rm s 
(43kb) to genomic insert (averaging 15-23kb) was tested and established 
to be 1: 1. The arms and insert were added iogether and precipitated 
overnight at -20°C with 7.5M ammonium acetate/pH 7.0 and 2X volumes 
ethanol. The pellet obtained after centrifugation was washed twice with 
70% ethanol and vacuum dried. Ligation was carried out for 16 hours at 
15 ° C in a water bath in lX ligase buffer (Promega, USA) containing 1 
Weiss unit of T4 DNA ligase per µg of DNA. On the same day, a colony of 
KW251 cells (supE44, supF58, galK2, galT22, metBl, hsdR2, mcrBl, mcrA-, 
argA81:TnlO, recDlOl4, F-) [Promega, USA] was inoculated into 3ml LM 
medium (1 % tryptone, 0.5% yeast extract, 0.5% NaCl, lOmM MgS04) 
containing 0.2% maltose. The cells were grown overnight at 37°C with 
vigorous agitation. Fifty microlitres of the overnight culture was 
inoculated into 50ml of LM medium containing 0.2% maltose. The cells 
were grown at 37°C with vigorous agitation until the absorbance at OD6 o o 
reached 0.5-0.6. The cells were then pelleted, resuspended in half the 
volume of ice-cold lOmM MgS04 and kept on ice, ready for infection with 
recombinant phage particles. 
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5.2.JC In vitro packaging and infection of KW251 cells 
In vitro packaging of recombinant phage DNA was carried 
out using the Gigapack Gold packaging extract purchased from 
Stratagene, USA. The phage was packaged according to the supplier's 
recommendations. Briefly, DNA was added immediately to thawing 
freeze-thaw extracts containing phage packaging proteins, mixed 
quickly and placed on ice. Sonic extracts ( 15µ 1) containing phage 
preheads were then added. Phage proteins, preheads and DNA were 
mixed well without introduction of a1r bubbles, centrifuged quickly 1n a 
microfuge (15,800 x g, 3-5 seconds) and incubated at 22°c for 2 hours. A 
5 00 µl volume of phage dilution buffer (SM) containing 0.02M Tris/pH 7.4, 
O.lM NaCl and 0.01M MgS04 was then added. Packaged phage particles 
were incubated with KW251 cells at 37°C for 20 minutes , mixed with the 
appropriate amount of top agar (0.7% Sigma Type II agarose in LM) at 
45 °c and plated immediately onto 15cm LB agar plates prewarmed to 37°C. 
To construct a library that was representative of the whole genome, 30 
platings were made on 15cm plates to achieve a total of 8.4x 1 os clones for 
screening. The plates were incubated overnight at 37°C for 8 hours. 
5.2.2 Screening of recombinant A clones carrying the 
RadLV gp70 env sequence 
Plates were cooled at 4° C for approximately 2 hours to 
harden the top agar layer before plaque lifts were made. A 15cm 
diameter sterile Hybond N+ membrane (Amersham, Australia) was laid 
on top of each agar plate for 1 minute, removed , and the DNA on the 
membrane was fixed by placing it for 20 minutes (with the side 1n 
contact with the agar facing up) on a piece of Whatman No. 3 filter 
paper pre-soaked with 0.4M NaOH. After fixation, the membranes were 
washed at least thrice with 2XSSC. Specific nucleic acid sequences were 
detected as described previously (Chapter 2, Section 2.2.8E). RadL V gp70 
env positive recombinant phages were harvested with a sterile glass 
pasteur pipette by slicing off the top agarose layer and placing it in 1ml 
phage storage buffer, PSB (0.02M Tris/pH 7.4, O. lM NaCl, lOmM MgS04 , 2% 
gelatin) containing 30µ 1 chloroform. The samples were placed on a 
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rotator at 22° C for at least 2 hours or at 4° C overnight to allow the phage 
particles to diffuse out of the agar into the medium. 
Selected clones were replated twice and plaque lifts were 
taken after each replating. The purity of the clones was determined by 
hybridization to 32P-labelled RadLV gp70 e nv probe. 
5.2.3 Preparation of A DNA from phage lysates 
A volume of 2µ1 purified phage particles 1n PSB from each 
individual 'A clone was spotted onto freshly plated KW25 l cells and 
incubated at 3 7° C overnight. A plaque of size 5mm in diameter usually 
yielded sufficient infectious phage particles for preparation of a good 
phage lysate. The 5mm plaques were placed in 200µ1 SM buffer with a 
drop of chloroform. The phage particles were allowed to diffuse out at 
room temperature for at least 2 hours, centrifuged to remove agar and 
chloroform and the supernatant, containing phage particles, was used to 
infect 500µ I of an overnight culture of KW25 l cells which had been 
resuspended in IOmM MgS04. The phage/cell mixture was incubated at 
3 7 ° C for 20 minutes to facilitate the adsorption of phage particles onto 
cells. Prewarmed LB medium (20ml) was then added and the infection 
was allowed to continue with vigorous agitation at 350rpm until complete 
lysis of bacteria was achieved. Sodium chloride was added to achieve a 
final concentration of IM and the mixture was left on ice for 45 minutes 
to allow phage particles to dissociate from the cell debris. As an optional 
step, the lysed mixture could be incubated with I OOmg/ml of DNasel and 
I OOmg/ml of boiled RN ase A for a further 45 minutes at 3 7° C before the 
addition of NaCl. The cell debris was removed by centrifugation at 
2000 x g for 20 minutes, polyethylene glycol (PEG) 6000 was added to a 
final concentration of 10% and the mixture was kept at 4°C overnight. 
After centrifugation for IO minutes at 17,200 x g 1n a Sorvall centrifuge 
using a SS34 rotor (Du Pont, Australia), the phage/PEG pellet was 
resuspended 1n SM buffer and extracted with an equal volume of 
chloroform. The aqueous phase was transferred to an ul tracen tri fuge 
tube and the phage particles pelleted at 110,000 x g 1n a SW55 Ti rotor for 
2 hours at 4°C. The pellet was dissolved slowly in 400µ1 SM buffer at 40c 
overnight. The phage particles were then placed in a phage caesium 
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chloride (CsCl) gradient (2% sodium N-lauroyl sarcosine, 0.005M 
Tris-HCl/pH 8.0, 0.04M EDTA/pH 8.0, 400µg/ml ethidium bromide, 63% w/v 
CsCl) according to Buckley & Goding (1988) and ultracentrifuged at 
348,000 x g overnight using a TLA 100.4 rotor (Beckman, USA). The phage 
DNA band was extracted with a 2 lG needle attached to a 1ml syringe and 
the ethidium bromide was removed by extracting thrice with an equal 
volume of water saturated butanol. The phage DNA was precipitated with 
an equal volume of isopropanol at -20°C, washed twice with ethanol, 
vacuum dried and resuspended in an appropriate amount of ddH2 0 or 
TE/pH 7.4. The DNA was stored at -70°C. 
5.2.4 Strategy for mapping 
and flanking . genomic 
A clones 
DNA 
. 
carrying viral 
5.2.4A Southern analysis of endonuclease restricted A-DNA 
Composite physical maps were deduced fron1 partial 
restriction endonuclease mapping and sequence analysis of DNA regions 
in the immediate vicinity of 'A arms using the T7 (5' T AA TAC GAC TCA CT A 
TAG G) and SP6 (5' ATT TAG GTG ACA CTA TAG) sequencing pnn1ers 
(Fig. 1 ). Four restriction enzymes were used, namely, Sfil, Hi ndlll , E c oR I 
and P stl. The use of Sfil, which is present in the 'AGEM-11 vector at both 
ends of the polycloning site allowed the size of most inserts to be 
determined since the 8-base Sfil recognition sequence occurs 
infrequently in genomic DNA. The Hi ndlll site occurred only once m the 
9kb right arm of 'AGEM-11 and was therefore useful for positioning of the 
insert with respect to the vector. Al though there are numerous P st I 
restriction sites in the left 20kb arm of 'AGEM-11, none was present in the 
9kb right arm. Since P st! typically cuts at each LTR (Chattopadhyay et 
al., 1982), this enzyme could therefore be used to size the 3 ' LTR/host 
junction using the L TR probe. Eco RI sites are not present in either the 
vector or the RadL V provirus and could provide useful information on 
the size of the genomic DNA flanking the LTRs and also indicate new 
sites which may have been generated by recombination within the 
VlfUS. The restricted 'A clones were electrophoresed through agarose 
gels, transferred to Hybond N+ membranes and hybridised to RadL V 
proviral DNA probes as described in Section 2.2 .8 for Southern analysi s. 
65 
s 
B 
left arm (20kb) T7 Central stuffer (14kb) 
s 
B 
H 
4.9kb 
SP6 right arm (9kb) 
Fig. I A simplified structural map of the 11.GEM-ll vector used for Cl-V13D genomic 
library construction (not drawn to scale). The vector was purchased as dephosphorylated 
BamHI (B) arms (Promega, USA). The S.fil (S) sites at the ends were used to detennine the 
size of the cloned inserts while the HindIII (H) site was instrumental in the positioning of the 
provirus and its flanking genomic sequences. The SP6 and 17 RNA polymerase transcription 
start sites are indicated. 
1234567 1234 56 AB 
Fig. 2 An ethidium bromide stained gel illustrating unidirectional deletion using 
Exonuclease III (ExoIII). This method allowed the rapid construction of plasmids 
containing progressive unidirectional deletions of any inserted DNA. This facilitated 
efficient sequencing of large DNA fragments. ExoIII deletions of two plasmid clones 
are shown here. Numbers represent time points at one minute intervals. Lane (A) 
represents HindIII-digested DNA (kb) and lane (B) represents the 3kb linearised 
pGEM7Zf(+) plasmid. 
The position of viral probes are shown 1n Figure 1 (Chapter 4). 
Subcloning and sequencing of HindIII and PstI fragments of interest 
(including host-virus junctions) were also carried out as part of the 
mapping strategy. Procedures for subcloning and transformation have 
been described in Section 4.2.4. 
5.2.4B Isolation and subcloning of LTR-host junction DNA 
Hind III-fragments compns1ng 5' L TR-host junction 
sequences from A-1 (-3.2kb), A-7 (-2.8kb) and A-17 (-4.8kb), and the 3' 
LTR-host junction from A-1 (-8.0kb) were subcloned into the plasmid 
pGEM7Zf( +) at the Hin dIII polycloning site according to the procedure 
described 1n Section 4.2.4. A Hi ndIII LTR-host junction fragment of A-2 7 
(-1.5kb) was also subcloned. Fragments subcloned into plasmids were 
given the prefix pA. They were therefore designated as pA- 1 f2 ( H), 
pA-lfl(H), pA-7G, pA-17f2(D) and A-27f(C)l, according to the A clone from 
which they were derived. Plasmid DNA was prepared as described in 
Section 4.2.4E. 
5.2.4C Cycle sequencing with dye primers 
Double stranded A DNA (7µg) or plasmid DNA (lµg) for 
sequencing was denatured in 0.25M NaOH/EDTA for 5 minutes at 370c, 
placed on ice and neutralised with 3M sodium acetate/pH 6.0 to give a 
final concentration of lM. The denatured DNA was precipitated with the 
addition of 3X volumes 95% ethanol, kept at -700c for 15 minutes or -20°C 
overnight. The pellet was washed, vacuum dried and resuspended 1n an 
appropriate amount of water. Cycle sequencing was performed in the 
FTS-1 thermal cycler (Corbett Research, Australia) 1n 4 sealed capillary 
tubes each containing 20µ1 cocktail of d/ddNTP mix, 0.4pmol/µl dye 
primer (T7 or SP6), lX sequencing buffer, 0.6U AmpliTaq and an 
appropriate amount of DNA template. All reagents were supplied in the 
Tag Dye Primer Sequencing kit T7 /SP6 (Applied Biosystems Inc. , 
California, USA). Cycling parameters were 2 minutes at 94°C for 1 cycle, 
followed by 30 cycles of 94°C for 20 seconds, 53°C for 20 seconds and 72°C 
for 60 seconds. The 4 reactions from one sample were pooled at the end of 
the sequencing reaction , precipitated with 1.5µ1 of 3M sodium acetate/pH 
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5.2 and 80µ1 of 95% ethanol, pelleted, washed, and vacuum dried. The 
samples were electrophoresed on a 6% polyacrylamide gel containing 8% 
urea at 1600V for 14 hours 1n an automated DNA sequencer (ABI Model 
3 73A) and analysed using the ABI Data Analysis Program software , 
Version 1.2.0 (1989). Electrophoresis was carried out at the Biomolecular 
Resource Facility 1n the John Curtin School of Medical Research , 
Canberra, Australia. 
5.2.5 
5.2.5A 
Analysis of flanking genomic DNA distal to the 
LTR 
Identification of transcribed regions using [ a3 2 P J -dC T P 
labelled cDNA 
3 2P-labelled cDNA was prepared from Cl-V13D 
polyadenylated RNA. This was used as a probe to identify transcribed 
regions in isolated recombinant A-clones by Southern analysis. Total 
RNA was prepared as described in Section 3.2.5A and enriched for 
polyadenylated RNA using chromatography on oligo(dT)-cellulose as 
described by Sambrook et al. (1989). Briefly, the separation column was 
prepared by filling a 1ml silanized glass syringe with 0.5g of oligo(dT)-
cellulose (Sigma, USA) resuspended in O. lM NaOH. The glass syringe was 
plugged with silanized glass wool. A maximum of 10mg total RNA could be 
loaded per column. Equilibration of the column was carried out with poly 
A buffer (50mM sodium citrate, 0.5M NaCl, lmM EDTA, 0.1 % sodium 
N-lauroyl sarcosine/pH 7.5) until the pH was <8.0. Five to ten milligrams 
of total RNA was heated to 65°C for 5-10 minutes , cooled rapidly to room 
temperature and an equal volume of 2X poly A buffer was added. The RNA 
solution was loaded onto the column and the eluate collected into a sterile 
tube, heated again to 65°C for 5 minutes, re-applied to the column and 
collected. This process was repeated thrice . The column was then washed 
with 5-10 column volumes of poly A buffer or until OD2 60 absorbing 
material no longer eluted. Polyadenylated RNA was then eluted with 2-3 
column volumes of freshly prepared and autoclaved elution buffer 
(lOmM Tris-Cl/pH 7 .6, lmM EDT A, 0.05 % SDS ). Fractions of 400µ1 were 
collected into silanized Eppendorf tubes and those containing RNA 
(checked at OD260) were pooled. The RNA was precipitated with O. lX 
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volume of 3M sodium acetate/pH 5.2 and 2X volumes ethanol at -20°C 
overnight. It was pelleted, washed twice with 70% ethanol , vacuum dried 
and resuspended in a small volume of DEPC-water and kept at -70° C. 
The synthesis of 3 2 P-labelled cDNA was carried out 
according to Sambrook et al. (1989). One microgram RNA was mixed with 
250ng (dN)6 hexamers (Pharmacia, USA) at 65°C for 10 minutes. The 
mixture was chilled on ice and a cocktail consisting of reverse 
transcriptase (RT) buffer (Promega, USA), 500-600mM each of dGTP, dTTP 
and dATP (Pharmacia, USA), lOmM DTT, 50U/ml RNAsin (Promega, USA) 
and lOOOU/ml Moloney munne leukemia virus reverse transcriptase 
(Gibco, BRL, USA) was added followed by approximately lOOµCi of 
[a32p]-dCTP (Amersham, Australia). Synthesis was carried out at 42°C for 
1 hour. The reaction was chased with 600µM cold dCTP for 15 minutes at 
42°C and finally terminated with 0.5M EDTA/pH 8.0 (0.03M final 
concentration). RNase A (0.5µg) was added and the mixture was left at 
3 7 ° C for 1 hour, extracted once with phenol and passed through a G-50 
Sephadex column to remove unincorporated label, as described 1n 
Section 2.2.8D. 
To check the integrity of synthesised cDNA, the labelled 
product was electrophoresed through a 1 % alkaline agarose gel 
containing 0.05M NaOH and 0.001M EDTA. Loading buffer (0.3M NaOH , 
6mM EDTA, 1 % Ficoll, 0.15% bromocresol green , 0.25% xylene cyanol) was 
added to the sample before loading. Electrophoresis was carried out at 
0.25V /cm with freshly prepared 50mM NaOH and lmM EDT A as running 
buffer. After electrophoresis, the gel was soaked 1n 7 % TCA 
(trichloroacetic acid) for 30 minutes at room temperature . It was dried 
overnight with paper towels and exposed to X-ray film (Kodak , 
Australia). 
Southern blots of Hindlll- or Pstl-digested A DNA were 
analysed using the 3 2 P-labelled cDN A probe. All fragments hybridis ing 
to the cDNA probe but not with labelled wild-type A or RadL V sequences 
were taken to represent transcribed or cDNA + genomic sequences. Some 
of these were subcloned into pGEMR vectors (Promega , USA ) and 
sequenced. 
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5.2.5B Isolation and subcloning of transcribed or cDNA + fragments 
Hind III fragments were used for subcloning since this 
enzyme gave very clear restriction patterns and there 1s only one 
HindIII site present in the 9kb right arm of AGEM-11 (Fig. 1). Reprobings 
with 3 2 P-labelled cDNA were carried out to ensure that the right 
fragments were subcloned. The isolation of DNA fragments and 
subcloning are described in Section 4.2.4. 
5.2.5C Unidirectional deletions uszng Exonuclease I II ( Exol /1) 
The rapid construction of recombinant plasmids containing 
progressive unidirectional deletions of a DNA insert was carried out as 
described in Promega's Protocols and Applications Guide (Titus, 1991). 
This method allowed for efficient sequencing of cloned DNA fragments . 
Closed circular plasmid DNA was prepared as described in Sections 4.2.2D. 
The plasmid (5-10µ g) containing the insert was doubly digested to 
completion using two different restriction enzymes, one generating a 3' 
protrusion which protected the sequencing pnmer binding site in the 
vector from Ex o III digestion, and the other which left a 5' overhang or 
blunt end adjacent to the insert, from which deletions proceeded. 
Reaction volumes were scaled according to the amount of starting DNA 
and the desired number of time points. Prior to exonuclease digestion, 
the doubly digested DNA was extracted once with TE-saturated phenol and 
precipitated with 0.1 X volume 2M NaCl and 2X volumes ethanol at -70°C 
for 15 minutes. It was then pelleted and washed once with 70 % ethanol, 
dried under vacuum and dissolved in an appropriate amount of Ex o I I I 
buffer (66mM Tris-HCl/pH 8.0, 66mM MgCl2) . The DNA was warmed to 
3 7 °C, exonuclease III [Promega, USA] (300-500U for a 6.5kb insert) was 
rapidly mixed in and the reaction was incubated at 37°C. At 30 second or 1 
minute intervals, 2.5µ1 of the sample was removed into a tube containing 
7. 5 µ 1 freshly prepared S 1 nuclease mix which had been chilled on ice 
(0.04M potassium acetate/pH 4.6, 0.34M NaCl, 1.35mM ZnS04, 50% glycerol, 
12U S 1 nuclease [Promega, USA]). When all time points had been taken, 
the tubes were removed from ice and kept at room temperature for 30 
minutes to enable S 1 nuclease digestion of the single stranded DNA 
overhangs. One microlitre of S 1 stop buffer (0.3M Tris base , 0.05M EDT A) 
69 
was then added and the tubes were heated at 70° C for 10 minutes to 
inactivate S 1 nuclease. Two microlitres from each reaction was removed 
and electrophoresed on a 0.8 % agarose gel to confirm controlled 
digestion. Two representative Exo III digestions are shown in Fig. 2. The 
rest of the sample from each time point was transferred to 37°C and 1µ1 of 
T4 DNA polymerase mix (0.01M Tris-Cl/pH 8.0, 5mM MgCI2, 2.5mM DTT, 
0.5% BSA, 0.2U T4 DNA polymerase) was added to each sample . The 
reaction was incubated at 37°C for 3 minutes, after which 1µ1 of dNTP mix 
(0.125mM each of dA TP, dCTP, dGTP and dTTP) was added. Incubation was 
carried out for a further 5 minutes at 37°C to ensure blunting of DNA 
ends, cooled to room temperature and 40µ1 of T4 ligase mix (0.5M Tris/pH 
7.6, lOmM MgCl2 6.25% PEG, lOmM DTT, 0.25mM ATP) containing 1 Weiss 
' 
unit T4 DNA ligase was added to each sample. Self ligations to repair the 
plasmids were carried out at 12° C overnight in a water bath. For 
transformation, the DNA was first precipitated, washed with 70 % ethanol , 
vacuum dried and resuspended 1n an appropriate amount of water. 
Transformation was carried out using the heat shock method as 
described in Section 4.2.4B . 
5.2.6 Computational analysis 
Computational analysis was carried out using a variety of 
software packages. The FastA utility was used to fast match sequences 
with the GENBANK and EMBL databases. The BLAST software , a very fast 
sequence companson tool developed by the National Centre for 
Biotechnology Information (California , USA) was al so used . Both FastA 
and BLAST are accessible through the GENBANK ON-LINE SERVICE (GOS) 
and are available on the Australian National Genomic Information 
Service (ANGIS) network. ANGIS is operated by the Australian Genomi c 
Information Centre , The University of Sydney. 
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5.3 Results 
5.3.1 Partial restriction mapping of 
the RadLV gp70 env sequence 
presence of recombinant and 
in Cl-V13D 
A clones 
confirmed 
defective 
carrying 
the 
. 
viruses 
Phage plaques were screened using the RadL V gp70 en v 
probe. A total of 30 A clones hybridised to this probe on the first plating. 
They were isolated, replated and screened twice using the same probe. 
Ten were lost in the third plating, leaving 20 for analysis. The results are 
presented 1n Table 1. Of these, 8 clones appeared to possess the full 
complement of retroviral genes, 1e. gag, pol, env, and yielded two 
fragments which hybridised to the LTR probe when digested with P stl, 
representing the 5' and 3' LTR-host junctions (Table 2). 
A clones lacking viral genes, for example one or both LT Rs, 
LTR/gag or LTR/gag/pol (A- 4, 6, 7, 8, 10, 12, 15, 16, 20, and 21) may have 
been truncated during library construction with Sau 3AI , which 1s a 
frequent four-base cutter. However, A-18 and A-26 (with 2 LTRs) have 
part or all of their pol or gag genes deleted at regions covered by the 
respective probes used. They could represent defective vnuses with 
internal deletions in their genome. 
With the exception of A-5 and A-11, all cloned full length 
vuuses were found to carry an internal Hindlll site at the pol or gag 
genes, as indicated by Southern analysis using the L and pol probes 
(Table 2). The presence of this restriction site distinguished them from 
the RadL V /V 13 clone (Rassart et al., 1986), which was used to generate 
the Cl-V13D cell line (O'Neill, 1992). They appear to represent 
recombinants in the gag or pol region, while still retaining the RadL V 
gp70 en v sequence. This concurred with Southern analysis of genomic 
DNA from Cl-V13D using the same enzyme and the RadLV gp70 en v 
probe, which had earlier indicated the presence of many provuuses 
having an internal Hi ndlll site (Section 4.3.3, Fig. 9). P s tl digestion of 
these viruses each gave a typical 8.2kb viral fragment which hybridised 
to all 5 viral probes , and another fragment of variable size hybridising 
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TABLE 1 
Restriction 
enzymes 
Clone 
1 
3 
4 
5 
6 
7 
8 
1 0 
1 1 
1 2 
1 3 
1 5 
1 6 
1 7 
1 8 
1 9 
20 
2 1 
26 
27 
Summary of Southern analysis on recombinant AGEM-11 
clones using Hin dill and Ps ti restriction endonucleases 
and 5 viral probes, namely LTR, leader/gag (L), pol, 
gp70 env and plSE. 
Hindi II Pstl Hindlll or P st I 
LTR LTR L pol gp70 p15E 
++ ++ + + + + 
++ ++ + + + + 
+ + - - + + 
+ ++ + + + + 
- - - + + + 
+ + + + + + 
+ + - - + + 
+ + - - + + 
+ ++ + + + + 
- + - - + + 
+++ ++ + + + + 
- - - - + + 
+ + - - + + 
++ ++ + + + + 
+ + + - + + 
++ ++ + + + + 
- - - - + + 
- - + + + + 
+ ++ - + + + 
+++ ++ + + + + 
+, ++, +++, - represent one, two, three or no fragments detected by Southern analysis. 
TABLE 2 
Clone 
1 
3 
5 
1 1 
13 
17 
19 
27 
Clone 
1 
3 
5 
1 1 
13 
17 
19 
27 
Southern analysis of Hindlll- and Pstl-digested-A clones 
using 5 viral probes, namely LTR, leader/gag (L), pol, 
gp70 env and plSE. Only A clones carrying the full 
length virus are shown. Data points represent fragment 
sizes in kilobases. 
LTR L 
8.0/3.0 3.0 
10.5/6.6 10.5 
7.8 7.8 
7.8 7.8 
6.0/5.0/3.0 5.0 
23.0/4.8 4.8 
8.0/6.0 8.0 
7 .0/3 .0/1.5 3.0 
LTR L 
8.2/2.0 8.2 
8.2/4.2 8.2 
5.5/2.6 5.5 
5.5/2.5 5.5 
8.2/0.7 8.2 
8.2/3.6 8.2 
8.2/6.9 8.2 
8.2/1.0 8.2 
Hindi II 
pol 
8.0 
6.6 
7.8 
7.8 
5.0 
23.0 
6.0 
7.0 
P stl 
pol 
8.2 
8.2 
5.5 
5.5 
8.2 
8.2 
8.2 
8.2 
gp70 pl5E 
8.0 8.0 
6.6 6.6 
7.8 7.8 
7.8 7.8 
6.0 6.0 
23.0 23.0 
6.0 6.0 
7.0 7.0 
gp70 pl5E 
8.2 8.2 
8.2 8.2 
5.5 5.5 
5.5 5.5 
8.2 8.2 
8.2 8.2 
8.2 8.2 
8.2 8.2 
with the L TR probe, indicating that they are normal full length vuuses 
(Chattopadhyay et al., 1982) [Table 2]. 
The two clones, A-5 and A-11 appeared to be identical and 
gave two L TR fragments when digested with P s ti, one approximately 
2.5kb and the other approximately 5.5kb. This does not appear to be a 
cloning artefact as a similar 5.5kb fragment was also observed In 
Pstl-digested Cl-Vl3D genomic DNA analysed with the RadLV gp70 env 
probe (Chapter 4, Fig. 7). This 5.5kb fragment hybridised to all 5 viral 
probes, suggesting that it could represent a defective virus with internal 
deletions of some viral sequences and having a P st I site either 3' to the 
p15E or 5' to the L sequences. 
Three L TR fragments were observed by Southern analysis 
when A-13 and A-27 were digested with Hindlll (Fig. 3). Three 
possibilities could account for this: 1) this represents an in vitro cloning 
artefact, 2) there is a genuine L TR structure in close vicinity of the full 
length v1rus in situ, or 3) recombination between two different 
proviruses at the LTR, or a single point mutation in one L TR has 
generated a vuus with non-identical LTRs, one of which possesses a 
Hi ndlll site. The presence of a Hin dlll restriction site at each L TR is not 
indicated since only 3, and not 4, LTR fragments were observed (Fig. 3 ). 
The presence of a third LTR (possibility 2) was proposed since LTR 
structures, containing no other viral genes, have been reported In 
endogenous chicken proviruses (Hughes et al. , 1981) and in MoMuL V-
induced rat thymomas (Lazo & Tsichlis, 1988). It was proposed that during 
recombination between the ends of normal proviruses, the remainder of 
the viral genome would form a free circle. Under these circumstances, 
the rest of the viral genome could be lost from the germline, leaving 
behind the single copy of L TR in the host genome. 
Only 2 LTR fragments were observed in both A-13 and A-27 after 
digestion with P st I, one of which represents the full length viral 
fragment of -8.2kb containing the 5'L TR and the other the smaller 
3 'LTR/host junction fragment. Because of this discrepancy , the 1.5kb 
Hindlll LTR fragment from A-27 [(pA-27f(C)l] was subcloned and 
sequenced to determine the positioning of the L TRs , and to analyse the 
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Fig. 3 Southern analysis of a few selected Hindlll-digested 'A, clones using the L TR probe. Lane numbers 
refer to the 'A.-clone designation. DNA size markers are indicated. 
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Fig. 4 Hypothetical partiai restriction map of 'A.-27. This was based on the sequence of the 1.5kb HindIII L TR 
fragment, as well as the assumption that Pstl cuts at each L TR to generate a normal 8.2kb full length virus 
fragment. The HindIII site (H*) was confirmed by sequencing to be 250bp from the Pstl site in the LTR 
structure(~). Hybridisation with the L TR probe would give 3 fragments, namely 7.0kb, 3kb and 1.5kb, 
as depicted (See also Fig. 3). SP6 and T7 RNA polymerase transcription initiation sites at the arms are 
indicated. RadL V probes used to identify viral fragments are indicated by bold black lines. The restriction 
enzymes used were S(Sfil), H(HindIII) and P(Pstl). Mouse genomic flanking sequences are represented by 
a single line. The orientation of provirus relative to 'A, arms could not be determined as HindIII sites occur at 
both vector/insert junctions. 
validity of a third L TR structure. Comparison with munne LTR sequences 
using the BLAST utility indicated that this L TR structure is only 180bp in 
size, and the Hi ndIII site is approximately 250bp from the P s tl site in the 
L TR. Southern analysis of pA-27f(C) 1 and sequencing indicated that no 
other viral genes are present (data not shown). Based on these results 
and the sizes of viral fragments generated by digestion of A -2 7 with 
HindIII and Pstl, it was concluded that HindIII could not cut internally at 
one or both LTRs. The lack of a third LTR fragment with P s tl digestion 
could be due to another P s tl site in close proximity, generating a small 
fragment of undetectable size. A hypothetical restriction map of A - 2 7 , 
showing the positioning of the 3 LTRs is shown in Figure 4. However, the 
possible presence of this third L TR structure can be confirmed only with 
further subcloning and sequencing of the fragments carrying the L TR-
host junction. A -13 has not been mapped due to difficulties with 
subcloning. The possibility that A-13 and A-27 are both cloning artefacts , 
and that a third LTR structure is not present in the in situ situation has 
not, as yet, been excluded. 
5.3.2 Mapping of viral clones and flanking 
DNA distal to the LTR/host junction 
. genomic 
The partial restriction maps of A.-1, A-7 and A.-17 , deduced by 
restriction mapping and sequencing are shown in Figures 5 , 6 and 7. The 
restriction endonuclease Sfil was used to estimate the size of the inserts. 
None of the inserts appear to carry a S/il recognition site except 
A -1 (Fig. 5). The size of the insert in A -1 was estimated to be 
approximately 20.2kb. Restriction sites at the 3' end of the insert 1n A- 1 
were determined by sequencing of the L TR fragment , pA-1 fl (H), and 
direct sequencing of A.-1 from the T7 primer site at the left arm (Fig . 5). 
The Kpnl sites were deduced from restriction mapping of pA-lfl (H). The 
Hindlll site 1n the genomic DNA adjacent to the 5'LTR is approximately 
1 OObp from the P s ti site in the L TR. This was confirmed by the 
subcloning and sequencing of pA- 1 f2 ( H ) . 
The physical map of A-7 and positioning of the viral/genomic DNA 
insert was deduced from restriction mapping with H i n dlll , subcloning of 
73 
s 
right arm (9Kb) 
SP6 
s 
p 
HIEV 
LTR 
H 
11•11 
L 
-
-
p).-1f2(H) 
p K 
pol env L TR 
gp70 p15E 
-
p).-1f1 (H) 
p K p 
I 
Sm 
s 
T7 
left arm (20Kb) 
' 
llcb 
Fig. 5 Partial restriction map of A-1 showing the position of the full length virus and flanking genomic DNA. The SP6 and 17 RNA polymerase transcription initiation sites at the 
right and left arm, respectively are indicated. The RadL V probes used to identify viral fragments are indicated by bold black lines. The restriction enzymes used were S(Sfil), H(Hindlll), 
E(EcoRl), P(PstI) and KpnI (K). SphI (Sp), EcoRV (EV) and SmaI (Sm) sites were mapped by sequencing either A-1 using the T7 primer site at the left arm or the 3' and 5' L TR 
fragments [pA-1 f2(H) and pA-1 fl (H), respectively], which had been subcloned into pGEMR vectors. Genomic regions are represented by a single line. The sizes of the right and left 
A-arms are indicated. 
the 5'L TR fragment, pA-7G and direct sequencing of A- 7 using the T7 and 
SP6 primers. The size of the insert in A-7 was estimated to be - 16.4kb. The 
positioning of the pA-7K fragment, which is a cDNA + fragment, was 
determined by restriction analysis of A-7 with EcoRI. A fragment > 18.0kb 
hybridising to all 5 viral probes was obtained. Sequencing of pA- 7 K 
revealed the presence of an EcoRI site 747bp from the 5' Hindlll site. 
Since no Eco RI sites are present in vector or provirus, and Eco RI -
digested A-7 revealed the presence of only one Eco RI site in the insert, 
the positioning of pA- 7K could be accurately determined to be 
approximately 5.3kb upstream from the 5' L TR (Fig. 6). 
The restriction map and positioning of A-17 with respect to the 
vector was deduced similarly by direct sequencing of A -17 as well as 
subcloning and analysis of the 5' LTR fragment, pA-17f2(D). The cDNA + 
fragment, pA-17D, was mapped approximately 1.8kb upstream of the 5' 
LTR (Fig. 7). 
5.3.3 Sequencing and computational analysis of 
cDNA + regions 
The approach used to identify new genes expressed as a 
result of retroviral integration was to identify restriction fragments of 
RadL V gp70 en v + A-clones which encode sequences transcribed 1n 
Cl-V13D. Fragments which hybridised to 32P-labelled cDNA from Cl-V13D 
but not to 32P-labelled whole virus or wild type A (data not shown) were 
taken to represent transcribed flanking genomic DNA sequences . Six 
fragments were successfully subcloned from 6 different A-clones and 
four were completely sequenced (Table 3). Some of the sequences are 
presented in the Appendices. 
Southern analysis of genomic DNA was carried out using 
32P-labelled subcloned cDNA+ fragments as probes. A smear of 
unresolved DNA molecules was observed, indicating the presence of 
repeat elements. A representative Southern blot using 3 2 P-1 ab e 11 e d 
p A-17D as probe is shown in Figure 8. Sequencing and comparison to the 
EMBL and Genbank databases using FastA and BLAST programs revealed 
regions in all clones having almost 100% homology with mouse B 1 and 
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Fig. 7 Partial restriction map of A-17. The SP6 and n RNA polymerase transcription initiation sites are shown. RadL V probes used to identify viral fragments are indicated 
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TABLE 3 Fragments comprising cDNA + regions successfully subcloned into pGEMR vectors. 
* 
+ 
** 
ND 
A-clones Enzyme used 
1 Pstl 
7 Hindlll 
8 Pstl 
1 3 Hindlll 
1 7 Hindlll 
27 Hindlll 
Fragment size (kb) Designation of clone Sequence shown 1n 
Appenq_ix. # 
1. 18 
2.6 
6.0 
2.4 
3 .84 
2.6 
pA-1BB 
pA-7K 
pA-8K+ 
pA-13AB 
pA-17D 
pA-27BD+ 
1 
2 
3 
4 
5 
Number of B l/B2 
rep~ .. ats *. 
1 
4 
ND 
1** 
1 2 
1** 
Values represent the number of regions within the fragment which are homologous with either B 1 or B2 
repeats. 
Only partial sequence has been obtained. 
These fragments have also di-nucleotide and imperfect tandem repeats. 
Not determined. 
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Fig. 8 Southern analysis using 32P-labelled pA-17D as a probe on EcoRI-
digested DNA from Cl-V 13D and progeny clones derived following intrathymic 
passage of Cl-V13D into CBA/H mice. CBA/H liver (LV) DNA was included 
as control. DNA size markers are indicated. 
B2 repetitive sequences (data not shown). Some of these repeats possess 
poly (A) tracts. The B 1 and B2 repeats, as well as stretches of dinucleotide 
(CA) and tandem repeats (pA-27BD, pA-13AB) have been highlighted in 
the sequences listed in the Appendices. In particular, pA-7K and pA-1 7 D 
contained multiple regions with homology to B 1 and B2 repeats (4 and 12 
repeats, respectively; Table 3). Simple repeats like (CAG)n, (GTG)n and 
(CTG) in mature transcripts of genes have been shown to be unstable and 
associated with disease (reviewed by Epplen et al., 1993). The 
significance of the imperfect tandem repeats (GAAG)n (GA) n and the 
( CT)n (CA) repeats present in pA-27BD is at present unknown. 
Both pA-7K and pA-17D cDNA + regions have been positioned 
5' to the virus in the partial maps of A- 7 and A-17, respectively (Figs. 6 & 
7). The cDNA + fragment, subcloned as pA-1BB could not be positioned 
exactly in A-1, but was mapped also upstream of the virus. pA-1BB has 
been subcloned as a P st I fragment. Its position was deduced on the basis 
of elimination. It does not contain any KpnI or SmaI restriction sites, 
which distinguishes it from a P s tI fragment of approximately the same 
size downstream of the virus. Since it also contains no L TR sequences, 
pA-1BB cannot be downstream of the virus (Fig. 5). Clones pA-13AB and 
pA-27BD could not be positioned, since partial restriction maps of A- 1 3 
and A-27 could not be constructed. 
5.4 Discussion 
Restriction analysis has been used to confirm the presence of 
multiple recombinant and defective ecotropic proviruses in the Cl- V l 3D 
genome. Several full length viral genomes have been cloned, including 
A-7, and were shown to possess an internal Hindlll site either 5' to the 
pol probe and 3' to the L probe, or 3' to the po I probe (Tables 1 & 2). No 
unaltered RadL V /Vl 3 proviruses appeared to be represented amongst the 
A-isolates carrying ful 1 length proviruses. Al 1, however, hybridised to 
the specific RadL V gp70 env probe . Many of the proviral clones isolated 
were found to be truncated , probably as a result of the Sau 3A 1 digestion 
used to make the library . It is possible that one of these could represent 
the input RadLV/V13 virus, cloned by Rassart et al. (1986). 
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To date, there has been no report of a cloned RadL V virus 
containing a HindIII site. The virus present 1n 'A-7 (Fig. 6) could 
represent recombination between the RadL V en v sequence and an 
endogenous ecotropic virus in DBA/2j mouse which has a Hi ndIII site in 
the gag/pol sequence . This 1s consistent with earlier data which 
demonstrated the presence of at least one endogenous virus in DBA/2j 
mouse which carnes an internal Hi ndIII site (Chapter 4 , Figs. 3c, 4c & 
5c ). The other full length viruses cloned in 'A -1 and 'A-1 7 could al so 
represent recombinants between endogenous viral sequences 1n DBA/2j 
mice having an internal HindIII site and RadLV env sequences. 
In view of the fact that numerous truncated proviral clones were 
isolated, a genomic library constructed with Eco RI or a less frequent 
cutter, which does not cut the provirus internally, may have been a 
better option. However, Sau 3AI was used with the objective of studying 
genes in the vicinity of retroviral integration. Since Sau 3 AI digestion 
can generate overlapping clones, the library constructed using thi s 
enzyme will be useful for future isolation and characterisation of 
complete genes. 
The subcloning of LTR-host junctions proved to be difficult for 
some of the viral clones. The LTR-host junction fragments p'A- 1 f 1 ( H ), 
p 'A-17f2(D) and p'A-27f(C) 1 required further subcloning for complete 
sequence analysis. The exception was p'A-7G , which could be easil y 
deleted by exonuclease III to generate overlapping fragment s for 
sequencing. Restriction and partial sequence analyses of success full y 
subcloned LTR-host junctions have been used to deduce the composite 
maps of three 'A-clones, namely 'A-1 , 'A-7 and 'A-1 7. 
The subcloning of cDNA+ regions using 32P-labelled cDNA from 
Cl-V13D was also undertaken . 32P-labelled cDNA was used to determine if 
there are any coding genomic DNA sequence s 1n the vi ci nity of 
retroviral integration. A feature of these cDNA + fragment s 1s the 
presence of B 1, B2 and other tandemly repeated sequences. These are 
interspersed abundantly in 'A -7K, 'A-17D and 'A-27BD. The rodent B 1 and B2 
repeats are members of SINES (short interspersed repeat sequences) and 
are equivalent to the Alu repeats in humans (reviewed by Weiner et al. , 
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1986). The B 1 repeat elements are approximately 70 - 300bp long, while 
the B2 repeats are typically about 190bp long (Grigoryan et al ., 1985). A 
3' terminal oligo(A) tract sequence occurs in almost all SINES , and varies 
from 4 to >50bp . Although the A-rich sequence is usually a pure 
homopolymer tract , it is sometimes supplemented with or replaced by 
simple sequences such as (NAx)y (Weiner et al. , 1986). Some of the repeat 
sequences identified in the cDNA + fragments, ranging in length from 
68bp to 384bp, also contained these poly(A) tracts (Appendix 1 - 5). 
Single copy DNA in eukaryotic genomes has been reported to be 
interspersed with many reiterated sequences. These include LINES (long 
interspersed repeat sequences), SINES and the simple tandem repeats or 
repeat blocks comprising di- or trinucleotides. LINES are about 6 - 7kb 
long (Weiner et al., 1986). Both LINES and SINES are also designated as 
mobile genetic elements or non-viral retroposons because of their 
ability to move from one genetic locus to another via an RNA 
intermediate. They share this property with the retroviruses , c op z a 
elements in Drosophilia and Ty elements in yeast (Shapiro , 1983 ) . There 
have been a number of reports on transposition of these elements into 
oncogenes and other structural genes. As a result, the activities of these 
genes were affected (Katzir et al. , 1985; Arman et al., 1986, Morse et al. , 
1988). 
There IS increasing evidence to indicate that these repetitive 
sequences interspersed In the eukaryotic genome are not just 'junk ' 
DNA. Some of them have been shown to have specific regulatory role s 
and to code for functional proteins (Davidson & Britten, 1979; Laimins et 
al. , 1986; Mathias et al. , 1991 ). For example , SINES have been shown to 
carry a functional internal RNA polymerase III promoter and have been 
implicated as a possible ong1n of DNA replication and/or RNA 
polymerase III transcription (Weiner et al. , 1986). SINES have al so been 
proposed as tissue-specific markers ; examples are the rat ID (o r 
identifier) sequence, which has been propo sed as a brain-spec ific 
transcript marker (Sutcliffe et al. , 1984, Weiner et al. , 1986) and mouse 
SET 1 (or B2) sequences , which has been proposed as a marker for 
mRNAs specific to both normal embryonic and on c ogeni call y 
transformed cells (Murphy et al., 1983 ; Scott et al. , 198 3). Transc rip tion 
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levels of B2 sequences have been observed to be elevated in tumour cells 
and it was suggested that this may be related to tumour progression 
(Grigoryan et al., 1985). (CA)n blocks have been associated with sites of 
recombinational events (reviewed by Rogers, 1983) and alterations in CA 
repeats have been shown to occur m human gastric and colonic cancers 
(Mironov et al., 1994). Expansion of simple di- or trinucleotide repeats 
from a few to hundreds or more have also been shown to be associated 
with a number of inheritable genetic diseases (Kunkel, 1993 ). Also, 
certain (GT)n or mixed (GT)n/( GA )n stretches of intronic simple repeats 
are shown to be preserved in immunologically relevant genes and they 
bind nuclear protein molecules with high affinities (Epplen et al., 1993 ). 
The role of repeats as transcriptional silencers has also been 
documented. Fanning et al. (1985) demonstrated that the location of the 
MMTV-8 provirus within a repeat region inhibited viral transcription. 
As a result, little or no MMTV-specific RNA can be detected in the 
mammary gland. However, the virus is transcriptionally active when 
cloned and transfected into mouse cells, suggesting that transcriptional 
inactivity of the provirus was due to an inhibitory effect exerted by the 
flanking genomic sequences. Another example of repeat elements 
inhibiting transcription was provided by Youssoufian & Lodish (1993). 
The authors demonstrated that transcription of the munne 
erythropoietin receptor (EpoR) gene 1s inhibited by a repetitive element 
located upstream of the EpoR promoter, and that the inhibitory effect is 
both distance and orientation dependent. The mouse EpoR gene has been 
shown to undergo transcriptional activation upon differentiation of 
embryonic stem cells in vitro. 
The number of B 1 and B2 repeats present m pA-7K and pA- 1 7 D 
(4 and 12, respectively, Table 3) appeared to be higher than the 
frequency estimated over the whole genome. This has been estimated to 
be 1 per 3 x 104 bp in the mouse haploid genome (Weiner et al., 1986; 
Grigoryan et al., 1985). The frequency of repeats Ill pA-7K and pA- 1 7 D 
was much higher, namely 1 per 650bp and 1 per 320bp, respectivel y. 
Furthermore, all full length viruses subcloned were found to be 
integrated Ill regions possessing repeat elements. Taken together, the 
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data suggested that repeat reg10ns may represent 'hot spots ' or preferred 
sites for retroviral integration . 
LINES and SINES have been shown to be transcribed (Economou-
Pachnis et al., 1985; Young et al., 1982; Skowronski & Singer, 1985 ; 
Weiner et al., 1986). Since there are probably many of these reiterated 
sequences present in cDNA, it is not possible to determine if the repeats 
identified in the subcloned cDNA + fragments are actually transcribed in 
Cl-V13D. These fragments will therefore be simply referred to as cDNA+ 
fragments or regions in this study. 
The presence of repeat sequences in some of the cDNA + fragments 
has made the search for putative open reading frames and coding 
regions difficult. Computational analysis has revealed no other 
significant homology with sequences 1n the nucleic acid databases , 
indicating that the repeats could either be present 1n purely intronic 
regions, or that they could represent novel sequences (data not shown) . 
Some small stretches of putative coding sequences present between 
repeat elements, and in some cases encompassing some of the repeat 
sequences, were indicated by computational analysis (data not shown) . 
These findings will need to be confirmed by isolating the corresponding 
cDNAs. 
In view of the evidence that repeat elements may have regulatory 
roles and are highly mobile genetic elements , it 1s possible that 
retroviral integration into the vicinity of repeat elements could result in 
tumorigenesis either by a) disruption of any normal regulatory role 
attributed to sequences in the repeat , or b) increased instability of these 
elements, leading to enhanced retropositioning. 
SUMMARY 
A genomic Ii brary of C 1-V 13 D has been constructed and "A clones were 
selected for their capacity to hybridise with the specific RadL V gp70 e n v 
probe. Analysis of these clones by a combination of approache s, 
including subcloning , partial restriction mapping and sequen cin g, has 
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confirmed the existence of multiple recombinant and defective vuuses 
in Cl-V13D. To check for the presence of coding genomic sequences , 32p_ 
labelled cDNA from Cl-V13D was used to probe Hindlll- and Pstl-digested 
virus-positive A clones by Southern analysis. Transcribed or cDNA + 
regions, not hybridising to 3 2 P-labelled wild type A and vuus sequences , 
were subcloned and analysed . A notable feature of these cDNA + regions 
was the frequent presence of B 1, B2 and simple repeats , which made 
attempts to identify other possible coding regions very difficult. Some of 
these sequences were shown to be present 1n significantly higher 
frequency in A clones than in the genome as a whole. All of the A clones 
carrying full length vuuses appeared to be integrated 1n region s 
possessing repeat elements. Since some B 1 and B2 repeats have been 
documented to code for functional proteins and to play regulatory roles , 
it is tempting to hypothesise that viral integration next to these mobile 
genetic elements could provide a mechanism for oncogenes1s via 
disruption of their normal gene regulatory function. In addition , these 
elements are genetically unstable and integration of the virus could 
cause further genetic instability, resulting in enhanced transposition. 
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CHAPTER 6 
Sequence analysis 
junction 
6.1 Introduction 
of 
• ID 
the S'L TR-host 
A-7 
The analysis of LTR-host junctions and common integration sites 
has led to the discovery of cellular genes disrupted by retroviral 
integration (Bergeron et al., 1991; Sels et al., 1992; Tremblay et al., 1992). 
In rodents, the c-myc, Pim-I, Mlvi-1, Mlvi-4, Tp-1 genes have been 
identified as common MuL V provirus integration sites (reviewed in 
Section 1.5 .3). Their rearrangements have been found to correlate with 
development and progression of T cell leukemia. In Chapter 5, analysis of 
c DNA+ regions in the vicinity of retrovirus integration has revealed the 
frequent presence of repeat elements. 
In this study, a few LTR/host junction DNA were subcloned 
successfully. One of these, namely pA-7G was completely sequenced. 
p A-7G contained the 5'LTR and a small stretch of adjacent host DNA 
sequences ( ..... 253bp) subcloned from A-7 (Chapter 5, Fig. 6). This chapter 
was focused on the characterisation of pA-7G. The objectives were to (1) 
identify any potential new gene and (2) determine if this gene, which 
corresponded to the flanking genomic sequence, was rearranged and 
expressed differentially in Cl-V13D compared to germline DBA/2j and 
other cell types. Another objective was to determine if this site of 
retroviral integration was common to other lymphoid tumour lines 
induced by RadL V. Finally, attempts were made to characterise this 
flanking genomic sequence using the ANGIS network to determine if 
there was any significant homology with both nucleotide and amino acid 
sequences recorded in the GENBANK, EMBL, SWISS-PROT and GENPEPTIDE 
databases. It was anticipated that since Cl-Vl 30 represents an immature , 
partially transformed lymphoid cell line, the isolation of any new genes 
8 1 
1n the vicinity of retroviral integration may give an insight into the 
transformation process or early differentiation of lymphoid cells. 
6. 2 Materials and Methods 
6.2.1 Derivation of A- 7 
The derivation of 11.-7 and DNA preparation are described 1n 
Sections 5.2.1 - 5.2.3. The composite map is shown in Figure 6, Chapter 5. 
The 3'LTR has been truncated by Sau 3AI during library construction. 
Restriction mapping and Southern analysis using all viral probes have 
indicated that it is unlikely to be a defective virus. 
6.2.2 Subcloning of the S'LTR-host junction from A- 7 
The 2.55kb Hi ndIII fragment, compns1ng the 5 ' LTR-host 
junction, was subcloned into the pGEM7Zf( +) plasmid at the Hin dI I I 
polycloning site. The procedure for subcloning has been described 1n 
Section 4.2.4. The orientation of this fragment within the plasmid 1s 
depicted in Fig. lb. It has been designated as p11.-7G (Chapter 5 , Fig. 6). 
6.2.3 
6.2.3A 
Analysis of flanking 
the LTR 
. genomic DNA 
Unidirectional deletion of p}...-7G using Exolll 
immediate to 
The procedure for unidirectional deletions, which 1s used to 
generate overlapping smaller fragments for sequencing, has been 
described in Section 5.2.5C. The p11.-lfl(H) and p11.-17f2(D ) clones, 
carrying L TR/host junction fragments, were not Ex o III deleted either 
because a) there were no enzymes that could generate protective 3' 
overhangs without cutting the insert as well, or b) there were no 
suitable enzymes to generate 5' overhangs. The p11.-7G clone was easily 
ExoIII deleted and therefore sequenced using this method. SphI was used 
to generate the exonuclease III resistant 3' overhang and Eco RI to 
generate the 5' overhang. Twelve time points, four at 1 minute intervals 
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and eight ai 30 seconds intervals were taken. The deletion-containing 
plasmids were then ligated to re-circularise and transfected into E. coli 
hosts using the heat shock method as described in Section 4.2.4B. 
6.2 .3B Cycle sequencing of p1-7G Exolll deletions with dye 
primers 
Cycle sequencing using dye pnmers has been described in 
Section 5.2.4B. The T7 dye primer was used since the deletions proceeded 
from the T7 transcription start site. 
6.2.3C Southern analysis 
The procedure for Southern analysis is described in Section 
2.2.8. The 7G probe was used. It is a 297bp fragment amplified from pA- 7 G 
using the 7GR (5' AGG GAG TGG GCA GGA GAA) and the SP6 primers (5' A TT 
TAG GTG ACA CT A TAG). Preparation of this probe was necessary because 
there were no suitable enzymes to completely eliminate the adjacent L TR 
sequences. The 7GR pnmer was designed from the genomic DNA 
sequence 1n the A-7G clone (Fig. la) using the Oligo (Wejciech Rychlik, © 
1991) and Amplify version 1.0 (Bill Engels, © 1992, Wisconsin University, 
Genetics, USA) programs. Amplification was carried out 1n a standard 
3-step cycling reaction compns1ng an initial denaturation at 94° C for 3 
minutes, followed by 35 cycles of 94°C for 15 seconds, 48°C for 15 seconds 
and 72° C for 45 seconds in the FTS-1 thermal cycler (Corbett Research , 
Australia). Amplification was performed twice . The first amplification 
was carried out in a 20µ1 reaction containing 20ng DNA template , 7 .5pM 
of primers OSP6 and 7GR, 0.2mM dNTP (Pharmacia, USA), 0.2U Super Taq 
enzyme 1n IX Super Taq buffer (P.H. Stehelin & CIE AG , Basel , 
Switzerland) . The amplified probe was electrophoresed through 1 % GTG 
SEAKEM agarose (FMC BioProducts, USA) and electroeluted. The second 
amplification was performed under the same conditions using the first 
amplified product (lOpg) as the template. This final preparation was 
electrophoresed , excised and extracted from the gel using the Geneclean 
kit (BIO 101, USA). 
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a) 
b) 
~ 
1 CAATCATAAT GAAGTGGCAC GACAGGTTCC CGACTGGAAA GCGGGCAAGT GACCGAACGC AAATTAATGT GAGTAGCTCA CTCATTAGGC ACCCCAGGCT 
101 TTACACTTTA TGCTTCCGGC TCGTATGTTG TGTGGAATTG TGAGCGGATA ACAATTTCAC ACAGGAAACA GCTATGACCA TGATTACGCC AAGCTATTTA 
SP6 ~ 
201 GGTGACACTA TAGAATACTC AAGCTATGCA TCCAACGCGT TGGGAGCTCT 
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501 };;qqJrTCATAA GGCTTAGCCA GCTACCTGCA GTAACGCCAT TTTGCAAGGC ATGGGAAAAT ACCAGAGCTG ATGTCCTCAG AAAAACAAGA ACAAGGAAGT 
601 ACAGAGAGGC TGGAAAGTAC CGGGACTAGG GCCAAACAGG ATATCTGTGG TCAAGCACTA GGGCCCCGGC CCAGGGCCAA GAACAGATGG TCCCCAGAAA 
701 TAGCTAAAAC AACAACAGTT TCAAGAGACC CAGAAACTGT CTCAAGGTTC CCCAGATGAC CGGGGATCAA CCCCAAGCCT CATTTAAACT AACCAATCAG 
801 CTCGCTTCTC GCTTCTGTAC CCGCGCTTAT TGCTGCCCAG CTCTATAAAA AGGGTAAGAA CCCCACACTC GGCGCGCCAG TCCTCCGATA GACTGAGTCG 
901 CCCGGGTACC CGTGTATCCA ATAAAGCCTT TTGCTGTTGC ATCCGAATCG TGGTCTCGCT GAACCTTGGG AGGGTCTCCT TCAGAGTGAT TGACTGCCCC 
1 oo 1 1 AAccTciG@G±:to±±±e.jtTTI Fig. 1 Partial nucleotide sequence of a) pA-70 and b) a very simplified map depicting its 
orientation in the pGEM7Zf( +) vector. 
p 
H ~ I ••• ~ 
T7 
p).-7G 
1 kb 
a) Only the nucleotide sequence up to the 3' end of the 5'L 1R is shown here. The full 
nucleotide sequence is presented in Appendix 6. The boxed region represents the L 1R 
sequence. The SP6 and 7GR primers are heavily underlined and the arrows indicate the 
direction of transcription. The genomic sequence immediate to the L 1R is boxed and 
shaded. Numbers represent base pairs. The unboxed, unshaded sequence belongs to the 
pGEM7Zf( +) vector. The 11 bp inverted repeats at the 5' and 3' end of the L 1R are shaded. 
b) The heavy black line represents a probe which was prepared by digesting the plasmid 
and insert with HindIII and Pstl. It contained approximately 30bp L 1R sequence and was 
designated as 7G/L 1R. 
6.2.3D Northern analysis 
The procedure for Northern analysis has been described in 
Section 3.2.5. RNA was prepared from Cl-Vl3D as well as from the RadLV-
induced thymic lymphoma cell lines, BL/VL3 and C6VL/l. RN A from 
various tissues was also prepared from CBA/H, DBA/2j and C57BL/Ka mice 
for comparative analysis. The probes used were 7G (PCR product, Section 
5.2.6D) and 7G/LTR, an -300bp Hindlll/Pstl fragment (Fig. lb). This 
probe also contains approximately 30bp of the 5'LTR sequence. 
6.2.4 
6.2 .4A 
Strategy for isolation and analysis of Cl-V13D 
cDNA corresponding to the genomic flanking 
DNA sequences in pA- 7 G 
Preparation of poly(A)+ RNA and cDNA synthesis 
The preparation of poly(A)+ RNA from Cl-Vl3D and DBA/2j 
liver (LV) was carried out as described in Section 5.2.5A. Synthesis of 
first strand cDNA was carried out according to Sambrook et al. ( 1989) , 
with minor modifications. The reaction was carried out at 420 C for 60 
minutes 1n 20µ1 Reverse Transcriptase buffer (Gibco-BRL, USA) 
containing mRNA (1 to l.5µg) or total RNA (IOµg), 3pM NOT-TT primer (5 ' 
GGG CCC ATG CGG CCG CAA TTA ATT TTT TTT TTT TTT TTT), lmM dNTP 
(Pharmacia, USA), lOOOU/ml Moloney murine leukemia virus reverse 
transcriptase (MoMuLV RT) from Gibco-BRL, USA and IOOU/ml RNAsin 
(Promega, USA). The NOT-TT primer was a gift from Jim Roberts, CSIRO , 
Di vi son of Plant Industry, Canberra, Australia. All ingredients except 
RNAsin and MoMuL V RT were premixed and heated to 95° C for 
approximately 2 minutes and cooled to 42° C. Premixed RNA sin and 
MoMuL V RT was then added. At the end of the reaction, the mixture was 
heated to 95° C for 5 minutes before chilling on ice. Reactions were 
carried out on the Cambia thermal cycler (Cherlyn Electronics Ltd , 
Cambridge, England). 
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6.2 .4B Amplification of 117G-cDNA II and DBA/21 liver cDNA uszng 
PCR 
cDNA prepared as described above was amplified using NOT-
TT and 7GR as reverse and forward primers, respectively. The amount of 
cDNA template used was equivalent to that synthesised from 50ng 
poly(A)+ RNA or from 1mg total RNA. Two rounds of amplification were 
carried out. The first amplification reaction mix comprised 5pM 7GR and 
3.6pM NOT (5' GCG GCC GCA ATT AAT TT) primers, 0.2mM dNTP and 0.2U 
Super Taq enzyme in lX Super Taq buffer. The total reaction volume was 
1 8 µ 1. The reagents (primers, dNTP and template) were premixed and 
heated to 94° C before the addition of enzyme and buffer. The cycling 
parameters were 5 cycles of 94°C for 15 seconds, 540c for 30 seconds and 
72 °c for 2 minutes, followed by 40 cycles of 940c for 15 seconds, 50°C for 
30 seconds and 72°C for 2 minutes. The amplified material was diluted 
lOOX. This was used as the template for re-amplification using NOT-TT as 
the reverse primer. The protocol comprised 40 cycles of 94° C for 15 
seconds, 54°C for 30 seconds and 72°C for 2 minutes. The reactions were 
carried out in the FTS-1 thermal cycler (Corbett Research, Australia). 
The products were electrophoresed on 1.5 % low melting temperature 
Nusieve GTG agarose gel (FMC BioProducts, USA), excised, extracted using 
the Magic PCR preparation kit (Promega, USA) and stored at -20°C. 
6.2.4C Cycle sequencing of 11 7G-cDNA II with dye terminators 
Cycle sequencing of PCR products was carried out using dye 
terminators with NOT-TT and 7GR as primers. Sequencing (25 cycles) was 
performed in a 20µ1 reaction mix containing 9.25µ1 Dyedeoxy Terminator 
premix (Applied Biosystems Inc, USA), 3.2pM primer and 0.2ng/bp DNA 
template in sealed capillary tubes in the FTS-1 thermal cycler (Corbett 
Research, Australia). Cycling parameters were a) denaturation at 96° C 
for 30 seconds, b) 54°C for 15 seconds and c) 600C for 5 minutes. At the 
end of the sequencing reaction, the mixture was adjusted to 100µ1 with 
ddH20, extracted twice with phenol/chloroform mix (ABI, USA) and the 
sequenced product was precipitated with O. lX volume 3M sodium 
acetate/pH 5.2 and 300µ1 of ethanol for > 15 minutes on ice. It was pelleted, 
85 
washed and vacuum dried. The samples were electrophoresed as 
described in Section 5.2.4B. 
6.2.4D Computational analysis 
FastA and BLAST utilities were used for sequence analysis. 
The BLAST utility also translated the nucleotide sequence into all six 
reading frames and simultaneously compared them with amino acid 
sequences in the protein databases (EMBL and Swiss-Prot databases). 
6.3 Results 
6.3.1 Rearrangement of a single 
integration was detected in 
7G probe 
gene via 
Cl-V13D 
retro viral 
with the 
To confirm that the 7G probe was the correct fragment 
after amplification from plasmid 11.-7G, it was 3 2 P-labelled and tested on 
the same blot as depicted in Figure 3, Chapter 5. Besides hybridising 
strongly to the correct 11.-7 HindIII fragment (---3.0kb), it also hybridised 
strongly to the 2 smaller LTR fragments in 11.-27 (Fig. 2). The smaller 
1.5kb fragment, subcloned as p11.-27f(C)l [Section 5.2.6AJ was sequenced 
and confirmed to share 100% homology with the mouse genomic 
flanking sequence in p11.-7G. Since both the provirus in 'A.-7 and in 'A.-27 
gave an approximately 3.0kb 5'LTR-host junction fragment , it is possible 
that both viruses are the same. 
Southern analysis was performed to detect any genetic 
rearrangement or polymorphism corresponding to the p11.- 7G flanking 
genomic DNA m various tissues and cell lines. Hin dIII-di gested Ii ver, 
spleen and thymus DNA from DBA/2j, CBA/H and C57BL/Ka were 
compared with C 1-V l 3D DNA using the 7G probe . A single fragment was 
detected in all 3 strains 1n all the tissues examined, indicating 
homozygosity for both alleles. The size of this fragment was 
approximately 1.1kb in both DBA/2j and CBA/H while the fragment 
detected in C57BL/Ka was approximately 3 .5kb (Fig. 3 a). Polymorphism 
86 
A-clones 
2 3 .1 
9.4 
6.6 
4.4 
2.3 
2.0 
0.5 
1 3 s 7 11 13 17 18 19 21 2 7 
Fig. 2 Southern analysis of selected HindIII-digested A-clones, using 32P-labelled 7G as probe. This 
probe hybridises to the 2.8kb LTR fragment in A-7 and the smaller 3.0kb and 1.5kb LTR fragments of 
A-27 . DNA size markers are indicated. 
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Fig. 3 Southern analysis of HindIII-digested DNA using 32P-labelled 7G probe. a) Polymorphism was observed in the different mouse strains studied, which include syngeneic 
DBA/2j and allogeneic CBA/H and C57BL/Ka (Ka) mice. b) Rearrangement of the c-7G gene is obs~rved in Cl-Vl3D compared to nonnal adult spleen (Spl) , thymus (Thy) and 
liver (L V) cells from different mouse strains. BLNL3 and C6VL/l are RadL V-induced thymic lymphe,ma cell lines. DNA size markers (kb) are indicated. 
was therefore indicated at this locus amongst these mouse strains. 
Cl-V13D retained the germline band of approximately 1.1kb, and there 
was evidence of acquisition of a new rearranged 2.8kb fragment (Fig. 
3b). Both the 1.1kb and 2.8kb fragments were of equal intensity and were 
weaker than the germline 1.1kb fragment present in DBA/2j liver DNA 
control. This suggests that the virus has integrated into one allele . The 
rearrangement seen 1n Cl-V13D appears to be specific for this cell line 
since spleen, liver and thymus DNA from syngene1c DBA/2j mouse do not 
possess this new band. Analysis of DNA from two RadL V-induced thymic 
lymphoma cell lines, BL/VL3 and C6VL/1, also showed no 
rearrangements compared to their germline C57BL/Ka controls. This 
confirmed a rearrangement unique to Cl-V13D and not to all RadLV-
induced tumour cell lines. 
6.3.2 Tissue-specific 
with the 7G 
. 
expression 
probe 
of a gene homologous 
Northern analysis of C 1-V 13D revealed the presence of 3 
mRNA tran_scripts of 1.6kb, 3.1kb and 4.6kb hybridising to the 7G/LTR 
probe (Fig. 4a). The 7G/L TR probe contained -30bp of LTR sequence (Fig. 
lb). The 7G probe, which has no LTR sequences, detected a 1.6kb and a 
4.6kb transcript (Fig. 4b). These transcripts were detectable in Cl-V13D 
and in its progeny clones ET4-D, ET4-D(Tl-E) and ET4-D(Tl-E)M7A (Fig. 
4a). Analysis of this same Northern blot with the LTR probe revealed the 
presence of 2 fragments corresponding to the 3.1kb and 4.6kb 
fragments, but not the 1.6kb band (data not shown). 
The gene detected here is arbitarily designated c-7G (c to 
represent cellular sequences). c-7G was observed to be also expressed by 
WEHI-279, a B cell lymphoma, as well as C6VL/l and BL/VL3, which were 
derived from 2 different RadL V-induced T cell lymphomas. It is also 
expressed by adult lymphoid tissues such as the spleen and thymus from 
DBA/2j mice but not expressed by liver cells from adult syngene1c 
DBA/2j and allogeneic CBA/H mouse strains. The expression of c - 7 G 
therefore appears to be tissue specific, with expression confined to cell s 
of lymphoid origin. The level of expression does not seem to be elevated 
m Cl-V13D in comparison with the DBA/2j spleen control. 
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Fig. 4 Demonstration of tissue-specific expression of c-7G by Northern analysis. Total RNA (20mg/sample) from Cl-V13D was compared to RNA from liver (L V), spleen (Spl) 
and thymus (Thy) tissue. RNA from T lymphoma cell lines, BLNL3 and C6VL/l and WEHI-279, a B cell lymphoma cell line were also included for comparison. RNA size 
markers are indicated. Arrows indicate the levels of migration of the 28S and 18S ribosomal RNA species. a) The RNA was hybridised to the 7G/L TR probe, which is a 
HindIIl/Pstl fragment derived by the digestion of pA-7G. b) The 7G probe, derived from amplification of A-7G by PCR with the 7GR and SP6 primers was used for analysis. 
6.3.3 Sequence analysis of the 5' LTR in pA- 7 G 
Analysis of the L TR sequence revealed the presence of two 
11-base palf inverted direct repeats at the 3' and 5' end of the LTR (Fig. 
la). These inverted repeats are similar to those seen in the Moloney 
virus 5'LTR (van Beveren et al., 1980). This feature was proposed to 
reflect the integration properties of a transposon. Comparison of the L TR 
sequence in pA-7G with other MuL V proviral L TR sequences using the 
BLAST utility demonstrated approximately 98% homology with the LTR of 
the RadL V variant, G6T2 and with the endogenous BL/Ka(B) provirus, an 
ecotropic, non-leukemogenic virus. Further analysis also revealed that 
the 7G-L TR lacked the 43 bp and 16bp direct repeats present 1n the 
moderately leukemogenic pMol502 and V21 BLNL3 viral clones (Rassart 
et al., 1986). 
6.3.4 Computational 
genomic DNA 
analysis 
adjacent 
of the flanking 
to the LTR 
The flanking genomic DNA sequence present 1n A- 7G was 
compared with nucleic acid sequences in the GENBANK and EMBL nucleic 
acid databases. No significant homology was observed. When translated 
into all six reading frames (Appendix 7) and compared to protein 
sequences 1n the Swiss-Prat, PIR and GenPeptide databases using the 
BLAST utility, homology with several proteins in the database was 
observed 1n two minus reading frames. Only those which have included 
at least 20 amino acids for comparison and having >50% homology are 
shown (Table 1 ). The homology was found to be mainly in the region 
coding for a long stretch of charged glutamic acid (E) residues in the 
first minus reading frame (nucleotides 140 - 207), and a stretch of mixed 
basic and acidic amino acid residues in the second minus reading frame 
(nucleotides 140 - 250) [Fig. 5]. 
If one of these hypothetical reading frames is correct, it 
would suggest that a) the virus is integrated 1n a transcriptionally 
opposite direction to the 7G gene and b) this gene may code for a protein 
with a highly charged region. No start codon was found in either of the 
putative reading frames. This indicated that if the flanking region was 
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TABLE 1 Homology of charged amino acid residues coded by c-7G to protein sequences in the GENBANK 
database using the BLAST utility 
Accession 
Xl5209 
HSG9a 
M6 l l 85 
Protein 
Ryanodine receptor (pig) 
G9a protein (human) 
Glutamic acid rich protein (bovine) 
HUMNUCl.EO nucleolin protein (human) 
ZFFZCMYC 
SSCRCRNA 
RATCSM 
HSRAP74 
HSCENPBR 
HAMBZBP 
MMUBF 
S67171 
c-myc gene product (zebra fish) 
calcium release channel (pig) 
calmodulin-binding protein (rat) 
transcription factor TFIIF (human) 
ma3or centromere autoantigen (human) 
DNA-binding protein (rodent) 
nucleolar transcription factor (mouse) 
U 1 small nucleolar ribonucleoprotein (human) 
MUSHSP86B heat shock protein (mouse) 
% homology* 
RF "-1" (84 a.a) RF "-2" {84 a.a.) 
86 (25/31) 
70 (26/37) 
67 (25/37) 
61 (21/34) 
76 (19/25) 
88 (22/25) 
80 (20/25) 
72 ( 18/25) 
86 (19/22) 
82 (19/23) 
63 (24/38) 
61 (16/26) 
75 (18/24) 
67 ( 19/28) 
55 (21/38) 
58 (14/24) 
69% (18/26) 
87 (14/16) 
59 (19/32) 
50 (17 /34) 
76 (16/21) 
66 (22/33) 
*: includes identical and homologous amino acids as defined by BLAST algorithm. 
Reference 
Takeshima et al. (1989) 
Milner et al. (1993) 
Sugimoto et al. (1991) 
Srivastava et al. (1990) 
Schreiber-Agus et al. (1993) 
Harbitz et al. (1992) 
Ono et al. (1989) 
Aso et al. (1992) 
Earnshaw et al. (1987) 
Sullivan & Glass (1991) 
Franklin et al. (unpublished) 
Hisatake et al. ( 1991) 
Elisei et al. (1993) 
Hoffman & Hovemann ( 1988) 
RF "-1": Reading frame -1 (K2E2GKE2QE6KE3TE3) RF "-2": Reading frame -2 ( R4ER2SKR2KR4KR2QKR2QE12K) 
5' to 3' (minus strand) 
10 20 30 
* * * 
40 50 
* * 
60 
* 
70 
* 
CC'ITATGAAGGGGTCTTTCAGTAGGGAGTGGGCAGGAGAAGCTGAGGCAGAAGGTTCATAGCAGATTCAA 
L W R G L S V G S G Q E K L R Q K V H S R F K> 
L M K G S F S R E W A G E A E A E G S e Q I Q> 
P Y E G V F Q e G V G R R S W G R R F I A D S> 
80 90 100 110 120 130 140 
* * * * * * * 
GTCTAGCGTGGGCTACATAGTGAGTCCTAAGC~CTGAACAGCATAGNCCCAACCTGTTTGGAATAAA 
S S V G Y I V S P K P A W T A e X Q P V W N K> 
V e R G L H S E S e A S L N S I X P T C L E ~ 
S L A W A T e W V L S Q P E Q H X P N L F G I K> 
-
150 160 170 180 190 200 210 
* * * * * * * 
GAAGGAGGAGGGAAAGGAGGAGCAAGAGGAGGAAGAGGAGGAGAAGGAAGAGGAGACAGAAGAGGAGACA 
E G G G K G G A R G G R G G E G R G D R R G D> 
::@:::tJittipJttsttifitiiJ:tiX?rn::ti<tti!(ft@t::t?t:atrn:::~:>ntr@Jit<:RJtijJfatt:attkttFi<@i t<a;, 
K E E G K E E Q E E E E E E K E E E T E E E T> 
220 230 240 250 
* * * * 
AGAGGAGGAGGAGGAGGAAGAGGAGGAGGAGGAGGAAAAGCTT 
K R R R R R K R R R R R K S F> 
at@t1J::::tn:J1t:ti?ttf n:::1:::::::::i :::::ti :Hti :::::::::1::::::::::1:::::nJ<:::: L> 
R G G G G G R G G G G G K A X> 
Fig. 5 Nucleotide sequence of pA-7G (flanking genomic DNA sequence only, 253bp) 
showing the minus strand and amino acid sequences translated in 3 frames. The amino 
acid residues are represented by the universal one letter code. Stop codons in the amino 
acid sequences are represented by (•).The cluster of charged amino acid residues in 
the minus one reading frame is underlined while those in the minus 2 reading frame is 
shaded. The charged residues are K, R, H (basic) and E, D (acidic). The putative 
acceptor site, Y-N-Y-A-G/ in the minus 1 reading frame is indicated by the dinucleotide 
AG, which is boxed. 
part of a functional gene, it could not be the first exon and must encode 
intronic sequences as well. Attempts at identifying a splice acceptor site 
was made by analysing the surrounding nucleotide sequence. According 
to Ohshima & Gotoh (1987), the nucleotide frequencies around an 
acceptor site (consensus: Y-N-Y-A-G/, where Y 1s a pyrimidine and N 
represents any nucleotide) typically comprise > 70% pyrimidines (C,T, or 
U) up to positions around -20. However, the authors indicated that the 
criteria they have used to predict a candidate acceptor sequence may 
exclude a few real acceptors. Even if a sequence fits into the consensus, 
it should still be tested experimentally. Only one acceptor site having the 
consensus sequence Y-N-Y-A-G/ appears to be present in the minus 1 
reading frame of c - 7 G. Although this site compnses only 50 % 
pyrimidines up to positions around -20 (Fig. 5), it may still represent a 
genuine acceptor site. However, more experimental work will need to be 
done to confirm this. 
6.3.5 Attempts to isolate cDNA clones corresponding 
to c-7G: screening of a C6VL/1 cDNA library and 
amplification of cDNA from Cl-V13D by PCR 
Since C6VL/1 was shown to express c- 7 G (Fig. 4 ), a cDNA 
library of C6VL/1, donated by I.L. Weissman (Stanford University , CA) 
was screened with the 7G probe. Of a total of 48,000 cDNA clones screened, 
none hybridised to the 7G probe, indicating that c - 7 G 1s not abundantly 
transcribed in C6VL/1. A second approach attempted was to amplify cDNA 
from Cl-V13D by 3'-RACE (Rapid Amplification of cDNA Ends; Frohman et 
al., 1988) using the primers 7G and NOT-TT. Three fragments of 
approximately 700bp, 500bp and 300bp were obtained . All 3 fragments 
hybridised to the 7G probe (data not shown). They were cycle sequenced 
with dye terminators usmg the 7GR pnmer. No significant homology to 
the flanking 70-genomic sequence was observed . The amplified 
fragments were also compared to sequences In the database s. With the 
exception of the 500bp fragment , which showed >95 % homology with th e 
CTLA-2a and CTLA-2~ mRNA, no significant homology (ie. >50 %) was seen 
for the 700bp and 300bp fragments. The CTLA-2 mRNA IS expressed in 
mouse activated T cells and mast cells (Denizot et al. , 1989). Full 
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characterisation of c- 7 G will involve the screening of more clones from 
a cDNA library constructed from the thymus or Cl-Vl3D. 
6.4 Discussion 
The 5'LTR sequence in p)...-7G was shown to lack the 43bp and 16bp 
direct repeats, which has been proposed to confer leukemogenic 
potential to the moderately leukemogenic pMol502 and V21 BL/VL3 viral 
clones (Rassart et al., 1986). However, leukemogenicity has also been 
attributed to sequence modifications in other viral genes, such as the 
gag/pol or env genes (Lenz et al., 1983; Rassart et al., 1986; Tsichlis, 1987; 
Aziz et al., 1989). A combination of viral determinants, acting in synergy, 
has been shown to be important 1n conferring leukemogenicity. For 
example, the leukemogenic potential of the recombinant MCF 24 7 viral 
clone has been mapped to a combined presence of the en v (gp70 and 
pl 5E) and the U3 region of the L TR. Neither gene alone could confer full 
leukemogenic potential (Holland et al., 1985). The presence of a Hi ndl I I 
site at the gag Ip o l region indicated that the 7G provirus is a recombinant 
virus and could have arisen from recombination between an endogenous 
ecotropic virus with an internal Hi ndlll site in DBA/2j mice and RadL V 
env sequences. The rearrangment of c-7G in Cl-Vl3D but not in 
germline DBA/2j confirmed that it is a newly acquired virus. This 
acquisition of proviruses by recombination and subsequent re-
integration constitute events which are likely to contribute towards the 
partial transformation of Cl-Vl3D during the period of in vitro culture. 
There have been very few studies carried out to identify common 
RadL V integration sites. A recent study by Tremblay et al. ( 199 2 ) 
demonstrated that in about 5 % of tumours induced by the BL/VL3 ( c 1 one 
V-13) RadL V, a provirus is found integrated into a region which was 
identified as a novel gene, Vin-I. Studies made by the same authors al so 
revealed that about 20 % and 18 % of the tumours show rearrangement in 
c-myc and Pim -1, respectively. The Vi n-1 gene has not been sequenced, 
but was shown to encode a 6kb transcript. There is no evidence to 
suggest that c - 7 G is equivalent to the V i n-1 gene. Preliminary analysi s 
of)... clones isolated from the Cl-Vl3D genomic library (Chapter 5) with 
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3 2 P-labelled v-myc as probe has indicated that none of the A clones 
carry proviruses integrated into the c- my c gene ( data not shown). 
The integration site of the 7G provirus was unique to C 1-V l 3D and 
was not observed in the RadL V-induced C6VL/l and BL/VL3 thymic 
lymphoma cell lines. Since Cl-V13D was derived from a DBA/2j strain 
mouse and C6VL/1 and BL/VL3 were derived from C57BL/Ka strain 
mouse, the differences in genetic background could have influenced the 
integration site. This was observed for Friend virus-induced leukemia, in 
which integration into the fim-1 and fim-2 genes was found to be fairly 
specific for the B6 X C (Fl) mouse strain, while none of the myeloblastic 
leukemias with ICFW or DBA/2 background showed rearrangments in 
these two regions (Sola et al., 1986). Since C6VL/l and BL/VL3 were 
derived from thymic tumours after infection of mice with RadL V, it is 
also possible that this integration event is specific to an in vitro 
infected, immature lymphoid cell type like Cl-V13D. 
Two frames translated from the minus strand of flanking genomic 
DNA in A-7G contain long stretches of charged amino acid residues (basic 
residues: K, R, H; acidic residues: E, D). Extremely long runs of >20 
consecutive charged residues, either purely acidic or mixed basic and 
acidic occur in about one-third of nuclear and cytoplasmic autoantigens. 
Less than 3 % of such runs are found in other mammalian proteins 
(Brendel et al., 1991). Such clusters of charged residues are also 
characteristic of eukaryotic regulatory proteins, including 
transcription and replication factors and heat shock proteins (Brendel & 
Karlin, 1989). Significant charged clusters are also found in nuclear, but 
apparently not cytoplasmic proto-oncogene products (Karlin & Brendel, 
1990). The long stretch of charged residues K2E2GKE2QE6KE3TE3 and 
R4ER2SKR2KR4KR2QKR2QE12K encoded by the mmus 1 and 2 reading 
frames, respectively, showed >50 % homology with some of the proteins 
reported in the literature. It would be premature at this stage to place 
undue emphasis on any single homology based on computational 
comparison, however the homologies do suggest that c-7G may code for a 
protein with important regulatory functions. The possibility that c - 7 G 
could be part of an untranslated region was not excluded. 
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Further attempts to isolate the c-7G cDNA using PCR amplification 
gave 3 products. None of these products shared any homology with the 
genomic nucleotide sequence flan~ing the LTR. One of the products , 
however, shared almost 100% homology with the CTLA-2a and ~ mRNA , 
which are transcribed 1n activated T cells and macrophages. The 
amplified products may not be related to the c- 7 G gene since NOT-TT is 
not a specific primer and it can anneal to almost all mRNA species. The 
7GR primer could also have annealed to other cDNAs with nearly similar 
homology and allowed for amplification of these cDNAs. 
SUMMARY 
A single 5' LTR-host junction subcloned as pA-7G was analysed in detail. 
Comparison of the flanking genomic DNA with sequences available in 
the GENBANK and EMBL nucleic acid databases failed to detect any 
significant homology. Southern analysis however showed that the c - 7 G 
gene 1s a unique sequence and produces different RFLP patterns in the 
strains studied. It is also specifically rearranged in C 1-V l 3D but not 1n 
other RadL V-induced or other tumour cell lines. It appears to be 
expressed by cells of lymphoid ong1n and not by adult liver cells. 
Preliminary analysis indicated that it is possible that a part of the 
protein encoded by c - 7 G contains a stretch of charged amino acid 
residues (>20 a.a.) in the minus reading frame. The presence of long 
stretches of charged amino acid residues has been reported to be 
associated with transcription factors and nuclear proto-oncogenes . c - 7 G 
may code for a protein with similar functions , which would be important 
in regulation of growth and transformation of an early lymphoid cell 
type like C 1-V13D . 
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CHAPTER 7 
General Discussion 
7 .1 A model for study 
The ability of type C munne retroviruses to induce leukemia is 
influenced to a great extent by the genetics of the host (Rowe, 1972). The 
development of leukemia usually occurs after a long period of time. To 
circumvent this, an established, partially transformed retrovirus-
infected cell line was investigated as a possible model to study the 
oncogen1c process in T cell leukemia. RadLV, a type C murine retrovirus, 
was used because it provides some interesting aspects for study. For 
example, it has a preference for immature cells in the thymus as targets 
for infection, and induces leukemia in mice after a lengthy process of 
clonal selection 1n the thymus. This allows the study of thymic 
involvement in T cell leukemia. In addition, the RadLVs do not carry any 
cell-derived sequences and elicit tumours by disrupting host cellular 
genes. They are therefore potentially useful for uncovenng novel 
proto-oncogenes involved 1n the tumorigenic process 1n early T cell 
progenitors. 
The RadLV-infected cell line, Cl-Vl3D has a unique lymphoid 
precursor phenotype (O'Neill, 1992). It was used 1n this study to 
investigate genetic changes occurnng after initial infection which 
could be associated with disease progression. These include retroviral 
recombination and/or integration events, any differentiative changes 
due to the thymic microenvironment and the disruption of cellular 
genes by retroviral integration. Although Cl-Vl3D could grow as a 
tumour in syngene1c DBA/2j mice via most routes, it was unable to grow 
subcutaneously in unirradiated DBA/2j mice. Also, its ability to grow as a 
tumour 1n allogeneic mice was restricted by strain and route of 
inoculation. It is therefore a partially transformed cell line. C 1-V l 3D has 
demonstrated a specific capacity to grow in the thymus and to become 
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selectively more tumorigenic after serial intrathymic passages. This 
observation provided the basis for evaluating favourably the usefulness 
of Cl-V13D as a potential biological tool in the dissection of oncogenic 
event(s) occurring intrathymically during disease progression. 
7. 2 The on co genie process 
7.2.1 A multitude of events 
Many naturally occurring tumours, including those which 
are virally-induced, evolve by step-wise genetic changes as part of the 
oncogenic process. For example, although integration of the avian 
lymphoid leukosis virus (AL V) into the c- my c gene was found in the 
majority of diseased birds, not all of these birds showed evidence of 
increased c- my c expression. Further analysis showed that DNA from 
AL V-induced lymphomas could transform recipient mouse cells, but the 
transforming DNA contained no c-myc sequences (Hayward et al ., 1981 ). 
It was suggested that integration into c-my c may simply be an initiating 
event, serving to render the cells susceptible to further oncogenic 
changes (Wyke, 1981). A similar mechanism has also been proposed for 
Burkitt's lymphoma in humans , in which the Epstein-Barr virus 
selectively infects B cells and renders them susceptible to additional 
neoplastic events. These results demonstrate that more than one 
mutational event is required to activate the full oncogenic potential of a 
single proto-oncogene. Cooperation between two oncogenes, where one 
is associated with a later stage of disease development by further 
provirus insertion is another example (Section 1.5.3). A sequential 
activation of one oncogene after another was considered necessary to 
induce a fully malignant state. 
In this study, the increasing tumorigenic potential 
exhibited by Cl-V13D cells after each passage through the thymu 
reflected changes indicative of stepwise oncogenic progre sion. While 
the involvement of the thymus in T cell leukemogenesis has been well 
established (reviewed in 1.5.1), it role as a unique microenvironment in 
regulating the growth of pre-leukemic or leukemic cell i le s well 
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understood. This study has focussed on genetic and phenotypic changes 
occurring in Cl-V13D cells during oncogenic progression as a result of 
replication and residence within the thymus. Based on evidence 
presented that cellular genes could be disrupted by retroviral 
integration, resulting in partial transformation or maturation arrest of 
cells, the characterisation of some of these genes in the vicinity of 
retroviral integration in Cl-Vl 3D was also initiated. 
7.2.2 The right micro environment? 
A wealth of literature supports the view that immature cells 
are 'selectively' targetted for initial neoplastic transformation. The 
susceptibility of immature cells has been demonstrated 1n leukemia 
(reviewed 1n Section 1.4) and also 1n other types of cancers like 
teratocarcinomas and colonic tumours (Jacob, 1980; Barnhill et al., 1993). 
In the case of hematopoietic cancers, immature target cells exhibit 
phenotypes indicative of muldpotential or bipotential cells. A 
consequence of this 1s that transformed cells cannot be definitively 
assigned to any particular cell lineage (reviewed in Section 1.4 ). Based 
on the concept of 'lineage promiscuity' (Greaves et al., 1986a) , it could be 
assumed that the choice of commitment of these bipotential or 
multipotential cells to a particular lineage IS intrinsically flexible. 
Theoretically, these transformed immature cells could give rise to a wide 
spectrum of leukemic diseases, depending on which growth factors are 
present and the microenvironment 1n which they develop 
(Diamandopoulous et al., 1979). This has been demonstrated In a number 
of functional and phenotypic analyses which showed that growth 
factors were capable of dictating the lineage commitment of imn1ature 
T-ALL (acute T-lymphocytic leukemia) cells (Kurtzberg et al., 1989; 
O'Conner et al., 1990). In another study , a subpopulation of uncommitted 
cells present m a mature T cell leukemia was shown to undergo multi-
lineage differentiation depending on the growth factors supplied 
(Griesinger et al. , 1989). Engraftment of chronic myeloid leukemic cell s 
into the thymus was reported to result In the differentiation of donor 
leukemic cells into T lymphocytes (Gishizky et al. , 1993). Taken together , 
these data show that well differentiated leukemia can change phenotype 
when exposed to a different microenvironment. This is indicative of the 
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existence of an immature leukemic cell pool which 1s capable of g1v1ng 
rise to cells of different lineages. 
In the model described here using the spleen-derived , 
RadLV-infected Cl-V13D cell line, two features highlight the importance 
of the microenvironment: a) the thymus was the only organ with little 
restriction to replication of C 1-V l 3D in allogeneic mice, and b) an 
increased number of viral particles (Chapter 4) was observed in Cl-V13D 
progeny cell lines reisolated after intrathymic passage, indicative of 
viral replication and productive infection. The ability of the thymus to 
support proliferation of leukemic cells like C 1-V l 3D and to select for cell 
clones with increased tumorigenicity highlights the uniqueness of the 
thymic microenvironment. The capacity of C 1-V l 3D to proliferate 1n the 
thymus and to acquire T cell surface markers suggested that it could be a 
precursor T cell. This is consistent with earlier evidence that RadL V 
preferentally infects immature T cell precursors, and that viral 
replication requires interaction of these cells with thymic cellular 
elements and factors present in the thymic microenvironment (Goffinet 
et al., 1983; Boniver et al., 1989). The presence of recombinant viruses 
(eg. MCF viruses) in Cl-V13D (Chapter 5) is also consistent with other 
evidence that MCF viruses also selectively replicate in rapidly dividing 
immature thymocytes present in the thymic cortex (O'Donnell et al. , 
19 84). Increased viral replication may directly or indirectly alter cell 
growth and thus contribute to the oncogen1c process. This has been 
documented for the MoMuL V (Tsichlis et al. , 1987) 
7.2.3 The preleukemic or leukemic cell 
There has been considerable evidence presented to suggest 
that the leukemogenic process 1s linked to the cell 's normal 
differentiation program (reviewed 1n Section 1.5.2 ). A cell 's 
susceptibility to leukemic transformation by retroviruses was shown to 
be dependent on its differentiative state , thereby providing an example 
of how the developmental state of a cell could be exploited by 
leukemogenic agents. This has been documented in the case of type C 
retrovirus-induced leukemogenesis (reviewed by Kaplan , 1961 ), where 
stem cells or lymphoid progenitors were shown to be most vulnerable to 
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infection by these leukemogenic viruses. In addition , normal 
differentiation events, such as the rearrangement of immunoglobulin 
(lg) and T cell receptor (TCR) genes have been shown to contribute to 
malignancies in B and T cells, respectively. A frequent occurrence is the 
translocation of a growth regulating gene into a highly fragile region 
such as a rearranging lg or TCR gene locus. This results 1n 
transcriptional dysregulation of the growth regulating gene and 
unregulated cell proliferation (Yunis, 1983; Croce et al., 1985). These 
examples also demonstrated clearly how the normal process of cell 
differentiation could effect leukemic transformation. 
The capacity of leukemic lines to respond to physiological 
inducers and to differentiate 1n vitro has been demonstrated 1n a 
number of independent studies (Friend et al., 1971; Sachs , 1978; Paige et 
al., 1978; Collins et al., 1978; Lazo et al., 1990; Hibi et al. , 1993). A similar 
capacity to differentiate 1n vivo was shown to be very much dependent 
on the maturation status of the leukemic cells and the 
microenvironment in which they replicate (Green et al. , 1985; Lazo et al. , 
1990; Gresser et al., 1991; Gishizky et al. , 1993). It has also been observed 
in T cell leukemia that tumour progression is associated with more 
mature T cell phenotypes (Lieberman et al. , 1979; O'Donnell et al. , 1984; 
Yefenof et al., 1991). This has also been documented for other types of 
leukemia (Jensen et al., 1992). Cl-V13D cells were shown to differentiate 
and express T cell surface markers. They also acquired increased 
tumorigenic potential while replicating in the thymus . These changes 
probably reflect maturation events associated with oncogen1c 
progression and manifestation of the disease. 
Analysis of the effect of oncogene expression on cell 
differentiation has been limited by the availability of good experimental 
systems. In vitro cultured cells have been used widely for thi s purpose . 
Key selection criteria appeared to be a) purity of cell type, b) ability to 
divide and c) ability to retain expression of normal differentiated cell 
phenotype (reviewed by Boettiger, 1989). Phenotypic and morphologi cal 
analyses of Cl-V l 3D cells have already indicated their lymphoid ongin 
(Chapter 2). The inability of sorted , Thy-1 positive Cl-V13D cells to retain 
a differentiated T cell phenotype in tissue culture did not indicate a clear 
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association between differentiation and oncogen1c progression 1n this 
study. However, genetic events associated with early differentiation of 
C 1-V l 3D cells may have occurred and remained unrecognised in the 
absence of available phenotypic markers. The evidence presented 1n 
Chapter 3 1s consistent with other evidence indicating that 
differentiation 1s intrinsic to the leukemogenic process, and supports 
the hypothesis that maturation within the thymic microenvironment 1s 
important for oncogenic progression in C 1-V 13 D cells. 
7.2.4 The role of the virus 
In some systems, further retroviral integration and 
recombinant events have been shown to contribute to the leukemogenic 
process (reviewed 1n Section 1.5.3). The possibility of these events 
contributing to oncogenic progression in Cl-V l 3D cells was investigated. 
However, the data presented in Chapter 4 showed no evidence of further 
retroviral events involving RadL V or RadL V-like en v gene sequences. 
Newly integrated vuuses, representing recombinants involving the pol 
gene were observed 1n some pnmary clones . but in v iv o tests for 
increased tumorigenicity associated with the generation of new 
recombinant viruses suggested that the retroviral events detected were 
probably random or incidental (Chapter 4 ). This analysis did not address 
the significance of multiple retroviral integration events which had 
occurred during in vitro culture of Cl-V13D cells following the initial 
infection. Subcloning of genomic DNA 1n the vicinity of retroviral 
integration was therefore carried out to isolate and characterise genes 
which may be responsible for the partial transformation and maturation 
arrest of Cl-V13D cells in vitro. Since certain recombinant virus 
structures have been identified and proposed to be important for clonal 
selection during tumour development (van der Putten , 1981 ), the 
analysis of recombinant vlfuses which have evolved during 
transformation of Cl-V13D in vitro was also attempted. 
Restriction enzyme analysis of viral genomes has revealed 
the presence of both recombinant and defective viruse s. Thi s was 
evident by the presence of a Hi ndIII site in several cloned proviruses. 
This site is not present m the original RadL V /V 13 clone (Rassart et a l., 
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1986) used to infect and immortalise spleen cells, from which C 1-V 13D 
was derived (O'Neill, 1992). The consistent presence of a Hin dill site at 
the gag Ip o l region in all full length viruses cloned suggested that this 
virus structure may play a role in cell transformation in vitro. 
7.2.5 The role of proto-oncogenes and other genetic 
elements 
Simple repeat sequences, once considered to be 
meaningless or "junk" DNA have become increasingly important 1n 
disease association (Kunkel, 1993; Thibodeau et al. , 1993; Mironov et al., 
1994 ). There is increasing evidence to indicate the involvement of LINE 
and SINE repeat elements in many cancers. These repeats are also termed 
mobile genetic elements because of their ability to retrotranspose. These 
elements have now been shown to have regulatory roles and may encode 
proteins (Section 5.4). The transposition of these elements into single 
copy loci could have profound effects on gene activity (Economou-
Pachnis et al., 1985; Katzir et al. , 1985; Arman et al., 1986; Morse et al., 
1988). 
Translocations involving fragile sites or breakpoint cluster 
regions 1n specific chromosomes are common in T and B cell leukemias. 
Sequence analysis of the breakpoint cluster region in the ALL-1 gene in 
acute leukemia has revealed a high density of Alu repeats, which are 
equivalent to the rodent B 1 repeats (Weiner et al. , 1986). Seventy percent 
of these breaks were found to occur in the region delineated by exons 6 
and 7, which is composed mainly of Alu sequences. It was proposed that 
the high density of Alu repeats could make the breakpoint cluster region 
more prone to recombination (Gu et al., 1994). 
So far, no studies have linked repeat elements with 
retroviral integration sites. A LINE sequence, inserted 6kb from the 
region of MoMuL V integration (M lv i-2), was proposed to be a genetic 
change required for neoplasia (Economou-Pachnis et al. , 1985). The 
presence of B 1 and B2 repeats in the vicinity of all full length viruses 
cloned from C 1-V 13D (Chapter 5) suggests a possible association bet ween 
repeat elements and viral integration sites. Several interesting 
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possibilities exist: a) a genomic reg10n containing repeats is a 'hot spot' 
for events such as recombination and integration, b) repeats and 
retroviruses could cooperate with or antagonise each other, leading to 
disruption of gene function, or c) the presence of one in the vicinity of 
the other could promote additional recombination or enhanced 
retropositioning, resulting in further genetic instablity. Another 
interesting possibility is that these repeat elements may themselves be a 
gene, or part of a gene with specific function, which can be activated by 
retrovirus insertion. The Set 1 and 2 transcription units, which contain 
dispersed repetitive elements, are examples . These units have been 
shown to be activated in SV40, Abelson MuL V and Rous Sarcoma vuus-
transformed cells (Scott et al. , 1983). Activation of genes of this type by 
retroviral insertion may contribute directly or indirectly to the 
transformed phenotype. It is possible that retroviral integrations in the 
vicinity of repeat elements in Cl-V13D may not be completely random 
and may have a role in the transformation of Cl-V13D. This possibility 
was considered in view of the biological role of repeats as regulators, 
their documented involvement in cancers as genetically unstable mobile 
elements and as possible hotspots for recombination and retroviral 
integration. 
The identification of proto-oncogenes that play important 
roles in tumour development has led to a better understanding of the 
molecular events underlying the oncogenic process . Characterisation of 
common integration sites in MoMuL V-induced lymphoma has led to the 
discovery of genes associated with tumour initiation and progression 
(Tsichlis et al., 1990; Bear et al., 1989; Breuer et al., 1989). Analysis of the 
L TR-host junction has been used as a procedure for isolating novel genes 
associated with tumour development. In this study, the 5 'L TR-host 
junction, subcloned from '"A- 7 and designated as p'"A- 7G, was fully 
sequenced. It was possible that it could be part of an untranslated region. 
However, translation of the nucleotide sequences proximal to the 5 'LTR 
in p'"A-7G has revealed that it could also code for an interesting stretch of 
charged amino acid residues. Similar stretches of charged residues have 
been reported in association with eukaryotic regulatory proteins , 
nuclear proto-oncogene products and many G protein-coupled receptors 
(Karlin & Brendel, 1990). The disruption of genes coding for these 
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proteins by retroviral integration could result 1n disruption of normal 
cellular functions. 
7.3 Strategies for future investigations 
The results of this study suggest an association between 
differentiation and increased tumorigenic potential 1n Cl-V13D 
following replication of cells in the thymus. However , the possibilty 
exists that genetic changes associated with early differentiation are not 
reflected 1n the acquisition of stable phenotypic markers. Another 
approach to identifying genetic changes during oncogenic progression 
1n Cl-V13D would be to employ karyotypic analysis to check for 
cytogenetic lesions 1n the pnmary , secondary and tertiary clones 
reisolated after first, second and third passage through the thymus. Any 
cytogenetic lesions associated with specific chromosomes could be 
analysed for the presence of genes associated with cell differentiation . 
Recent advances in the mapping of the mouse genome should facilitate 
the linking of these genes to specific chromosomes (Copeland et al. , 
1993 ). 
Further characterisation of the subcloned LTR-host fragments , 
including c- 7 G could provide interesting information on novel proto-
oncogenes and the regulation of early lymphoid cell proliferation. A 
preliminary attempt to isolate the cDNA corresponding to c - 7 G from a 
cDNA library of the C6VL/l T cell lymphoma line was unsuccessful , 
suggesting that c - 7 G mRNA 1s a transcript with low copy number. 
Further work 1s needed to subclone the full length c - 7 G cDN A from a 
thymic cDNA library or from a cDNA library constructed from C 1-V l 3D 
cells. The intervening DNA . . regions 1n subcloned cDNA + fragment s, 
which do not carry any repeat sequences and which have no significant 
homology to sequences m the GENBANK and EMBL nucleic acid databases 
could be investigated further. Computational analysis has indicated that 
some of them may be parts of uncharacterised gene sequences since 
they have high coding probabilities. These sequences could be used as 
probes to analyse Northern blots 1n order to determine if they are 
specifically transcribed in C 1-V l 3D cell s. Any transcribed re gion s found 
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could be used to screen a cDNA library of the appropriate tissue or cell 
line and positive cDNA clones could then be isolated, sequenced and 
characterised. Putative regulatory sequences (enhancers or promoters) 
could be assessed for their function by subcloning into an appropriate 
expression vector, for example, the pCAT reporter plasmids (Promega, 
USA), where their ability to regulate the expression of a reporter gene 
can be determined. 
7. 4 Summary and general conclusions 
This study presents an attempt to elucidate some of the 
mechanisms involved in T cell leukemogenesis using a partially 
transformed cell line, Cl-V13D. This cell line was derived by in vitro 
infection of pnmary spleen cells with RadL V, a non-oncogene bearing 
murine type C retrovirus. The data obtained is consistent with published 
data on the involvement of the thymus in supporting proliferation of 
leukemic cells and retrovirus replication. Oncogenic progression was 
seen to occur in Cl-V l3D cells after intrathymic replication. Analysis of 
phenotypic changes revealed that C 1-V l 3D cells differentiated under the 
influence of the thymic microenvironment, consistent with progression 
towards a more mature phenotype during tumour progression in T cell 
leukemia. No further retroviral integration events were observed 
involving the original RadL V virus, as indicated by Southern analysis 
using the specific RadL V gp70 env probe. However, recombinant and 
defective viruses were detected and several of these were subsequently 
subcloned and characterised. These viruses were present in the original 
Cl-V13D cell line and probably arose during the period of in vitro 
culture. These retroviral recombination and reintegration events could 
have resulted in the partial transformation and maturation arrest of 
Cl-V l 3D cells. Finally, subcloning and analysis of genomic sequences 1n 
the vicinity of retroviral integration from a Cl-V13D genomic library 
revealed the consistent presence of repeat elements of the B 1 and B2 
family. It 1s possible that these elements represent 'hot spots ' for 
retroviral integration. Destabilisation of these mobile genetic elements 
or disruption of their normal regulatory role via retroviral integration 
could be important in oncogenesis. Sequence analysis of a transcribed 
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genomic fragment adjacent to the 5'LTR in the pA-7G genomic clone has 
revealed the possibility that the particular gene involved could encode a 
stretch of charged amino acid residues. Stretches of such charged 
residues are found in proteins important in regulation of cell function s. 
Subcloning and characterisation of its full length cDNA will be the next 
step towards understanding its involvement 1n the transformation and 
maturation arrest of C 1-Vl 3D cells. 
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Appendix 1 Nucleotide sequence ofpA-lBB (1.187kb) 
1 GCAGCATAAT CAGAGTCAGG CTACCTTACC TGCTTMMciilc.i@J&}i\icicikit cc.dci&ekfiki§.\ 
~;; 1a1a111L;•1!,!!!!~~!!!!!~!~~; 
241 GCCACTGAAT TACTCTCTCC 
301 CGCACGACTT TAATCCCGGC 
361 AGTCCAGCCT GGTTTCCAAA 
421 TGTCTTCACA AAACAAAAGG 
481 CGTTTGCTCT TTTCTTCTCT 
541 TGGCTCCCTG TCTGGGGCTT 
601 CAGCTCCCTT CAAATGTCAC 
661 TGTCTGGGAC CTTCCCTTAC 
721 TATCTGTGCT CAGGAAAGGT 
781 ATCCCTAGGA CCAATAGGAG 
841 AAGCTGGTTC CCACCCAACA 
901 GACAGACAGG GTGGTGGTGA 
961 TTCCTGCTGT CCCTGCAATT 
1021 AAGCCGGCAT GAGGCACCCA 
1081 CCGGGCCCTG GGAGGAGGGG 
1141 GTGGGCTACT GTATGTATCC 
TCCCAGTATA AAAAGAGGTT 
ACTTGAGAGG CAGAGGCAGG 
GCGAATTCCA GGATTAGTCA 
GAGAAGAAGG GAGTTTGACT 
CCTCCTCCTC TTCCAGGAGA 
CTGTTATAAA GCTGGCCCAA 
CGTTTCCTAA GCTCGGTGTT 
AGTAGGAGAC GGGGTGGCTG 
AAGCTCATAC TAAGATGCAT 
CCATCTGGAC CTAGCAAACT 
CCAGGGGCTC CCTCACTTCA 
CAGTGGCCCA GAAATGACTT 
CTCATTTGGC TTGTCTGAGC 
CCTCCTTCAG GCCAAAGGAA 
CTCCCAGCAA TGGAGCACCT 
TAAACTTGGT AAGGACGCCG 
GACGGAGCCG 
TGGATGGATT 
GGACTACATG 
GCGGCAGATG 
TGGCAAGCCC 
AGGAGNATGA 
ATCCTGGGTT 
CCAGCCCCTG 
AGGGCGCTTC 
TTCCCCTACC 
CAGTCCAGTC 
TAGCCAGGGC 
CTCAGTTTCT 
CAAAAAATGA 
GGGCAGGATT 
CTCCTCTG 
GGCGTGGTGG 
TCTGAGTTGG 
GAGAAATCTT 
GTCACAGTTG 
ATGAGCAACG 
TCTTCCCTAA 
AACCTGGTTC 
GCATAGAGGG 
ATACTGATCG 
CCTAACAAAG 
ACAAGGAAAG 
TAGGTCCTTG 
TCATTCATTA 
CTGACAAGTG 
CCTAGAGGGA 
Shaded region represents repeat sequence. The poly(A) tract is underlined. 
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Appendix 2 Nucleotide sequence of pA-7K (2.610kb) 
1 AAGcTTGAAA TGTTcTcTTA AAAAGTGGcT TAAGti:&.c±ett<ktiAGi±s&cmt H.1ft.l.00Attir1@L 
1
:~ lllilll!llllli llilliill!IIIR llllll llllllllli 
181 wAomr:t:AG.AWAt /t.M:mANA.w1~1:,/ t!\TG.~lt :r:r .:TAlfcf<rvv1AAA1>GGT GGc TT AA T GG T ACAGT Ge Tc 
2 41 AccT ATcT TA TTTGTTTGT T TNG.i ahh@0±t :tfa#{±A&.cc.c1r rn&rn±±&fcc&@t <lARc±wsAc±fa< 
:~~ lllillll ll lilffil lllil!!! !~!!!!! !!!I!~! !!~~! 
421 AAAGAAACCA ATAAATGGAT ATGCATGCAT GTACTTCTAT TCTTGGAGCC CAAAGGAGAG 
481 TAAGACAGGG AGATTCCTAA CTCAAGGCCA GCATGAGCAA CATAGTGACA CGTGTCTTTG 
CTTCAAAAGC GTCCAAACAC TAAAAACCGG 
841 GACAAACGAG GTTTTGTTTT ATTTTTCACA TGAAGAAGCA GCAAGGAAGA AAAATAAATA 
901 AATAAATAGT TGGTTGTGTG GGTTTGAAAA GCCTATGGGA AAATAATTAA CTAGTGGTTG 
961 GCACCCTCCT TTGAACAATG GCCCAGTCTC CAGATTGACG CACACAGTTT GGGGTCCAGC 
1021 TATTGAAGCA GTCACTAGGG GTGGCTCTCA GTACTCTCCA CACTGTAGCT CCTTGAGACT 
1081 GGAGTCAGCC GAGCACCCCA ATAGCCTTGG GAGGGTTGTG GCGAGTCGCA CTGTCCTGGG 
1141 TTCTGATTCT CTGAGAAATT GCAAGGGCTT AGCAGGATTG TGAATATTCT AATTAGGCAT 
1201 GTGTAATTTG ATTTTGGAGC GGTGGAACTT GTGAGGTCTT TTGAACCTAC ACAGGAGAAA 
1261 AAACAACTTA AGCCTTTGAA AATGAATGGA CATATCAGTG GATTATGATG CACACAAGTC 
1321 CCTCCAGCTT TGAGCCCTGC TCTGGGATAT ATCGGATGCC CAATAAATTA ATAAAGTTGT 
1381 TGATTTGAGT GGGAGTCCGT TGGACTCCAA AAAGAGGATG GGTTTCTCTG TCTTTCCACA 
1441 AAGCCCAACT CTTTGATCAC ATCAAGGCCT CTGGCCACTG CTCTGCCTAC AGTAGTTAAC 
1501 TCCATTCACT CAGTCTTTCA CCATTCTTTG GAAAAGAATA CTCCTCTTTC CTTCCTTCTC 
1561 CCCCACCCCT TCTTTCCTTC TCTTTTTGAT GCAGGNTCCC CCTATGCAAC CC TG.GC.TGGC: 
1861 GCTCCTCCTC CTTCTATTAG ACTCTCTCCC TGTCTCTCCC TCCCTTCTCC TCTTATTCTG 
1921 CATAGTGTGT GTGTGTGTGT CTGTGTGTAT ACAAAAGGGT TATTCACTGA ACCCGAAGCA 
1981 GCTCACCTGT TAGGCTAGAC TAACCAGCTT GTGAACCCCC AGAGCCTCCT TGTGCCTGCC 
2041 TCCCCCAGTG ATGAGATTTC ACATGTACTC TACAACCAGT TTTTTTTTTT TCTTCCCCAT 
2101 GAGTCCCGTG ATCTGAACAC AGACAGGTCT TCGTGTTACC AGGGAGCTTG GGGCCTCCTT 
2161 TCATAGGTTC TTAGTCCCCT TGATGCAAAT TTTTAAAAAG AATTTGGAAG GACTTAAGGA 
2221 CCAGCATGTA GAGTCCAGGA GAGTTTGGAG GAGAGGCAGG CTGCAAAGCT CGGCAGCTGC 
2281 CAGGAGGAAG TAGGTGGAAA GGGAGAGGAG AGAAAGCCAC ATCTTTAAAA TTACAGTCCA 
2341 AGAAGGCACA GGCTCCGAGA TGGAGGCAAG CAAACAGCTG TGTGGCAGAA GTGGGGTCT T 
2401 CAGAAAAAGA GTGAAAATGT CCAGAGGGTC ACGAAAGGAG ATACGTACTC AGAAAGGGAG 
24 61 AGGAGCCGGG TGCAGTGGTG CTCACCTTCT GTCCGCAGGA GGCAGGACAG GTTCTCTATG 
2521 ATTTTAAAGC CAACCTGGTC TGCATAATTG GATTCCAAGC CAGACTTACA TTGTAAGACC 
2581 CCGTGACCTT GGATTTCTTG ACATTCTTCG 
Shaded regions represent repeat sequences. The poly(A) tracts are underlined. 
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Appendix 3 Nucleotide sequence of pA-13AB (2.48kb) 
1 AAGCTTTAAG GTTAAATGTA ACTCTATTTA AAGTAGGTAT CAGAGCTGGA GGAGCCAAGA 
61 GTTGAGTCGG CAGCAGTTAG CTTTTAAGAG GACCTTGGTT CAGTTCCCCA ACGTGGCACT 
121 CACACTGGTC TGACCCCACC TCCAGGGGAT CACACACCTT CTTCCAGCCC CTATACCATT 
181 TGCATGTGCA CACGTACATG TACAGGTGTA!CACACACACA CACACACACA!AAGAGCGGAA 
241 CATGGACATG TAAGTATTTA AGTAGTTCCC ATGAAACTCA TACAGGAAGA ATGTCCACTG 
301 GGGAAGCTCT TTCGGCCCTC GTTCACCACA TCCTCGTCCC 
361 TGGGCCAGCC CATCAGGGAA GCAGCGGTAG AAGAAGTCTG 
421 TAATTTACTC TCTCAGGAAG TATTTTTCAG .TAATAGTAGA 
481 CTAATGTCAT AGGCAAAATA ATGTAATGGG GTGAGATTAG 
541 CCTTAGCCAC GCGGCCAATG TTCAAGAAAG TCTCTAGCAT 
601 AGCAGCTAGT CATACTGCAG CTTTAGGTAC ATAAAGGTGG 
661 GACAGGACGC AGACCAGGTG GTACACTTGG AACAGGCAGA 
721 GGTGAGAAAG GAGAGACTAG TCTGAGAATC CGGGTAAACA 
781 GTGTGTGTGG GGGGCGCTCA GGGAGGTTTG AGTGCCAAGG 
841 TATCAGTTTG ATTATGTTGG TAAAGACACC ATTCAGAGCT 
CCGTGCACGT 
GGCGGGGCCT 
TGTCAATAAT 
TGTTTATACT 
ATGATTGTAT 
TCGCTGTGGG 
GGGCAGGGAG 
CTGCTTGAGA 
CTTCTCACTT 
AGGGCAAGGC 
CAGATCAGAA 
GGAAGAAATA 
CTGTTGACCA 
GAGAAAAAGG 
CTTAGCACAG 
AAATACTCAG 
AGGGAGTTCT 
ATGTGGTGGT 
ACCTGCCCAC 
TGGCAGCTGG 
901 AAAGCAAAGA AGCCGTTAGT GCCATCTGCT TGGAGAAGAG TAAGCCACCA CCTCATGAGT 
961 TAGAGCCTTC ATTGCTTTGA GATAGAACCC AACCAGAATA AAAACCCAAA CGGCCTAGGG 
1021 GCAGAGAAGT GGAGCACTGA GGAACACCTA TGTGGCACCT GTGTTAATAG GGAACACCTG 
1081 TGTGGTGTCT GTGTTAATAA GGAAcAccTG tG.Cc&oo.c.&.~Miutfai~sc.A.c.£.c&te.c.1mfa~~1ii.tt 
i;~i IIIIIMlllllllllll lllll@ll lllll~ililllllB!I IEIII 
1261 U&AAAAGGGAC ACCTGTGTGG CGCCTGTGTT ATTAAGCACA TTCTCATCAG TACTGCTTTT 
1321 TGGTCTCATG GGGTAAAAAG ACATCTTTAG GGGTACAGAG TACTGAACCC CATAGCTACT 
1381 TGCCAACACT AAGACAGGAA 
1441 CTGTCGGTAG CGTCACTTTC 
1501 GAAAGGCAAT GACCTGAAGG 
1561 AAGCACCAGC TGCCGCGCAC 
1621 CCCTAGCCCT GGAACTCAAG 
1681 CAGCTCACGC ACAAACATGC 
1741 GTAGAGCCAC AGCTCCTCGG 
1801 CCTGGGGAGG AAACGGGGAA 
1861 GCCGCTTAGG AAGTGCGAGC 
1921 AAGCCACAAA GAGCAGGACC 
1981 CGCCATACGT GCGGTTCAGA 
2041 GTGTCCAGCG CCACCTAGCG 
2101 CAGGAAATTC AGAGCTCATT 
2161 GGTCTCAAAG CAATGTGTCC 
2221 AACGTCATTC TCCAGAGATG 
2281 AACTATGTCT TTGGAGCATT 
2341 TTTGTGTCTC ATTTCCCAGT 
2401 TTCTTAAGTA GACCATACAG 
2461 AATGGAATGC CATTAAAAGC 
CAACTGGAAC AAGGGCGACT 
CTTAGAAACT TGGCGAGGAA 
TAAAACACAG GGTCGGTAAA 
TAACCAAGAT CGGGGCTNAG 
GCAGGGGAGG AGTCCCTGCC 
GGCCGGTGGG GAAGTATTCC 
GCTGGATCCG CCGCTGGAAG 
GATTGACAGG CTACGTCGGC 
GCCCAGGGAC GCCTGGAAGC 
CGCACGCCCA GCTCGGCTCC 
CGCTGACGTG GCCCCGGCGC 
AACTCCGCGG GGACTGACTA 
TGCTGTGTTA TGAGTACCAC 
TTCACCAACC ACCCAGATCA 
CTTCCTCTAC AAAAGCAAAC 
TCGAAGNGAA AAAACTGGGC 
AAACTGTACC ATGAAATTAC 
GACAATTTAT TAAAGTCAAC 
TACCGAGGCA 
GTTCAGGGAC 
ACCAAGTCCC 
ATTGCCCACC 
AGCGGAGGAG 
GCCTCCACGT 
GGAGGGAGCA 
GGAAGAACCT 
GTTGACAGAT 
CAGGGNCGCC 
GCCGTGGTTC 
CCAGCGGGGC 
CTAATAACAG 
GCTTATAGGA 
CAGAAAGCCC 
TGAGGGTGAG 
AGGTAAAGAA 
CTCAAGCAAG 
GGCTTGCTTG 
AGTGGAGTGA 
TCCTGGCCTA 
AGACGCCTCG 
GGCGGGAGGG 
ACGGGTTCCT 
GCTCGGTCAC 
GCCGCCCCGA 
CCTTACAGGA 
GTCCCCATCC 
CGCCCGCCCG 
CTCCGGGCTA 
ATCACCTTTG 
CAAGAAAAGG 
ACTTTAAAGA 
TGGTTGTATT 
CCAGCCCATA 
ACCTGAAATC 
Shaded region represents repeat sequences. The (CA)n repeat sequence is boxed. 
The poly(A) tract is underlined. 
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Appendix 4 Nucleotide sequence of pA-l 7D (3.848kb) 
1 AGCTTAGATGTGGTGCTGGGGCAGGGGAGAGTGGGCAAGGAGAGCCAGGTGTGCCCAGAGGGTGGCAGGC 
71 CAGGTTGTGTTCAGACTTGTACATCACTGACTAGGCTCTGTTTACAGACCAGTGTCCTCATCTGTACACC 
141 ACAGGAGCTGGGGTGGAGAAGGAGGATGGAGCCCATCCAAGAGGATGAGGGTGGGGTGGTGGTGGGGTTG 
211 GGGCCTATTCCAGAGAAGGTAATTATAGAAGCAGTTTACCTGGCTGACCAATGGAGCCCCTGAAAGSJ:St:.: 
281 GTAGAGTCAGCACCATACCAGGAAGCATTGGGAAGGGAGGTGGGGTGGGGTAGGAGAGTAAGATTTGAAC.\ 
351 ]Mif:@g@.§W#.!f.#.¢.i@g¢.¢.i@M#&Mtt@1@¢.W.#.¢¢4¢.f.~ Wr~ @V~@f:§jfi.¢.¢.fi.¢¢.ill#.M.i.W®Ntf cci'. 
421 AAAGAAACAAAGCAAAGCAAAACAAAAGCCAGGCTGGGAGTGTAGGCCAGCAACAATGTTCTTCAATAGC 
491 ACGCATGAGGCTCTGCTTGGTTCATCCCTAGGACAGCTCACATCCACTAAGTACTTGCCAAGTCCCACAG 
561 CATCCTAACCTTTTTACATCTATCTGTCAGTATACAGAGTTCTGTGCAACCCAGTATATTCTGAAGGCAA 
631 ACCATCAGCTTCAAATCCAGCCCCTACCACTTCCCAGCTGATGTGACTTTTTGTTCAATTTACTGTGTAN 
701 CTTAGAANCTCAGTTTTCTCCTCTGCAAAGTTGAGGTAACAAAGCACTAACACATGGGGCTGTGTGAGGA 
771 CCGAATGGAATCAGACTGCTTCCCTCAACTATGGAGTCTTATCAGAAGTCATCAGCTGGGTGTGGCACCT 
841 GGCATGATTCTCACACAGCCTAAAATTGGAAGCCCTGACCTCATTTTATAGATGAGAGCGAGTTGAGTTC 
911 TGAGAGTAAAGAGACTTGTCAAGTCATACGGCTAGAAACTTAACATGGCTGAGCCTTAACTCTGGGGTTT 
................ . .. . ............................................ .. .............. . .. . ..... 
981 AAAGTTTTTGAGCTCTTGCTCAGAAGTCTGGGAccAGAc±:&.d,kiX&.Wfud.&.:c±oo.t cAiWdiAXG.t tifilii±G:: 
.. AT ...... GAT .. . · .. .. · ... '.r-CW:I ... T ..... AGTGT:O.TT .... . GA.CA ...... M .. -~-. TG.G.A ... T-CO.W:A.GA:A ... OAT .... . 
1191 ATTCTTCTGAGTCTTAGGCAGGATGCTCTTTAGCTCCAAGCCAGCCTGGACTACAGAGCAAGGTCCTAAT) 
~!~~ ll llBllil li~llf~!!~~!! !~~,:!!~!!~~!!!!~f~!!~~!~:::: 
14 71 :iJi~~ GQAA®GwwwwG.r#~ G.~~~qgMAAGM·c·ciTciTcTAAT.GAAGGTGACATGGACACT 
15 41 .. G.CAAfr6±2HM!ili1hfriiic±m1HNfaW&iffii±i±Tfiliifa:fafafrfafaiTTAi lli±ifahfafrfrritTOO@rtiti&i@GhT.GG&: 
1611 \i±Git&A&i8i ij~@H9t:Mr.d±t.tTAGCO.¢T:~ 8roif68kd@AAE¥8.lci'ciitiad8.cif;&8¥.$4BSTc: 
~!~~ i911i~l-~iil\11!11;111,~••1111 
1891 }CA.GCTGCAGTGTACTCACATATGATAAATAAATAAATCTTTTAAAACAAGTCACATGCCGGGCA:T:G.GT:G(f 
19 61 /cooACAC<:HfahrAATC.CCAGCACTTGAGAGGCAGAG.GCAGG.CGMTT:TCTGAG.TTCAA008cAG8.M.M&rd 
2031 l~i.P~~Aqf~§.i#;fijg~§.!~$9#.q;.qqwlfiijA$.ijci.;ij:i~ii.i±.ijjij$.qw4~AAi~q~~N#.~il 
2101 : §~ GXA.f{~Q\:M!¢AAAAAA'AAAGTCACAGGCCAGAGAGAT TGCCGAGCAGAGCACCCACT GGT CTTCTAG 
21 71 AA CAA TGGTGcTcAAccAGTGciwc±aw¥.00Brmmciict&G1.@¥ckcc±mMai2i¥.cc&Afilticic1c 
~!~~ BIIIIIRIIBIUIIIIIRlilil&llllllillllird 
2381 \~Gb..q:;G.Alr®.w~~Q"1GCTTACAGTGGTTAGGCTCCAGTGGACTGGACACTCCCCAACCCCACTGTTGCC 
2 4 51 AcAcccTA GT ccTTTTcTc c±c&rc&r±Tc±±r±A±±±±c:T¥cfoo±±±±'fcii&#lci&i&&±r±c±&ifr~:1:::: 
2521 \i.G$:¢P-ik%.¥Mi%c.±c.*¥Y.&f:8Mfi.Mi&f281B8tdd.2iHBit88.¥:b8.B.8.k2H&.9h{fo:iA2.ii±R~d.¥B¥.G.t&\ 
2591 {fuc fo: CAAGCATATTTATTTGTATGTATGTAGGTATGCAGAGGACAACTGGGAGTCAGCTTGTTTTCCAAC 
2661 TTGTTGAGGTGGGTGGGGTCTCTTACTGTTGCTACACTGTGTAATCCAGGCTAGTTTGTTGACAAGCCTC 
2731 TGTAGTACATCTCCCTATAGCAGTGCTCGATTACAGATTGTACCACCAAATTTAGCTTTTGCCTCGGTTT 
2801 GGGGGCTTGAACTCAGGTTGTCAGGTTTGTATGGCTAGTGTTTTAACAGGCCAAACCATCTCTGCAACCC 
2871 TGAAACTGGTACGTTAAACAAACTCTCACCATTCCAACTAACATGTAAGAACTAGGTACGTGAGCCAGGA 
2941 TATTAAAGGGGAAAGTACTTGCCTGACAGTGTGCGGCACTGGGTTCTACTCTCA@MA¢~¢.M#¢~¢f 
3011 \mGAAAc.Aii:&i&AAA!GAGAGAGAAc.AcA±±±±±±ifriA±b±1%Mi&±XCifa~c±Aoo.AGGAAfcid.d±fcif 
30 81 iicTAcAAc Tc TATATAAAAA TccTcii.6Arkddci66cicd66GtGtHf@bhcAtGtcrrT±idicccici6Att'.1Y 
~~~~ llli~flil@@llilli1~,--~•,1•• 
3291 / !M;AACCTCACAAGGCAGAAGAGTCCACAGCTAATTAAGATGCCCAAAGTCAAAGCTCAGCTCTTCCAAC 
3361 CCTAGAGCTGGAGCAGGACTCTATACAATCACTCTTTGGCTCACTTAAAATTCTTCAAGGAAAATCAGGA 
3431 CACTTCCCAGGACAAAGATCAGTACTTCTCTCTAACCCATCTCTCTCCTGCTCAGCTCT GTCCCATCCCT 
3501 CACTTCCACTGCAAGGCTCCACACCTCCAGGCCTCCTGTCTTCGTTCTAGACTTCAGTTCCTTCCATGCT 
3571 AGTCATTTATACTANCAGTTCTACAGTGGAAACTGCTACCCCTCAGTCTCCTGACCTCTGTATCTCTGTA 
3641 . T.T+AACTCGTTGGTTACTTGGGTCTTGcTcccAcAcAcTTccTcTATAAG.ocib±&r±±&f£.H¥.±±±cT 
3711 ?ttAM~i$.f9:fJHft:t2.2,fdm&£~q$.$ft.i'P.~G1.A.f.q<%¢.A¢iPAcTAGAGGGTGTCGAGGGCAGiGGAC 
3781 AGCTTGCACAGTCAGTTCTCTC CTGTTACT AGATGGCTCTAGGAGGCTAAACTCAGGTCACCAAGCTT 
Shaded regions represent repeat sequences. Poly(A) tracts are underlined. 
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Appendix 5 Nucleotide sequence of pA-27BD (-2.6kb) 
AAGCTTTTGG GGCTGAAAAG ATGGCTCAAG CTACATCCCT AATACTTATG TAAAAGTCAG 
GAGGCATGNT AGTGCTTATA TGGAACACCA GCTTGGGAAG GTGGGGATCC AAACAGATGA 
ATCTCCAGCT CACTCCTCAC TGGCTGGCTC CTCAGTGTAG TGAATGAGAA AGATCCAGGC 
TCAGAGAGAG CAGCCACTGT CAGAGAGAGA GAGAATGAGG GAGGGAGGGA GGGAGGGAGG 
GAGGGAGGGA GGGAGGGAGG GAGGGGGGAG GGAGAGAGAA AGAGAGAGAG AGAGAGATCC 
AGTGTGTACT TGTGCTCGCA TGAGTGTGCG CAT;:i:ACACA CACACACACA CACACACACA 
CACACACACA CACAC~GGT TTTTCACTGC TCCAGTGTGC AGTCTCCATA GCAAAGTTTT 
CCAAGTTCCA GATTGCCATT TGTGCAGCAG GTGTGAGGGG CCACAGCTGG GTGAGCGTCT 
CCTTGACCTG CTTGTTCATG CAGGGCTTGG GACCTGTGGG TTTACTTACA TAGAGACTGA 
CCACAGTGTC AGTCCGATGG TGACCAAGTC CTTGAAGCTA GCATGCAGTG TGAACAGGGC 
TATGCACAAT GAACCTGACT GCAAATGCAA ATCCTAATAC TTAACTAGAC CTGAAACCTC 
TTCATTCACA 
CCGGAGAGAG AGAGGCACAG GGaGGCGCAT TGGGGGCTAG CCTCAGCTAC ACGAAGAGTT 
GGAAGCCAAC CTAGACTACA TAAGAGTGTC TCGAAGAAGA AGAAGAAGAA GA 
CATCCACCTC TCTGTCAGCA GGAAGCCCAG AGAAGGAGCT GAGAGGGGGC CTGAGGTATT 
GGGTTGGCAG AAACAGGTTA CTGAGAGGAT CTGGTGGGGG AGATGAGGAA GCCAGGTGGG 
GAAAGAGAGA AAGTCACCAC AGATGTGAGA AAGAGAGGCA TCCTGGAGAG CAACAGGGTA 
AGAGCTGAGG GGACTTTGTG AGGTAGGTGG CACTTGGCCT GAAGGACCTC ATAGGGCTTG 
TGGGATGGCT CAGCAATTGA GAGCACTTGT CCTTCCAGAA AACCCAGGTT CACTTGGTGG 
CACTACCTGG TAACTCCAGT GTCTGATGCT TTCTTCACAT CTGTAAGCAC CAAGCACTCA 
CCTGGTGCAC ATACCTGTGG AATATGCACA CTCACAAACA GACGGAGAGA I~~~I~~~I~ 
~~I~~~I~~~ I~~~I~~~I~ ~~I~~~I~~~ I~~~I~~~I~ ~~I~~~I~~~ I~~~I~~~I~ 
GATAGATAGA TAGATAGATA GATAGATAGA TAGATAAGAG TCAGGCAGTG GCAGCTCACA 
CTAATGCCAG CATTAGGGAG GCAGAAGCAG GTGGATCTCT GAGTTCAAGG CTAGCCTGGT 
TTACAGAGGG AGTTCCAGGA CACCCAGGTA TATACAGAGA AACCCTGGAG AGAGAGAGAG 
AGAGAGAGAG AGAGAAGGAG AAGAAGGAGG AGGAGGAGGA GGAGAAGGAG AAGAAGAAGA 
AGAAGAAGAA GAAGAAGAAG AAGAAGAAGA AGAAGAAGAA GAAGAAGAAG AAGAGAGAGA 
AAAAAGAAAA GAATGGGCCC CATATCGTGT TGTGCTTGGC AAAGTCCATG CTTATCTGAG 
AATATCCTCA GGTAGAGAAT TTCAGGTACA CATGAGTCCC CAGACCTTTT GCTGACAA 
CTCTCTCTCT 
CTCTCTCTCT CTCTCTCTCT CTCTCTCTCT CTCTCACACA CACACACACA CACACACACA 
CTCCTCCAAG CT 
Shaded region represents repeat sequences. The (CT)n(CA)n repeats have been 
boxed and imperfect tandem repeats (GAAG)n(GA)n and (TAGA)n(TAGG)n are 
heavily underlined. The imperfect poly(A) tract [(T An)Jy in the repeat sequence is 
lightly underlined. The gap between the two blocks of sequences represent -400bp 
of unsequenced DNA. 
,, 
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Appendix 6 The nucleotide sequence of pA-70 (2.815kb) 
lCAATCATAAT GAAGTGGCAC GACAGGTTCC CGACTGGAAA GCGGGCAAGT GACCGAACGC 
61 AAATTAATGT GAGTAGCTCA CTCATTAGGC ACCCCAGGCT TTACACTTTA TGCTTCCGGC 
121 TCGTATGTTG TGTGGAATTG TGAGCGGATA ACAATTTCAC ACAGGAAACA GCTATGACCA 
181 TGATTACGCC AAGCTATTTA GGTGACACTA TAGAATACTC AAGCTATGCA TCCAACGCGT 
241TGGGAGCTCT CCGGATCd~i iii~ii~i] ~iHEi6~60~bii~i~0i~iiiib61 
;m11111111f11 111~111;1;111111111111111111 1111111 
481 }$¢.P.!t.G.$-G.QQJ\]ACTGAAAGAC CCCTTCATAA GGCTTAGCCA GCTACCTGCA GTAACGCCAT 
541 TTTGCAAGGC ATGGGAAAAT ACCAGAGCTG ATGTCCTCAG AAAAACAAGA ACAAGGAAGT 
601 ACAGAGAGGC TGGAAAGTAC CGGGACTAGG GCCAAACAGG ATATCTGTGG TCAAGCACTA 
661 GGGCCCCGGC CCAGGGCCAA GAACAGATGG TCCCCAGAAA TAGCTAAAAC AACAACAGTT 
721 TCAAGAGACC CAGAAACTGT CTCAAGGTTC CCCAGATGAC CGGGGATCAA CCCCAAGCCT 
781 CATTTAAACT AACCAATCAG CTCGCTTCTC GCTTCTGTAC CCGCGCTTAT TGCTGCCCAG 
841 STCTATAAAA AGGGTAAGAA CCCCACACTC GGCGCGCCAG TCCTCCGATA GACTGAGTCG 
901 :::CCGGGTACC CGTGTATCCA ATAAAGCCTT TTGCTGTTGC ATCCGAATCG TGGTCTCGCT 
961 3AACCTTGGG AGGGTCTCCT TCAGAGTGAT TGACTGCCCC AACCTGGGGT CTTTCAT TG 
1021 GGGCTCGTCC GGAATTTGAA AACCCCCGCC CAGGGACCAC CGACCCACCG TCGGGAGGTA 
1081 AGCTGGCCAG CGATCGTTTT GTCTCCGTCT CTGTCTTTGT GCGTGTGTGT GTGTGTGCCG 
1141 GCATCTACTT TTTGCGCCTG CGTCTGATTC TGTACTAGTT AGCTAACTAG ATCTGTATCT 
1201 GGCGNCTCCG TGGAAGAACT GACGAGTCCG TATTCCCGAC CGCAGCCCTG GGAGACGTCT 
12 61 CAAGAGGCAT CGGGGGCCCC GCTGGGTGGC CCAATCAAGT AAAGTCCGAG TCCTGACCGA 
1321 TTCGGACTAT TTGGGGCCCC TCCTTTGTCG GAGGGGTACG TGGTTCTTTT AGGAGACGAG 
1381 AGGTCCAAGC CCTCGCCGCC TCCATCTGAA TTTTTGCTTT CGGTTTTTCG CCGAAACCGC 
1441 GCCGCGCGTC TTGTCTGTCT CAGTATTGTT TTGTCATTTG TCTGTTCGTT ATTGTTTTGG 
1501 ACCGCTTCTA AAAACATGGG ACATACCGTT ACCACCCCTC TGAGTCTGAC CCTAGAACAC 
1561 TGGGAAGATG TCCAGCGCAT CGCGTCCAAT CAGTCCGTAG ATGTCAAGAA GAGACGCTGG 
1621 GTCACCTTCT GCTCTGCCGA GTGGCCAACT TTCGGTGTAG GGTGGCCACA AGATGGTACT 
1681 TTTAATTTGG ACATTATTCT ACAGGTTAAA TCTAAGGTGT TCTCTCCTGG TCCCCACGGA 
1741 CACCCGGATC AGGTCCCATA TATTGTCACC TGGGAGGCTA TTGCCTATGA ACCCCCTCCG 
1801 TGGGTCAAAC CTTTTGTCTC TCCCAAACTC TCCCCCTCTC CAACCGCTCC CATCCTCCCA 
1861 TCCGGTCCTT CGACCCAACC TCCGCCCCGA TCTGCCCTTT ACCCTGCTCT TACCCCCTCT 
1921 ATAAAACCCA GACCTTCTAA ACCTCAGGTT CTCTCCGATA ATGGCGGACC TCTCATTGAC 
1981 CTTCTCTCAG AAGACCCTCC GCCGTACGGA GGACAGGGAC TGTCCTCCTC TGACGGAGAT 
2041 GGCGACAGAG AAGAGGCCAC CTCCACTTCT GAGATTGCTG CCCCCTCTCC CATAGTGTCT 
2101 CGCCTGCGGG GCAAAAGAGA CCCCCCCGCG GCAGATTCCA CCACCTCTCG GGCTTTCACA 
2161 CTCCGTTTGG GGGGTAATGG TGAGTTGCAG TACTGGCCGT TTTCCTCCTC TGATCTATAT 
2221 AACTGGAAAA ATAATAATCC TTCCTTCTCT GAGGAACCAC AGGTAAACTG ACTGCATTGA 
2281 TTGAATCCGT CCTCACCACC CACCAGCCCA CCTGGGATGA TTGCCAGCAA TTATTAGGGA 
2341 CTCTGCTTAC CGGGGAGGAG AAGCAGCGGT TGCTCCTGGA AGCCCGAAAG GCTGTCCGGG 
2401 GCAACGATGG GCGCCCCACC CAACTGCCCA ACGAGGTTGA CGCTGCTTTT CCCCTTGAAC 
2461 GTCCCGATTG GGATTACACC ACCCAAAGAG GTAGGAACCA CCTAGTTCTC TATCGCCAGT 
2521 TGCTTTTAGC AGGTCTCCAA AATGCGGGCC GAAGCCCCAC CAATTTGGCC AAGGTAAAAG 
2581 GAATAACCCA GGGACCTAAT GAGTCCCCCT CAGCCTTCCT AGAGAGACTC AAGGGGAAAC 
2641 CTATCGCAGA TACACTCCTT ATGATCCTGA GGACCCTGGG CAAGAAACGA ATGTATCTAT 
2701 GTCATTCATC TGGCAGTCCG CTCCAGACAT TGGTCGAAAG TTAGAGCGGT TAGAAGACTT 
2761 AAAAAGTAAA ACTTTAGGAG ATTTAGTGAG AGAAGCCGAA AGGATCTTTG AGAT 
Shaded region represents genomic DNA sequence and boxed region represents the 
LTR. Partial sequence of the viral gag gene follows. 
1 1 1 
Appendix 7 Nucleotide sequence of flanking genomic DNA in pA-7G and the 
corresponding amino acid sequences (single letter code) translated in six frames. 
a) 5' to 3' (plus strand) 
10 20 30 40 50 60 70 
5' * * * * * * * 
AAGCTTTTCCTCCTCCTCCTCCTC'ITCCTCCTCCTCCTCCTCTTGTCTCCTCTTCTGTCTCCTCTTCC'IT 
F S S S S S S S S S S S S C L L F C L L F L> 
K L F L L L L L F L L L L L L S P L L S P L P> 
A F P P P P P L P P P P P L V S S S V S S S F> 
80 90 100 110 120 130 140 
* * * * * * * 
CTCCTCCTCTTCCTCCTC'ITGCTCCTCCT'ITCCCTCCTCC'ITCTTTATTCCAAACAGGI'TGGGNCTATGC 
L L L F L L L L L L S L L L L Y S K Q V G X M> 
S P P L P P L A P P F P P P S L F Q T G W X Y A> 
S S S S S S C S S F P S S F F I P N R L G L C> 
150 
* 
160 
* 
170 180 
* * 
190 200 210 
* * * 
TG'ITCAGGCTGGC'ITAGGACTCACTATGTAGCCCACGCTAGACTTGAATCTGCTATGAACCTTCTGCCTC 
L F R L A * D S L C S P R * T * I C Y E P S A S> 
V Q A G L G L T M * P T L D L N L L * T F C L> 
C S G W L R T H Y V A H A R L E S A M N L L P> 
220 230 240 250 
* * * * 
AGCTTCTCCTGCCCACTCCCTACTGAAAGACCCCTTCATAAGG 3' 
A S P A H S L L K D P F I R> 
S F S C P L P T E R P L H K E> 
Q L L L P T P Y * K T P S * G> 
b) 5' to 3' (minus strand) 
10 20 30 40 50 60 70 
5' * * * * * * * 
CC'ITATGAAGGGGTCTTTCAGTAGGGAGTGGGCAGGAGAAGCTGAGGCAGAAGGTTCATAGCAGATTCAA 
L W R G L S V G S G Q E K L R Q K V H S R F K> 
L M K G S F S R E W A G E A E A E G S * Q I ~ 
P Y E G V F Q * G V G R R S W G R R F I A D S> 
80 90 100 110 120 130 140 
* * * * * * * 
GTCTAGCGTGGGCTACATAGTGAGTCCTAAGCCAGCCTGAACAGCATAGNCCCAACCTGTTTGGAATAAA 
s s V G y I V s p K p A w T A * X Q p V w N K> 
V * R G L H s E s * A s L N s I X p T C L E *> 
s L A w A T * w V L s Q p E Q H X p N L F G I K> 
150 160 170 180 190 200 210 
* * * * * * * 
GAAGGAGGAGGGAAAGGAGGAGCAAGAGGAGGAAGAGGAGGAGAAGGAAGAGGAGACAGAAGAGGAGACA 
E G G G K G G A R G G R G G E G R G D R R G D> 
R R R R E R R S K R R K R R R R K R R Q K R R Q> 
K E E G K E E Q E E E E E E K E E E T E E E T> 
220 230 240 250 
* * * * 
AGAGGAGGAGGAGGAGGAAGAGGAGGAGGAGGAGGAAAAGCTT 3' 
K R R R R R K R R R R R K S F> 
E E E E E E E E E E E E K L> 
R G G G G G R G G G G G K A X> 
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